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Abstract 
 
 Pathways for the biosynthesis of docosahexaenoic acid (DHA) and other 
polyunsaturated fatty acids (PUFA) were elucidated in two heterotrophic, marine 
microalgae; Schizochytrium sp. and Crypthecodinium cohnii.  PUFA-requiring 
auxotrophs of both of these algae were created and used as tools for studying PUFA 
biosynthetic pathways.  Additionally, equilibrium radio-labeling techniques were 
applied to algal cultures fed 14C-fatty acids.  Both organisms were found to possess 
two distinct pathways for PUFA biosynthesis.  One pathway, mediated by classical 
elongases and desaturases, was incomplete in both organisms and was not capable of 
complementing PUFA auxotrophic phenotypes or of producing PUFA de novo, but 
could produce DHA from simpler PUFA precursors.  The second PUFA pathway in 
each organism was desaturase and elongase independent.  In C. cohnii, this pathway 
was distinguished by a capacity to produce DHA from acetate, in a manner similar to 
that of Schizochytrium which was shown to employ a polyketide synthase (PKS) 
complex for primary DHA biosynthesis.  Additionally, genes of the Schizochytrium 
PUFA-PKS were successfully expressed in transgenic yeast, which produced DHA.  
Candidates for genes encoding C. cohnii PUFA-PKS components and other genes of 
C. cohnii PUFA biosynthesis were identified and discussed.  
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Chapter 1 - Polyunsaturated Fatty Acids and Microalgae 
 
Chapter 1 General Introduction 
 
 Fatty acids are an important class of compounds characterized by a 
hydrocarbon chain and a single carboxyl group.  Technically speaking, acetic acid is 
the simplest fatty acid; however, the term is generally applied to molecules with four 
or more carbons.  Fatty acids have three major roles.  They constitute the building 
blocks of cell membranes, modulating cell membrane fluidity.  Secondly, fatty acids 
in neutral or non-polar lipids serve as reservoirs of carbon and energy.  Lastly, some 
fatty acids and their derivatives act as signaling molecules with various effects and 
functions.   
 Fatty acid biosynthesis is generally well understood.  Fatty acids are formed 
by a collection of activities harbored in fatty acid synthase (FAS).  While the basic 
biochemical mechanism of saturated fatty acid (SFA) biosynthesis is essentially the 
same among all living things, the localization, organization of enzyme domains, and 
specific substrates, and products of fatty acid synthases may vary.  Fatty acid 
synthases must perform five or six distinct reactions involving nine or ten proteins or 
protein domains, most of which must be used multiple times in an iterative manner to 
make a single fatty acid.  In some bacteria (and the plastids of plants, algae, and some 
protozoans) FAS is multimeric; each domain is found on a separate polypeptide that 
non-covalently assemble into a large complex but which dissociate upon cell rupture 
(complicating in vitro analysis).  In the cytosol of fungi, metazoans, and certain other 
bacteria, FAS domains are usually found as fusions, such that the entire FAS complex 
may only be composed of two or three unique polypeptides or even a single large one.  
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Multi-domain FAS complexes are referred to as “type I” whereas the multimeric 
FASs are “type II” (Wakil et al., 1983). 
 The first committed step of fatty acid biosynthesis involves the carboxylation 
of acetyl-CoA to yield malonyl-CoA.  The formation of malonyl-CoA is catalyzed by 
acetyl-CoA carboxylase (ACC), which in most eukaryotes is activated by an allosteric 
interaction with citrate and suppressed by the products of FAS, usually an ester of 
palmitate.  Malonyl-CoA acyltransferase (MAT) covalently attaches malonyl-CoA to 
the phosphopantetheine moiety of acyl carrier protein (ACP); both of these domains 
are part of the FAS complex.  In some systems, an acetyltransferase (AT) domain 
prepares an acetyl thioester of ketoacyl synthase (KS).  KS is often referred to as the 
condensing enzyme because it performs the Claisen condensation reaction in which 
the acetate is ligated to the end of the malonate at the expense of a released carbon 
dioxide molecule.  The resulting 1,3-diketobutyl ACP-thioester is then subjected to 
ketoreduction (by ketoacyl reductase, KR) dehydration (dehydratase, DH) and another 
reduction (enoyl reductase, ER) before the 4-carbon acyl thioester is translocated from 
ACP back to KS.  The ACP domain then receives another malonyl-CoA from MAT.  
The butyl group from KS is ligated to the ACP-malonate thioester and the process is 
repeated until a fatty acid of typically 14, 16, or 18 carbons is formed.  Termination of 
fatty acid biosynthesis is dependent upon detection of a nascent acyl-ester length.  The 
mechanism by which this length is detected is different among different FAS 
complexes, but instead of transferring back to KS, the acyl chain is liberated from 
FAS by a thioesterase or a lipid acyltransferase (depending on the organism) (Stryer, 
1995).  Once removed from the FAS, saturated acyl chains may be channeled to any 
of a number of paths.  They may become esterified to coenzyme A (CoA) or the 
glycerol backbone of a membrane lipid, or to a triglyceride for storage in a lipid 
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droplet.  Alternately, a fatty acid (or an ester thereof) may be subjected to further 
modification (usually desaturation or elongation) or redirected to an organelle for 
catabolism via β-oxidation. 
 Saturated fatty acids are converted to unsaturated fatty acids by desaturases in 
most organisms.  Desaturase enzymes are typically very regio-specific in that 
placement of double bonds is tightly controlled.  This regio-specificity is relative to 
the acyl chain itself, or other desaturations within the chain (for review see: 
Behrouzian and Buist, 2003).  Because of this, multiple desaturations must be 
introduced sequentially.  One of the most common unsaturated fatty acids is oleic 
acid, which is formed by the desaturation of stearic acid (see Supplement Table 1.1 
and Supplement Figure 1.1 for fatty acid nomenclature).  Most desaturases are 
embedded in the endoplasmic reticulum and are specific for acyl lipids or acyl-CoAs.  
However, plants and some algae have two Δ9 desaturases, both for the formation of 
oleic acid.  The Δ9 desaturase of plant and algal ER membranes is most similar to the 
Δ9 desaturase found in non-photosynthetic organisms, but plant and algal plastids 
additionally contain a soluble Δ9-acyl-ACP desaturase.  Whether membrane-bound or 
soluble, the catalytic di-iron cores of all known desaturases are oxygen-dependent 
(Huang et al., 2004).  As an exception, some anaerobic bacteria possess a system for 
producing monounsaturated fatty acids that is not mediated by a classical, oxygen-
dependent desaturase. 
 The facultative anaerobe, Escherichia coli, has two dehydratases, FabA and 
FabZ, which can function interchangeably in the type II FAS to create trans-Δ2-acyl 
intermediates.  At this position, the trans double bond is usually reduced immediately 
by the enoyl reductase FabI, to form the saturated acyl chain.  However, FabA also 
possesses a trans-Δ2 to cis-Δ3 isomerase activity that is specific for acyl-ACP 
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thioesters of 10 carbons.  E. coli is unable to perform the enoyl reduction of a cis 
double bond at this position, so it is retained, and the fatty acid chain is further 
elongated to yield 14:1 n7, 16:1 n7, or 18:1 n7 (Rock et al., 1996).   
 In most other organisms, polyunsaturated fatty acids (PUFA) are formed from 
monounsaturated substrates by further desaturation (Figure 1.1).  Oleic acid may be 
again desaturated at the Δ12 position to form linoleic acid.  While this reaction is 
common in plants and algae and fungi, it is not found in humans.  Because humans 
(and other mammals) lack functional Δ12 and Δ15 desaturases, we also lack the 
ability to synthesize PUFA de novo and must obtain essential fatty acids like linoleic 
acid or more complex PUFAs through diet (Arab, 2003).  Linoleic acid is the first 
fatty acid in the “omega-6” biosynthetic pathway shown in Figure 1.1.  The first fatty 
acid of the “omega-3” pathway is α-linolenic acid, which is derived from linoleic acid 
after modification by a Δ15 desaturase.  In most organisms, these two fatty acids are 
desaturated at the Δ6-position before being elongated into 20-carbon PUFAs or 
“eicosanoids”. 
 In humans and other mammals, 20-carbon fatty acids are used as precursors to 
a number of effector molecules generally classified as prostaglandins and 
leukotrienes.  Prostaglandins are formed chiefly through the oxidation of PUFA by 
cyclooxygenase, which creates the basic prostanoic acid core structure of all 
prostaglandins.  In humans, the prostaglandins are divided into three main groups or 
“series” depending on the PUFA from which they are derived.  Series 1 
prostaglandins are derived from homo-γ-linolenic acid (HGLA), series 2 from 
arachidonic acid (ARA), and series 3 from eicosapentaenoic acid (EPA).  
Prostaglandins of each series have various effects on inflammation, blood 
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Figure 1.1 (continued).  Composite of demonstrated and hypothetical desaturase and elongase pathways.  Excluding stearic acid (18:0) and oleic acid (18:1), 
all n-3 desaturated fatty acids are grouped on the right and all n-6 fatty acids on the left.  “EL” - indicates Elongase, “∆(number)” - indicates a desaturation 
step at the indicated carbon, as numbered from the carboxyl function.  In all known systems, each intermediate fatty acid is thought to be released from a 
given desaturase or elongase before it becomes available to the next enzyme of the pathway.  Most known desaturase/elongase mediated pathways (standard 
pathways) use some subset of the activities shown.  For review of ∆5, ∆6, ∆9, ∆12, ∆15 (also called “ω-3”) desaturation as well as ∆6 elongation and ∆5 
elongation, see Wallis et al. (2002).  ∆4 desaturation is described by Qui et al. (2001) and ∆8 desaturation has been described by Arao and Yamada (1994) 
and Sperling et al., (1998).  ∆7 and ∆19 desaturations are hypothetical. 
  7
vessel constriction, and blood clotting (for review see: Calder, 2001) although the 
series 2 prostaglandins are the most common and well characterized.  It is thought that 
series 2 prostaglandin synthesis is promoted by cellular damage and the action of 
phospholipase A2, which liberates ARA and other free fatty acids from membrane 
lipids (Funk, 2001).  All of the non-steroidal anti-inflammatory drugs (NSAIDs) such 
as ibuprofen, acetominophen, aspirin, rofecoxib (Vioxx®), and celecoxib (Celebrex®) 
inhibit the oxidation of PUFA by cyclooxygenase (Cryer and Feldman, 1998). 
PUFAs are also the precursors of the leukotrienes, which are formed by the 
action of lipoxygenase and by non-enzymatic auto-oxidation.  Most leukotrienes are 
simply labile, hydroxylated PUFAs.  However, ARA-derived leukotrienes are thought 
to have important roles in rapid physiological responses like bronchiole contraction, 
superoxide production, chemotaxis, and asthma (Samuelsson, 1983).  The activities 
and functions of leukotrienes derived from linoleic acid, linolenic acid, HGLA, mead 
acid, and EPA are less clear.  Commercial sources of ARA are most commonly 
produced from the biomass of the oleaginous, filamentous fungus Mortierella alpina 
(Stredanska and Sajbidor, 1992). 
Further progress into the PUFA biosynthetic pathway is achieved by 
elongation of EPA or ARA.  In some systems, this elongase is specific for fatty acids 
with a cis-Δ5 desaturation, like ARA and EPA.  The products of these reactions 
(adrenic acid (22:4 n-6) and clupanodonic acid (22:5 n-3)) are further reduced by a Δ4 
desaturase to yield DPA n-6 or DHA.  Both Δ4 desaturases and Δ5 elongases were 
hypothetical until their discovery in the marine algae Thraustochytrium (Qiu et al., 
2001) and Ostreococcus tauri (Meyer et al., 2004) respectively.  In humans, the 
pathway from EPA to DHA is more complex.  Some mammals, including humans and 
rats, do not possess a Δ4 desaturase.  In these organisms EPA is instead elongated 
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twice successively to 24:5 n-3, desaturated at the Δ6 position, and then transported to 
peroxisomes where two carbons are removed by β-oxidation to yield DHA (Sprecher 
and Luthria, 1995).  This meandering pathway was elucidated primarily in studies on 
mouse models of Zellweger’s syndrome, a rare disorder of peroxisome formation.  
Later studies in humans demonstrated that the syndrome can be partially alleviated by 
DHA supplementation, depending on the severity of the case (Martinez et al., 2000). 
 Like EPA and ARA, DHA also appears to mediate some effects on immune 
function (anti-inflammation) (Kelley et al., 1999).  Recent studies have shown that 
these effects can be mediated by leukotriene-like DHA derivatives which, as a class, 
have come to be called resolvins and protectins (for reviews see Serhan et al., 2004 
and Das, 2006).  In addition to its roles in Zellweger’s syndrome and immune 
function, DHA conveys several other direct and better studied benefits.  It may be best 
known as a major structural component of grey matter and retinal lipids.  The statistic 
that brain tissue is composed of 60% lipid, 25% of which is DHA, is often quoted 
(Martinez, 1992).  Another study found that the lipid fraction of human cerebral 
cortex is approximately 9% ARA and 13% DHA (Carver et al., 2001).  DHA is also 
relatively abundant in human breast milk, presumably to aid in the development of 
neonatal nervous tissue.  Formula-fed infants have long been known to suffer more 
immunological problems and to perform less well on visual and cognitive tests than 
breast-fed infants (for review see: Anderson et al., 1999).  Collectively, these 
observations have led infant formula manufacturers to supplement their products with 
DHA and ARA.  Predictably, follow-up studies demonstrated that term and pre-term 
infants fed these DHA and ARA fortified formulas lost many of the known cognitive 
and immune deficits associated with unsupplemented formulas (Birch et al., 2000 and 
Field et al., 2000). 
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 DHA depletion has been correlated with some adult neurological disorders 
including depression (primarily postpartum and alcoholism-induced) and Alzheimer’s 
disease (for review see: McNamara and Carlson, 2006).  Conversely, supplementation 
with DHA appears to alleviate the symptoms of these disorders to some degree.  
Specifically, a recent study using an Alzheimer’s mouse model revealed that DHA-
fed mice performed better on memory tests than a syngeneic cohort of omega-3 fatty 
acid-starved mice (Calon et al., 2004).  DHA is thought to facilitate the repair or 
preservation of synapses in Alzheimer’s afflicted brains. 
 Lastly, EPA and DHA supplementation appear to reduce the risk factors 
associated with coronary heart disease (von Schacky et al., 2003).  In a recent USDA-
ARS study, volunteers taking DHA supplements lowered their triglycerides and 
elevated their high density lipoprotein (HDL) levels, relative to a negative control 
group (Nelson et al., 1997).  The mechanism behind this particular effect is a subject 
of strong interest and investigation. 
 The overall importance of long chain polyunsaturated fatty acids (LCPUFA) 
and in particular ARA, EPA and DHA, is undisputed.  Humans can only obtain these 
fatty acids from the diet or by synthesis from dietary precursors (Tinoco, 1982).  
Primary dietary sources of DHA and other LCPUFA include animal organ meats and 
fatty fish, both of which are generally unpopular in western cuisine.  Many studies 
have mentioned that populations with diets rich in fish have traditionally lower rates 
of the diseases and disorders described above (Khor, 2004).  However, fish are not the 
ultimate sources of LCPUFA in the food chain as they acquire it from other animals 
which first acquire it from marine microalgae (Henderson, 1996). 
 Fish oils may be the most common commercially available source of purified 
DHA triglyceride.  However, alternative algal sources of DHA have been recently 
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developed.  Two single-celled organisms in particular, Schizochytrium sp. and 
Crypthecodinium cohnii have been commercially grown in large-scale fermentors to 
make biomass consisting of as much as 20-30% DHA by dry weight.  The DHA from 
these microalgae is mostly triglyceride-associated and extracted from the biomass 
using procedures similar to those developed for vegetable oil processing (Apt and 
Behrens, 1999).  The ability to produce these oils via controlled fermentation 
processes gives PUFA-producing, single-celled organisms (as opposed to fish or other 
animals) a certain advantage in some applications.  The majority of fish oil comes 
from wild-harvested stocks (menhaden, salmon, tuna, and others) which suffer from a 
variety of environmental pollutants including mercury and PCBs (Olsen, 2001).  Also, 
oil extracted from wild harvests is initially more oxidized than fermentation-derived 
sources of oil, often lending these oils a “fishy” odor and taste if not rigorously 
deodorized.  For these reasons, strict quality assurance is difficult and therefore many 
fish oils are unsuitable for applications where sensory factors or precise knowledge of 
oil production conditions is critical.  The oil from C. cohnii is the primary source of 
DHA for infant formulas, although DHA from chicken egg phospholipids has also 
been used (Ratledge et al., 2001).  Schizochytrium biomass is used in animal feeds for 
production of DHA-enriched eggs and shrimp.  Oil from both microalgae is also sold 
in capsules to compete with capsules of fish oil supplements.  Unfortunately, PUFA-
containing oils from microalgae are also more expensive than most other sources of 
PUFAs.  Therefore, a considerable amount of effort has been placed on identifying 
the genes involved in PUFA biosynthesis with the intent of expressing these genes in 
more economically productive transgenic hosts.   
 Many marine organisms produce PUFAs, especially DHA and EPA.  In most 
documented examples, PUFAs are synthesized by desaturases and elongases from 
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fully saturated products of an endogenous fatty acid synthase.  However, in 1996, 
Kazunaga Yazawa reported the discovery of a novel gene cluster in the marine 
bacterium Shewanella.  The cluster encoded a complex that produced EPA, as 
opposed to saturated fatty acids produced by most FASs or the monounsaturated fatty 
acids produced by other known enteric bacterial FAS systems (Metz et al., 2001).  
Later, Morita et al. (2000) discovered a similar cluster in the DHA-producing 
bacterium, Moritella marina MP-1 (formerly Vibrio marinus).  Taken together, the 
deduced protein sequences of the gene clusters from both of these PUFA-producing 
marine bacteria resembled polyketide synthases more than fatty acid synthase. 
 The core catalytic mechanisms of fatty acid biosynthesis are also used in the 
synthesis of polyketide antibiotics and similar secondary metabolites.  Polyketides are 
a general class of molecules typified by multiple oxygen functions decorating the 
length of an acyl chain.  Polyketides are produced by enzyme systems where one or 
more of the reduction or dehydration steps of fatty acyl chain synthesis are omitted, 
resulting in acyl chains with multiple carbonyls, hydroxyls and unsaturations (for 
review see Hopwood, 1997).  In many cases, polyketide synthase (PKS) systems 
employ the use of different substrates besides malonate and acetate or possess 
additional enzymatic domains for isomerization, cyclization, or ether formation.  In 
the instance of these marine bacterial PUFA-PKS systems, the only significant 
difference from canonical saturated fatty acid biosynthesis is thought to be a regular 
alternation of an enoyl reduction step with a trans-cis double bond isomerization 
(Figure 1.2) in a process reminiscent of FabA-mediated, monounsaturated fatty acid 
biosynthesis in E. coli. 
 Polyketide synthase (PKS) complexes are also similar to FAS systems in that 
they can be targeted to different organelles, and they may be composed of single- or 
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Figure 1.2 (continued).  One theoretical scheme for PKS-mediated biosynthesis of several key LCPUFAs (adapted from Ratledge, 2004 and Metz et al., 
2001).  (Left Panel)  In this model, three discrete reaction cycles are needed.  Cycle 1 (Red) depicts the standard condensation reaction resulting in a 2-carbon 
extension of the nascent acyl chain.  This reaction cycle is essentially the same in elongases and saturated FAS systems.  Cycle 2 (Blue) depicts the first set of 
reactions to generate a cis double bond in the elongated fatty acid.  This cycle could proceed through an α-β dehydratase (the “normal” dehydratase, typified 
by EC 4.2.1.61) and a Δ2,3-Δ3,4 trans to cis isomerase (Brock et al., 1967) or a β-γ dehydratase and a trans to cis isomerase that leaves the double bond in 
the Δ3 position (Jang et al., 2000).  Cycle 3 (Yellow) illustrates the second reaction cycle for cis double bond formation.  (Right Panel) Possible reaction 
intermediates in the synthesis of some fatty acids found in C. cohnii and Schizochytrium.  Each reaction cycle is correspondingly color coded.  When all three 
cycles are employed sequentially, omega-3 desaturated fatty acids are the destined products.  Omega-6 desaturated fatty acids may occur when the cycle 1 
enoyl reduction step is used twice initially.  KS - ketoacyl synthase, KR - ketoacyl reductase, DH - dehydratase, ER - enoyl reductase, ISO - isomerase.  Fatty 
acids highlighted in green are discussed further in following chapters. 
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multi-domain polypeptides (and are also type II or type I respectively).  Like saturated 
FAS systems, PUFA-PKSs are also oxygen-independent and may produce more than 
one fatty acid end-product simultaneously.  FAS and PKS systems also both require 
covalent attachment of a phosphopantetheine group to ACP, allowing the holo-ACP 
to hold acyl-thioester intermediates.  This phosphopantetheine attachment is usually 
performed by a 4’-phosphopantetheinyl transferase.  Lastly, neither FASs nor PUFA-
PKSs will accept intracellular fatty acids as precursors or intermediates (unlike the 
standard PUFA pathway desaturases and elongases), although a PKS from 
Mycobacterium and a FAS from Cryptosporidium represent exceptions to this 
observation (Sirakova, 2001, Zhu et al., 2004). 
 These newly discovered PUFA-PKS systems of Shewanella and Moritella 
clusters were not only among the first bacterial systems known to specifically produce 
EPA and DHA, but they were also the only systems ever shown to make PUFA by a 
desaturase and elongase-independent mechanism.  Some clues pointing to the 
evolution of this mechanism may be gleaned by considering their natural 
environment.  Shewanella was isolated from the intestines of Pacific mackerel and 
Moritella marina was isolated from a 1200 meter-deep water sample off the coast of 
Oregon (Kato et al., 1998).  Presumably, oxygen-independent mechanisms of 
biosynthesis may have a selective advantage over oxygen-dependent, desaturase-
based systems of unsaturated fatty acid biosynthesis in bacteria from oxygen-depleted 
environments, like the ocean depths or metazoan entera. 
 Not all LCPUFA-producing fauna are prokaryotes.  For instance, the 
eukaryotic protist Schizochytrium, which was originally isolated from a stirred, 
shallow, esturarine pool (Barclay, 1992), makes two PUFAs - DHA and DPA n-6 
(Hammond et al., 2001).  Later, Metz et al. (2001) reported the discovery of three 
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genes from a Schizochytrium Expressed Sequence Tag (EST) sequencing project that 
were strongly similar to genes of the Moritella and Shewanella PUFA-PKS clusters.  
The presence of these genes (designated simply ORFs A, B, and C) and the absence 
of any intermediate PUFAs in the Schizochytrium fatty acid profile led to the obvious 
assumption that this organism also used a PKS-like mechanism to make PUFA.  This 
study also found that after Schizochytrium cultures were incubated for 24 hours with 
radiolabeled 16:0 18:0 and 18:3, 96-98% of the radioactivity was recovered as the 
original fatty acid.  However, two desaturase genes similar to those involved in the 
traditional pathways of polyunsaturated fatty acid biosynthesis were identified from 
the same EST dataset in which the PUFA-PKS genes were originally found.  While 
the evidence supporting the identity of these Schizochytrium genes as a PUFA-PKS 
seemed certain, the role of these desaturases was unclear.  Later Hauvermale et al. 
(2006) functionally expressed the Schizochytrium ORFs in Escherichia coli (when 
accompanied by an accessory gene whose product was needed to convert a 
component of the PUFA-PKS to an apo-enzyme).  The E. coli transformants of this 
study were capable of making DHA and DPA in ratios similar to what was observed 
in fatty acid profiles of wild type Schizochytrium, verifying the role of the 
Schizochytrium PUFA-PKS genes.  The role of extant desaturases in Schizochytrium 
however, was not clarified any further. 
 The questions surrounding the mechanisms of PUFA biosynthesis in 
Crypthecodinium are even more numerous.  The earliest studies of C. cohnii fatty acid 
biosynthesis were performed by Beach et al. (1974) and Henderson and Mackinlay 
(1991), who employed in vivo equilibrium labeling techniques with 14C-labeled 
acetate and fatty acids.  They both found that short saturates or monounsaturates (like 
stearate or oleate) could be incorporated in cultures of C. cohnii, but they could not be 
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further modified to more complex fatty acids like DHA.  It is unclear what the 
mechanism of this selectivity could be.  However, it is possible that when fatty acids 
are supplied exogenously to C. cohnii they may not be able to form acyl-esters 
required as substrates for further desaturation and elongation to DHA.  Alternately, 
and perhaps more likely, C. cohnii may possess yet another eukaryotic PUFA-PKS 
system, similar in function to the one of Schizochytrium. 
 In this study, the activities of desaturase and elongase-mediated “classical 
pathways” of PUFA biosynthesis are fully characterized in Schizochytrium and C. 
cohnii.  Specifically, the necessity of the Schizochytrium PUFA-PKS to PUFA 
biosynthesis is compared to the organism’s classical pathway activities through 
equilibrium labeling experiments and the use of genetically targeted disruptions of the 
PUFA-PKS genes.  The classical pathway activities of several auxotrophs of C. 
cohnii, which require supplemented fatty acids to grow, are similarly studied with in 
vivo equilibrium labeling experiments.  Also, the suitability of the Schizochytrium 
PUFA-PKS genes for heterologous expression in another eukaryote is investigated.  
Lastly, several thousand Expressed Sequence Tags (ESTs) from C. cohnii are 
collected and analyzed as candidate PUFA-PKS genes. 
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Chapter 1 Statement of Aims 
 
 The primary aim of the following thesis is to reconcile the potential roles of 
desaturases and elongases in two marine microalgae with these organisms’s apparent 
ability to make PUFA de novo via desaturase and elongase-independent mechanisms.  
From this central goal, several other aims were conceived and articulated as follows: 
 
• To determine if the PUFA-PKS of Schizochytrium is the only system required to 
supply the organism’s need for PUFA. 
• To determine if microalgae such as Crypthecodinium cohnii and Schizochytrium 
have an absolute requirement for PUFA. 
• To fully characterize the extant desaturase and elongase activities of C. cohnii and 
Schizochytrium. 
• To identify and analyze genes that may encode a PUFA-PKS system in C. cohnii. 
• To investigate strategies enabling functional heterologous expression of the 
Schizochytrium PUFA-PKS in other model eukaryotes, for biotechnological 
applications. 
 
 The answers to these questions will permit rational speculation concerning the 
acquisition and evolution of PUFA-PKS systems in eukaryotes.  They may also help 
inform tactics for isolating additional eukaryotic microbes that possess these 
interesting and commercially important PUFA-PKS systems. 
 
  18
Chapter 1 References 
 
Anderson JW, Johnstone BM, Remley DT (1999) Breast-feeding and cognitive 
development: a meta-analysis.  Am J Clin Nutr 70:525-535 
 
Apt KE, Behrens PW (1999) Commercial Developments in Microalgal 
Biotechnology.  J Phycol 35:215 
 
Arao T, Yamada M (1994) Biosynthesis of Polyunsaturated Fatty Acids in the Marine 
Diatom, Phaeodactylum tricornutum.  Phytochemistry 35:1177-1181 
 
Barclay WR (1992) Process for the heterotrophic production of microbial products 
with high concentrations of omega-3 highly unsaturated fatty acids.  US Patent 
5,130,242 
 
Behrouzian B, Buist PH (2003) Mechanism of fatty acid desaturation: a bioorganic 
perspective.  Prostaglandins Leukot Essent Fatty Acids 68:107-112 
 
Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG (2000) A randomized 
controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and 
mental development in term infants.  Dev Med Child Neurol 42:174-181 
 
Brock DJ, Kass LR, Bloch K (1967) Beta-hydroxydecanoyl thioester dehydrase. II. 
Mode of action.  J Biol Chem 242:4432-40 
 
  19
Calder PC (2001) Polyunsaturated fatty acids, inflammation, and immunity.  Lipids 
36:1007-24 
 
Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, 
Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects 
from dendritic pathology in an Alzheimer's disease mouse model.  Neuron. 43:633-
645 
 
Carver JD, Benford VJ, Han B, Cantor AB (2001) The relationship between age and 
the fatty acid composition of cerebral cortex and erythrocytes in human subjects.  
Brain Res Bull 56:79-85 
 
Cryer B, Feldman M (1998) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of 
widely used nonsteroidal anti-inflammatory drugs.  Am J Med 104:413-421 
 
Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology.  
Biotechnol J 1:420-39 
 
Field CJ, Thomson CA, Van Aerde JE, Parrott A, Euler A, Lien E, Clandinin MT 
(2000) Lower proportion of CD45R0+ cells and deficient interleukin-10 production 
by formula-fed infants, compared with human-fed, is corrected with supplementation 
of long-chain polyunsaturated fatty acids.  J Pediatr Gastroenterol Nutr 31:291-9 
 
Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology.  
Science 294:1871-1875 
  20
 
Hammond BG, Mayhew DA, Holson JF, Nemec MD, Mast RW, Sander WJ (2001) 
Safety assessment of DHA-rich microalgae from Schizochytrium sp.  Regul Toxicol 
Pharmacol. 33:205-217 
 
Hauvermale A, Kuner J, Rosenzweig B, Guerra D, Diltz S Metz JG (2006) Fatty acid 
production in Schizochytrium sp.: involvement of a polyunsaturated fatty acid 
synthase 
and a type I fatty acid synthase.  Lipids 41:739-747 
 
Henderson RJ (1996) Fatty acid metabolism in freshwater fish with particular 
reference to polyunsaturated fatty acids.  Arch Tierernahr 49:5-22 
 
Hopwood DA (1997) Genetic contributions to understanding polyketide synthases.  
Chem Rev 97:2465-2498 
 
Huang YS, Pereira SL, Leonard AE (2004) Enzymes for transgenic biosynthesis of 
long-chain polyunsaturated fatty acids.  Biochimie 86:793-798 
 
Jang GF, McBee JK, Alekseev AM, Haeseleer F, Palczewski K (2000) Stereoisomeric 
specificity of the retinoid cycle in the vertebrate retina.  J Biol Chem 275:28128-38 
 
Kato C, Li L, Nogi Y, Nakamura Y, Tamaoka J, Horikoshi K (1998) Extremely 
barophilic bacteria isolated from the Mariana Trench, Challenger Deep, at a depth of 
11,000 Meters.  Appl Environ Microbiol 64:1510-1513 
  21
 
Kelley DS, Taylor PC, Nelson GJ, Schmidt PC, Ferretti A, Erickson KL, Yu R, 
Chandra RK, Mackey BE (1999) Docosahexaenoic acid ingestion inhibits natural 
killer cell activity and production of inflammatory mediators in young healthy men.  
Lipids 34:317-324 
 
Khor GL (2004) Dietary fat quality: a nutritional epidemiologist's view.  Asia Pac J 
Clin Nutr. 13:S22 
 
Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early human 
development.  J Pediatr 120:S129-S138 
 
Martinez M, Vazquez E, Garcia-Silva MT, Manzanares J, Bertran JM, Castello F, 
Mougan I (2000) Therapeutic effects of docosahexaenoic acid ethyl ester in patients 
with generalized peroxisomal disorders.  Am J Clin Nutr 71:S376-S385 
 
McNamara RK, Carlson SE. (2006) Role of omega-3 fatty acids in brain development 
and function: Potential implications for the pathogenesis and prevention of 
psychopathology.  Prostaglandins Leukot Essent Fatty Acids 75:329-49 
 
Metz JG, Roessler P, Facciotti D, Levering C, Dittrich F, Lassner M, Valentine R, 
Lardizabal K, Domergue F, Yamada A, Yazawa K, Knauf V, Browse J (2001) 
Production of polyunsaturated fatty acids by polyketide synthases in both prokaryotes 
and eukaryotes.  Science 293:290-293 
 
  22
Meyer A, Kirsch H, Domergue F, Abbadi A, Sperling P, Bauer J, Cirpus P, Zank TK, 
Moreau H, Roscoe TJ, Zahringer U, Heinz E. (2004) Novel fatty acid elongases and 
their use for the reconstitution of docosahexaenoic acid biosynthesis.  J Lipid Res 
45:1899-1909 
 
Morita N, Tanaka M, Okuyama H (2000) Biosynthesis of fatty acids in the 
docosahexaenoic acid-producing bacterium Moritella marina strain MP-1.  Biochem 
Soc trans 28:943-945 
 
Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS, Kyle D (1997) The effect of dietary 
docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in 
humans.  Lipids 32:1137-1146 
 
Olsen SF (2001) Commentary: Mercury, PCB, and now eicosapentaenoic acid: still 
another reason why pregnant women should be concerned about eating seafood?  Int J 
Epidemiol 30:1279-1280 
 
Qiu X, Hong H, MacKenzie SL (2001) Identification of a delta-4 fatty acid desaturase 
from Thraustochytrium sp. involved in the biosynthesis of docosahexanoic acid by 
heterologous expression in Saccharomyces cerevisiae and Brassica juncea.  J Biol 
Chem 276:31561-31566 
 
Ratledge C (2004) Fatty acid biosynthesis in microorganisms being used for Single 
Cell Oil production.  Biochimie 86: 807-815 
 
  23
Ratledge C, Kanagachandran K, Anderson AJ, Grantham DJ, Stephenson JC (2001) 
Production of docosahexaenoic acid by Crypthecodinium cohnii grown in a pH-
auxostat culture with acetic acid as principal carbon source.  Lipids 36:1241-1246 
 
Rock CO, Tsay JT, Heath R, Jackowski S (1996) Increased unsaturated fatty acid 
production associated with a suppressor of the fabA6(Ts) mutation in Escherichia 
coli.  J Bacteriol 178:5382-5387 
 
Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions 
and inflammation.  Science 220:568-575 
 
Serhan CN, Gotlinger K, Hong S, Arita M (2004) Resolvins, docosatrienes, and 
neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered 
endogenous epimers: an overview of their protective roles in catabasis.  
Prostaglandins Other Lipid Mediat 73:155-72 
 
Sirakova TD, Thirumala AK, Dubey VS, Sprecher H, Kolattukudy PE (2001) The 
Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and 
octamethyl-branched fatty acids required for sulfolipid synthesis. J Biol Chem 
276:16833-16839 
 
Sperling P, Zähringer U, Heinz E (1998) A Sphingolipid Desaturase from Higher 
Plants.  J Biol Chem 273:28590-28596 
 
  24
Sprecher H, Luthria DL (1995) Reevaluation of the pathways for the biosynthesis of 
polyunsaturated fatty acids.  J Lipid Res 36:2471-2477 
 
Stredanska S, Sajbidor J (1992) Oligounsaturated fatty acid production by selected 
strains of micromycetes.  Folia Microbiol (Praha) 37:357-359 
 
Stryer, L (1995) Biochemistry, 4th Ed., WH Freeman and Company, NY. 614-622 
 
Tinoco J (1982) Dietary requirements and functions of alpha-linolenic acid in 
animals.  Prog Lipid Res 21:1-45 
 
von Schacky C (2003) The role of omega-3 fatty acids in cardiovascular disease.  
Curr Atheroscler Rep 5:139-145 
 
Wakil SJ, Stoops JK, Joshi JC (1983) Fatty acid synthesis and its regulation.  Annual 
Rev. Biochem 52:537-579 
 
Wallis JG, Watts JL, Browse J (2002) Polyunsaturated fatty acid synthesis: what will 
they think of next?  Trends Biochem Sci 27:467 
 
Yazawa K (1996) Production of eicosapentaenoic acid from marine bacteria.  Lipids 
31:S297-S300 
 
  25
Zhu G, Li Y, Cai X, Millership JJ, Marchewka MJ, Keithly JS (2004) Expression and 
functional characterization of a giant type I fatty acid synthase (CpFAS1) gene from 
Cryptosporidium parvum.  Mol Biochem Parasitol 134:127-135 
  26
Chapter 1 Supplementary Information 
 
 Fatty acids vary in hydrocarbon chain length and degree of unsaturation.  
However, the most common fatty acids have regular structural patterns.  Because of 
this, special fatty acid-specific systems of nomenclature have been developed.  While 
trivial names remain the most commonly used, a system based on IUPAC rules exists.  
Stearic acid is the trivial designation of a fully saturated 18-carbon fatty acid.  By 
IUPAC rules, this fatty acid becomes octadecanoic acid.  The nomenclature may 
deviate from the IUPAC system when double bonds are introduced, where double-
bond positions are numbered from Greek lettered references.  The first carbon from 
the carboxyl carbon is referred to as the “α” carbon and the next carbon from it, the 
“β” carbon, etc.  Double bond positions numbered relative to the carboxyl function 
are prefixed with the Greek letter Δ.  Double bond positions numbered relative to the 
distal carbon are prefixed with the Greek letter ω.  Natural fatty acid unsaturations are 
most commonly cis, and most natural cis double bonds are separated by regular 
methylene interruptions.  Therefore, a convention has developed of numbering only 
the first double bond of a fatty acid from the ω end.  Fatty acids that deviate from this 
norm are more elaborately described, usually by referencing each double bond 
position and configuration from the Δ end.  For example, linoleic acid is the trivial 
name of cis 9, cis 12-octadecadienoic acid.  This fatty acid can also be described as 
Δ9,12-octadecadienoic acid or ω-6 octadecadienoic acid (“ω-6” indicates that the first 
double bond occurs six carbons from the methyl terminus, towards the carboxyl end).  
To add even more “clarity” to fatty acid nomenclature, a system of shorthand has 
been developed that follows the formula “(carbon number):(double bond number) 
(relative bond position)”.  Using this shorthand, linoleic acid becomes 18:2 n-6 
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(where “n” substitutes for “ω”).  For carboxyl-end “shorthand” references, 
parentheses are most common, thus 18:2 (Δ9,12).  A list of fatty acid names and 
designations referenced in this work is shown in Supplement Table 1.1.  Structures of 
some important LCPUFA and oleic acid are shown in Supplement Figure 1.1.  Fatty 
acids are oriented with “delta” end carboxyl groups on the left and the “omega” end 
methyl groups on the right. 
  28
 
Carbons Double 
bonds 
Trivial Name Trivial 
Abbreviation 
Systematic name Shorthand 
14 0 Myristic Acid - n-Butadecanoic Acid 14:0 
16 0 Palmitic Acid - n-Hexadecanoic Acid 16:0 
18 0 Stearic Acid - n-Octadecanoic Acid 18:0 
18 1 Oleic acid - cis-Δ9-Octadecaenoic Acid 18:1 n-9 
18 2 Linoleic Acid - cis-Δ9,12-Octadecadienoic Acid 18:2 n-6 
18 3 α-Linolenic Acid GLA cis-Δ6,9,12-Octadecatrienoic Acid 18:3 n-3 
18 3 γ-Linolenic Acid ALA cis-Δ9,12,15-Octadecatrienoic Acid 18:3 n-6 
18 4 Stearidonic Acid, Moroctic Acid SDA cis-Δ6.912,15-Octadecatrienoic Acid 18:4 n-3 
20 0 Arachidic Acid - n-Eicosanoic Acid 20:0 
20 1 - - cis-Δ11-Eicosaenoic Acid 20:1 n-9 
20 2 homo-γ-Linoleic Acid - cis-Δ11,14-Eicosadienoic Acid 20:2 n-6 
20 3 homo-α-Linolenic Acid HALA cis-Δ11,14,17-Eicosatrienoic Acid 20:3 n-3 
20 3 homo-γ-Linolenic Acid HGLA (ETA) cis-Δ8,11,14-Eicosatrienoic Acid 20:3 n-6 
20 3 Mead Acid - cis-Δ5,8,11-Eicosatrienoic Acid 20:3 n-9 
20 4 - ARA n3 (ETA) cis-Δ8,11,14,17-Eicosatetraenoic Acid 20:4 n-3 
20 4 Arachidonic Acid ARA cis-Δ5,8,11,14-Eicosatetraenoic Acid 20:4 n-6 
20 5 Timnodonic Acid EPA cis-Δ5,8,11,14,17-Eicosapentaenoic Acid 20:5 n-3 
22 4 Adrenic Acid DTA cis-Δ7,10,13,16-Docosatetraenoic Acid 22:4 n-6 
22 5 Clupanodonic Acid DPA n3 cis-Δ7,10,13,16,19-Docosapentaenoic Acid 22:5 n-3 
22 5 - DPA n6 cis-Δ4,7,10,13,16-Docosapentaenoic Acid 22:5 n-6 
22 6 Cervonic Acid DHA cis-Δ4,7,10,13,16,19-Docosahexaenoic Acid 22:6 n-3 
 
Supplement Table 1.1.  Common fatty acids; sorted in descending order of complexity. 
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Supplement Figure 1.1.  Structures and annotations of three common fatty acids.  
HO 
O 
HO 
O 
HO 
O 
Arachidonic acid (ARA) - 20:4 n-6
Eicosapentaenoic acid (EPA) - 20:5 n-3
Docosahexaenoic acid (DHA) - 22:6 n-3
HO 
O 
Oleic acid – 18:1 n-9
α ω 
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Chapter 2 - Standard Pathway Characterization and Disruption of 
Polyunsaturated Fatty Acid Biosynthesis in Schizochytrium sp. 
 
Chapter 2 Abstract 
 
 Schizochytrium produces polyunsaturated fatty acids (PUFA) via a polyketide 
synthase (PKS).  Targeted mutagenesis of the genes encoding this PUFA-PKS was 
conducted to verify their function.  The resulting mutants were auxotrophic in that 
they required supplementation with PUFAs for growth.  Feeding experiments with 
radioactive fatty acids demonstrated the presence of a parallel elongase and desaturase 
system capable of producing PUFAs.  However this system is not capable of 
producing PUFAs from saturated fatty acid precursors as no ∆12 desaturase activity 
was detected.  The existence of a partially functional desaturase-elongase system is 
considered either an evolutionary residue or scavenging mechanism for intermediate 
fatty acids prematurely released by the PUFA-PKS or found in the organism’s native 
environment. 
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Chapter 2 Introduction   
 
 Schizochytrium sp. is one of several eukaryotic, heterotrophic organisms used 
to make commercial amounts of long chain polyunsaturated fatty acids (LCPUFA) by 
fermentation.  Schizochytrium is a member of the stramenopiles, a phylum which also 
includes photosynthetic diatoms and brown algae (Cavalier-Smith et al., 1994).  
Stramenopiles of the order Labyrinthulida generally belong to one of two established 
families, the Labyrinthulidae and the Thraustochytriidae; the genus Schizochytrium is 
a member of the latter.  Schizochytrium primarily makes two PUFAs: DHA and DPA 
n-6.  These fatty acids occur in a relatively constant 3:1 ratio among total cellular 
lipids of the microalgae (Barclay, 2002) and are found in most, if not all, known 
members of the Labyrinthulida (although in different ratios).  This suggests a 
physiological dependency or other central role in metabolism (Barclay, 2002).  DHA 
and DPA n-6 can comprise >60% of the total lipid-associated fatty acids of cultured 
Schizochytrium, which in turn can be as much as 43% of the dry cell weight (Barclay, 
2002).  No other PUFAs are found in the fatty acid profile in substantial quantities.   
 Targeted mutagenesis and disruption of gene function is a powerful tool for 
determining the function of known genes and has been used in a variety of settings.  
As a method for fatty acid biosynthetic gene identification, mutagenesis was first 
applied in Saccharomyces cerevisiae.  Random mutagenesis and negative selection of 
saturated fatty acid-requiring auxotrophs led to the discovery of α and β subunits of S. 
cerevisiae FAS (Schweizer et al., 1984).  Later, targeted mutagenesis was used to 
remove the OLE-1 gene of S. cerevisiae, creating a lethal phenotype complemented 
only by monounsaturated fatty acids, verifying this gene as the yeast Δ9 fatty acid 
desaturase (Stukey et al., 1989).  A transformation system for Schizochytrium exists 
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and preliminary data indicated that it was capable of vector-mediated homologous 
recombination (Roessler et al., 2002), allowing a similar approach to investigate 
biosynthetic fatty acid pathways in Schizochytrium. 
 Three genes, designated ORF A, ORF B, and ORFC, were first implicated in 
Schizochytrium PUFA biosynthesis (Metz et al., 2001) due to sequence similarity to 
the products of the PUFA-PKS gene clusters from the marine bacteria Shewanella 
(Yazawa, 1996) and Moritella (Morita et al., 2000).  The function of the Shewanella 
PUFA-PKS system was elucidated by the expression of a cosmid encoding the PUFA-
PKS locus, first in E. coli and later in Synechococcus sp., both of which accumulated 
EPA (Yazawa, 1996, Yu et al., 2000, Metz et al., 2001).  During the course of the 
present study, the Schizochytrium PUFA-PKS was also functionally expressed in E. 
coli (which now made DHA and DPA n6) similarly verifying it as a bona fide PUFA-
PKS (Hauvermale, et al., 2006). 
 Isotopic equilibrium labeling (and related techniques such as pulse and pulse-
chase) has a long and proven history in the elucidation of biochemical pathways, and 
some of the earliest studies with radioactive tracers were used to study cholesterol and 
fatty acid metabolism (Schoenheimer, 1933, Schoenheimer and Rittenberg, 1935).  
More recently, desaturase and elongase-mediated PUFA pathways have been revealed 
in the diatom Phaeodactylum tricornutum via equilibrium labeling techniques with 
14C-fatty acids (Arao and Yamada, 1994).  These studies have led to the cloning and 
identification of desaturases and elongases from a variety of microalgae (for review 
see: Warude et al., 2006).  Desaturase and elongase genes involved in the traditional 
pathway of polyunsaturated fatty acid biosynthesis have also been identified among 
Schizochytrium ESTs, raising questions about their role relative to the PUFA-PKS 
(Paul Roessler, Dow Chemical, San Diego, CA; personal communication).  
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Additionally, precedence for the standard pathway in thraustochytrids has been 
established.  Thraustochytrium, a close relative of Schizochytrium, harbors several 
enzymes of the standard pathway of PUFA biosynthesis, including the first-
discovered Δ4 desaturase (Qiu et al., 2001). 
 To reconcile the apparent presence of two biosynthetic pathways for PUFA 
production, two different approaches were applied.  First, a vector-directed, 
homologous recombination method targeted to the PUFA-PKS genes of 
Schizochytrium was used to disrupt ORFs A, B, and C individually.  Second, the 
classic pathway elongase and desaturase activities were characterized by equilibrium 
labeling with radiolabeled precursors. 
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Chapter 2 Materials and Methods 
 
 Host strains, transformations, and culture conditions   
  All vectors and constructs were propagated in E. coli UltraMax DH5-α 
FT chemically competent cells (Invitrogen, Carlsbad, CA) for plasmid purification 
using Qiagen kits appropriate for a given scale of culture (Valencia, CA). 
 Schizochytrium strain 2118 was isolated from a single colony of an ATCC 
stock culture (ATCC# 20888).  All Schizochytrium cultures were grown in M2B 
medium consisting of 10 g/L glucose, 0.8 g/L (NH4)2SO4, 5 g/L Na2SO4, 2 g/L 
MgSO4•7H2O, 0.5 g/L KH2PO4, 0.5 g/L KCl, 0.1 g/L CaCl2•2H2O, 0.1 M MES (pH 
6.0) 0.1% PB26 metals and 0.1% PB26 Vitamins (v/v).  PB26 vitamins consisted of 
50 mg/mL vitamin B12, 100 μg/mL thiamine, and 100 μg/mL Ca-pantothenate.  PB26 
metals were adjusted to pH 4.5 and consisted of 3 g/L FeSO4•7H2O, 1 g/L 
MnCl2•4H2O, 800 mg/mL ZnSO4•7H2O, 20 mg/mL CoCl2•6H2O, 10 mg/mL 
Na2MoO4•2H2O, 600 mg/mL CuSO4•5H2O, and 800 mg/mL NiSO4•6H2O.  PB26 
stock solutions were filter sterilized separately and added to the broth after 
autoclaving.  Glucose, KH2PO4, and CaCl2•2H2O were each autoclaved separately 
from the remainder of the broth ingredients before mixing to prevent salt precipitation 
and carbohydrate caramelizing.  All medium ingredients were purchased from Sigma 
Chemical, (St. Louis, MO).  Cultures of Schizochytrium strain 2118 were grown to 
log phase and transformed with a Biolistic™ particle bombarder (BioRad, Hercules, 
CA) with the gene disruption constructs described below.  The Biolistic 
transformation procedure was essentially the same as described previously (Apt et al., 
1996).  Primary transformants were selected on solid media containing 20 g/L agar 
(VWR, West Chester, PA), 50 μg/mL Zeocin® (Invitrogen, Carlsbad, CA), and 0.5 
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mM DHA, DPA, or myristic acid (NuChekPrep, Elysian, MN) complexed with 10-30 
g/L randomly methylated β-cyclodextrins (Cyclodextrin Technologies Development, 
Inc, High Springs, FL).  All primary transformants were manually transferred to grid-
plates containing or lacking polyunsaturated, free fatty acid supplements.  Putative 
auxotrophs were confirmed by a second round of inoculation on these plates. 
 General vector construction 
  All restriction enzymes, alkaline phosphatase, and mung bean nuclease 
were purchased from New England Biolabs (Beverly, MA) and used according to the 
manufacturer’s instructions.  Synthetic linker and primer oligonucleotides were 
purchased from Sigma-Genosys (The Woodlands, TX).  PCR products were amplified 
with Pfu DNA polymerase (Stratagene, La Jolla, CA).  Restriction fragment and 
amplicon purification was performed with either PCR clean-up kits or Qiaex gel 
extraction kits from Qiagen (Valencia, CA).  agarose gels were made with 1% 
SeaKem™ agarose or 1% low-melt agarose (Cambrex Bio Science Rockland, Inc., 
Rockland, ME).  DNA ligations were performed with the Rapid DNA Ligation Kit 
(Roche Diagnostics Corporation, Indianapolis, IN) and 2 μL of each ligation were 
used to transform DH5-α competent cells (Invitrogen, Carlsbad, CA).  Transformed 
bacterial colonies were grown in 5 mL mini-cultures of Luria broth (LB), with 100 
μg/mL ampicillin (Sambrook and Russell, 2000).  Plasmids were extracted from mini-
cultures with miniprep kits (Qiagen).  Constructs were verified by DNA sequencing 
(Lark Technologies, Houston, TX).  All reagents and kits described were used 
according to the manufacturer’s instructions unless otherwise noted. 
 Disruption vector construction 
  Vectors harboring Schizochytrium ORFs and a vector capable of 
conferring resistance to Zeocin when used to transform Schizochytrium 
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(pTUBZEO11-2) were kindly provided by Craig Weaver, Brad Rosenzweig, and Jerry 
Kuner (Martek Biosciences, Boulder, CO).  The vector, pTUBZEO11-2, was 
originally constructed by Paul Roessler (SEQ ID NO:9 of PCT Publication No. WO 
02/083869 A2).  The vector sequence is included as Supplement 2.1.  The vector 
contained the ble gene of Streptoalloteichus hindustanus (Gatignol et al., 1988) to 
confer resistance to Zeocin.  The endogenous Schizochytrium promoter from the α-
tubulin gene was used to drive expression of this selectable marker.  A heterologous 
terminator from the SV40 virus coat protein locus (accession number M24873) 
followed the ble coding region.  These three elements; promoter, ble ORF, and 
terminator, were collectively designated as the “Zeocin resistance cassette”, “Zeocin 
cassette”, or simply “ZEO”.   
  ORF A disruption construct - Vector pBSK:A, which harbored only 
the coding region of ORF A in the vector background pBLUESCRIPT SK-, was 
digested and linearized with SmaI.  The Zeocin resistance cassette was liberated from 
pTUBZEO11-2 by digestion with PstI.  The fragment was treated with T7 DNA 
polymerase to create blunt ends before ligation to the linear pBSK:A.  Chemically 
competent strains of E. coli DH5-α were transformed directly with this ligation mix.  
Resulting transformants were mini-cultured from colonies and plasmids were purified 
and digested to screen for insertion of the Zeocin cassette.  One clone was selected for 
having a Zeocin cassette encoded on the plus strand, relative to ORF A transcription.  
This plasmid, pBSK-ΔOrfA-zeoR#2 was prepared in large scale for use in 
Schizochytrium transformation. 
  ORF B disruption construct - Vector pJK324:ORFB, which harbored a 
large genomic fragment encompassing all of ORF B and its regulatory regions in the 
shuttle vector background pBLUESCRIPT SK-, was digested and linearized with MfeI 
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and AgeI to liberate an 865 bp fragment, which was discarded.  The Zeocin resistance 
cassette was amplified from pTUBZEO11-2 by PCR using the primers 5'Tub7CO-
Mfe (GAC TCA ATT GCC AAT TTT AGG CCC CCC ACT GAC C) and 
3'SV407CO-Age (GAC TAC CGG TAG ACA TGA TAA GAT ACA TTG ATG 
AG).  The amplicon was digested with MfeI and AgeI and ligated to the remainder of 
the pJK324:ORFB digest described above.  This ligation was used directly for 
bacterial transformations.  Transformants were mini-cultured for plasmid extraction 
and restriction-digest verification.  A single clone, pBSK-ΔOrfB-zeoR#6, containing 
a fragment corresponding to the size of the Zeocin cassette was prepared in large scale 
for use in Schizochytrium transformations. 
  ORF C disruption construct - To remove an intervening BamHI site, 
the vector pBR002 (a genomic fragment of ORF C in pBLUESCRIPT SK-) was 
digested with MfeI and XbaI, purified, and ligated to itself.  The resulting plasmid 
(pBR002#4) was digested with BamHI, treated with alkaline phosphatase, and ligated 
to a BamHI-digested fragment liberated from the vector pTUBZEO11-2 (~1126 bp).  
The plasmid derived from a colony transformed with the above ligation (pΔOrfC-
zeoR), was digested with BamHI and PstI to identify a clone in which the direction of 
transcription of the Zeocin resistance cassette was oppositely oriented to the direction 
of transcription of ORF C.  One plasmid, pBSK-ΔOrfC-zeoR#1, was chosen and used 
to transform Schizochytrium strain 2118 by particle bombardment. 
 Gas Chromatography (GC) and High Pressure Liquid Chromatography 
(HPLC) 
  Fatty acid methyl esters (FAMEs) were prepared from freeze-dried 
biomass according to the method described by Morrison and Smith (1964).  One 
microliter injections of FAMEs were separated on a gas chromatogram fitted with a 
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flame-ionizing detector and a FAMEWAX 30-meter column (0.25 mm id, 0.25 df).  
FAME separations were performed as described by Arterburn et al. (2000).  Eluted 
FAMEs were identified and quantified by comparison to authentic standards. 
 HPLC separations of FAMEs were performed using either of two protocols 
based on one described by Özcimder and Hammers (1980).  FAMEs were 
resuspended in 50-200 µL of acetonitrile after evaporating ~2 mL of hexane from the 
FAME reaction.  FAME injections of 5-50 μL were separated by HPLC with a glass 
Chromsep LiChrosorb 7 RP18 (reverse phase) column (Varian, Palo Alto, CA) into 
which a 15-0% (v/v) water gradient in acetonitrile was channeled over 40 minutes at a 
flow rate of 1 mL/minute.  Alternately, FAME injections of 5-20 μL were separated 
by HPLC with a Metachem 3 Taxsil, 250x4.6 mm column (Varian, Palo Alto, CA) 
into which acetonitrile was applied in water: at first 60% isocratic for 35 min., 
transitioning then to a gradient of 60-70% from 35 to 40 min., the 70% mixture was 
maintained as isocratic from 40 to 60 min., over the next minute a gradient descended 
to 60% from 60 to 61 min., and lastly held at 60% (each by vol.) for an additional 9 
minutes.  Eluted radioactive FAMEs were mixed in-line with Scintiverse LC (Fisher, 
Hampton, NH) liquid scintillant (1:2, v/v) for detection of beta-particle emissions.  
Fatty acids were identified and quantified by comparison to authentic reference 
standards. 
 Nucleic Acid Isolation and Identification 
  DNA - Wet pellets from 1 L of Schizochytrium wild-type and mutant 
cultures (approximately 30 g), grown overnight, were washed with sterile water, 
weighed, and lysed with extraction buffer (20 mM Tris-HCl pH 8.0, 50 mM NaCl, 10 
mM EDTA, 0.5% SDS) (1 mL Extraction Buffer per 100 mg wet cell pellet) and 100 
µg/mL proteinase K for ~45 minutes at 50 °C.  After this, 100 µg/mL of DNAse-free 
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RNAse A was added and the lysate incubated at 37 °C for an additional 15 minutes.  
DNA was then extracted from the lysate twice with an equal volume of 
phenol/chloroform/isoamyl alcohol (24:24:1, by vol.) by gentle shaking for 30 
minutes at room temperature.  The aqueous phase of the extract was further extracted 
twice with an equal volume of chloroform/isoamyl alcohol (24:1, v/v).  Whole gDNA 
was precipitated from the remaining aqueous fraction by addition of 0.1 volumes of 3 
M sodium acetate and 2 volumes of 100% ethanol.  DNA was gently wound out of the 
solution with a glass rod, washed with 70% ethanol, dried, and resuspended in tris-
buffered water (pH 8.0). 
  RNA - Flash-frozen pellets from 1 L of logarithmic-phase wild-type 
and auxotrophic mutant cultures of Schizochytrium were pulverized in liquid nitrogen-
cooled mortars that had been oven-baked overnight at 176.6 ºC.  Total RNA was 
extracted from the resulting frozen powder in 30 mL of buffer containing 0.1 M Tris-
HCl (pH 7.5), 1.5 M NaCl, 50 mM EDTA (pH 8.0), 20 g/L cetyl trimethyl ammonium 
bromide (CTAB), and fresh dithiothreitol (DTT, 8 mg/mL).  The slurry was 
centrifuged at 5000 x g for 20 minutes before mixing the supernatant with an equal 
volume of biotechnology grade phenol:chloroform:isoamyl alcohol  (25:24:1, by vol.) 
(Midwest Scientific, St. Louis, MO).  Phases were separated by centrifugation at 
10,000 x g for 30 minutes and the aqueous phase was re-extracted with 
phenol:chloroform:isoamyl alcohol.  The aqueous phase was then mixed with an 
equal volume of 2-propanol and incubated at 4 ºC overnight.  The resulting precipitate 
was centrifuged to a pellet at 5000 x g for 20 minutes, washed with 80% ethanol, 
dried briefly, and resuspended in RNAse-free water before treatment with RNAse-
free DNAse (New England Biolabs, Beverly, MA) at 37 ºC for 2 hours.  RNA was 
again extracted and precipitated as above.   
  40
  Southern and Northern Blotting - 100 µg of gDNA was digested 
overnight at 37 °C with NcoI.  Digested DNA was fractionated on 1% agarose gels 
(10 µg per lane) and transferred to Nytran-Supercharge membranes (Whatman, 
Middlesex, UK).  RNA was fractionated (10 µg per lane) using 2.2 M formaldehyde 
agarose gels (Sambrook and Russell, 2000) and transferred to Nytran-N membranes 
(Whatman, Middlesex, UK) using the manufacturer’s protocol for neutral DNA 
transfers or RNA transfers as appropriate.   
 All probes were synthesized using dCT[32P] (ICN, Costa Mesa, CA) and the 
Prime-a-Gene labeling system (Promega, Madison, WI) according to the 
manufacturer’s instructions.  Probe templates were prepared from digested fragments 
of each ORF.  Probe template specific to ORF A was created by digestion of pYES-
ORFA (see Chapter 3) with NcoI and BsrGI and the resulting 1146 bp fragment was 
gel purified.  Probe template specific to ORF B (spanning the center of the ORF) was 
created by digestion of pYES-ORFBss (see Chapter 3) with NcoI and the resulting 
3583 bp fragment was gel purified.  Probe template specific to ORF C was created by 
digestion of pYES-ORFC (see Chapter 3) with NcoI and EcoRI and the resulting 1560 
bp fragment was gel purified.  RNA millennium markers (Ambion, Austin, TX) were 
electrophoresed and blotted with total RNA samples, while the Quanti-Ladder 
markers (Origene, Rockville, MD) were electrophoresed and blotted with DNA 
samples.  Both marker-ladders were detected with probes made from HindIII 
digested, lambda phage DNA (Origene, Rockville, MD). 
 Southern and northern blots were probed in UltraHyb hybridization buffer 
according to the manufacturer’s protocol (Ambion, Austin, TX).  After drying, blots 
were wrapped in cellophane and imaged on a BioRad Personal Molecular Imager FX 
(BioRad, Hercules, CA). 
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Chapter 2 Results 
 
 Disruption Vector Construction 
  Vector constructs for the disruption of each ORF of the Schizochytrium 
PUFA-PKS were made to test the feasibility of targeted gene disruption in 
Schizochytrium.  Each construct contained the targeted ORF and an additional insert 
of ~1100 bp which conferred resistance to the antibiotic Zeocin.  In the ORF B and C 
disruption constructs, the Zeocin resistance cassette was inversely oriented such that 
transcription would proceed from the minus strand relative to the disrupted PUFA-
PKS ORF.  Because of this, multiple premature stop codons occur within the 
translated frame of each ORF (Figure 2.1).  In the ORF A disruption construct, the 
Zeocin cassette was in the opposite orientation and did not introduce a frame-shift.  
However, several new stop codons relative to the ORF A translation frame were 
introduced.  To improve the potential for recombination, each construct was arranged 
such that 1500-7500 bp of target gene sequence flanked either side of the Zeocin 
cassette. 
 Generation of Schizochytrium Disruption Mutants 
  Cells bombarded with vector-coated tungsten particles were allowed to 
recover overnight before being transferred to solid media containing Zeocin and 
myristic, docosahexaenoic, and docosapentaenoic acids complexed with cyclodextrins 
for further growth (at concentrations described in the Materials and Methods).  One 
bombardment typically yielded 10-100 primary transformants.  Each primary 
transformant was then screened for auxotrophy by observing its ability to grow on 
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Figure 2.1.  Cartoon depicting the position of the Zeocin disruption cassette in ORF genes in constructs intended to mediate disruption of ORFs A, B and C of 
the Schizochytrium PUFA-PKS.  ORF sequences are translated in directions shown by open arrows or triangles.  The Zeocin resistance marker (ZEO) 
sequence is translated in the opposite direction relative to the direction of translation of ORFs B and C but when found in ORF A, the encoded ZEO protein 
(sh ble) is translated in the same direction as the ORF.  The tubulin promoter, the SV40 terminator and the coding region of the Zeocin resistance gene (in 
yellow) are indicated.  Gene sizes are shown to scales indicated by the circular rulers in units of base pairs. 
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solid media containing Zeocin and cyclodextrins, but no free fatty acids.  Between 10 
and 40% of the primary transformants also acquired a phenotype indicative of fatty 
acid auxotrophy. 
 Phenotyping of the Disruption Mutants of Schizochytrium 
  Verified auxotrophic mutants were further characterized by observing 
growth on solid media supplemented with a number of fatty acids (Table 2.1).  The 
phenotypes of all three disruption mutants are similar.  None are able to grow without 
supplemented PUFAs less complex than linolenic acid.  Supplementation with 
polyunsaturated fatty acids of 20 and 22 carbons in length allowed better growth of 
the mutants than with 18 carbon PUFAs.  One ORF A-disrupted mutant (DHA-14) 
was selected for further study and grown in liquid cultures supplemented with several 
free fatty acids.  The cultures were harvested for FAME derivation and analysis by 
GC (Table 2.2).  These data show that only some of the PUFAs which permit growth 
of the mutants are converted to several more complex PUFAs (EPA and 18:3 n6).  
However, conversion to DPA n-6 and DHA in particular does not appear necessary 
for survival as none of the fed fatty acids were converted to DHA in detectable 
amounts.  ARA and DPA n6 were not converted to anything at all by this analysis. 
 Characterization of the Classical Pathway in Wild Type 
  To determine which classic pathway enzymes are active in 
Schizochytrium, liquid cultures of wild-type cells were equilibrium labeled with [1-
14C]-free fatty acids and patterns of conversion were observed (Table 2.3).  Initial 
experiments with various labeling techniques indicated that the most repeatable 
results could only be obtained by equilibrium labeling.  Pulse and pulse-chase 
labeling experiments produced inconsistent results and were therefore discontinued 
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Supplemented FFA ORF A knockout ORF B knockout ORF C knockout Wild Type 
22:6 n-3 ++ ++ ++ ++ 
20:5 n-3 ++ ++ ++ ++ 
20:4 n-6 ++ ++ ++ ++ 
18:3 n-3 + + + ++ 
18:3 n-6 + + + ++ 
16:0 - - - ++ 
14:0 - - - ++ 
none - - - ++ 
 
Table 2.1.  Observed growth of Schizochytrium wild type and auxotrophic, PUFA-PKS-disrupted “knockouts” on solid media supplemented with the 
indicated free fatty acids.  The designator, “++” indicates growth indistinguishable from wild type, “+” indicates impaired growth, and “-“ indicates no 
observed growth.  
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Fatty 
Acid 
Added 
Percentage FAME Recovered in: 
 14:0 16:0 16:1 18:0 18:1 n-9 18:3 n-6 20:3 n-6 20:4 n-6 20:5 n-3 22:5 n-3 22:5 n-6 22:6 n-3 ? 
none* 10 34 8 1 7 - - 1 1 - 11 27  - 
18:3 n-6 1 17 3 1 21 12 33 2 - - 1 - 9 
20:4 n-6 8 43 11 2 16 - 1 7 - - - - 12 
20:5 n-3 9 44 18 2 14 - - - 3 8 - - 2 
22:5 n-6 11 44 8 2 10 - - 1.0 - - 22 - 2 
22:6 n-3 6 38 11 2 14 - - - 2 - - 25 
2 
 
Table 2.2. Fatty acid methyl esters (FAMEs) derived from total lipids of wild-type and ORF A disrupted Schizochytrium cultures grown in liquid media 
supplemented with the indicated free fatty acids.  * Indicates the wild type culture, all others were ΔORFA mutant clone DHA-14.  All values are expressed 
as a FAME area percent of total FAME peaks.  FAME % values of unknown peaks which did not co-migrate with commercially available FAMEs are shown 
in the column “?”.  Each datum correlating to an added fatty acid is from a single study.   
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16:0 18:0 18:1 n-9 18:2 n-6 18:3 n-3 18:3 n-6 18:4 n-3 20:2 n-6 20:3 n-6 20:3 n-9 20:4 n-3 20:4 n-6 20:5 n-3 22:4 n-6 22:5 n-3 22:5 n-6 22:6 ??
16:0 97§ - § - - - -  - - - - - -  - - - - 3
18:0 72 6 - - - -  - - - - - -  - - - - 22
18:1 n-9 90 - - - -  - - - - - -  - - - - 10
18:2 n-6 70 13* 4# -  - - - * - -  - - - # 13
18:3 n-3 49* - 2  - - - * - 43  - * - - 1
18:3 n-6 49# -  - 5 - 7* 7 31  - * - # -
18:4 n-3 27  - - - 8* - 59  - * - 5 -
20:2 n-6 93  -  -  -  -  -  -  -  -  - 7
20:3 n-6 31 - 1* 19 44  - * - 3 -
20:3 n-9 77 - - 2  - - 3 15 4
20:4 n-3 31* - 61  - * - 6 -
20:4 n-6 39 46  - - 3 9 -
20:5 n-3 75  - 8 - 16 -
22:4 n6 31 42 17 20  -
22:5 n-3 26 - 74 -
22:5 n-6 74 26 -
14C-Fatty 
Acid 
Added
Wild-type Schizochytrium  Culture FAME Percentage of Label Recovered in:
 
Table 2.3.  Radio-labeled fatty acid methyl esters (FAMEs) derived from total lipids of wild-type Schizochytrium cultures grown in liquid media 
supplemented with the indicated 1-14C labeled free fatty acids.  All values are expressed as percent of total recovered activity per FAME.  Three distinct 
groups of FAME standards appeared as a single co-migrating peak during HPLC separation: *the first group consisted of 18:3 n-3, 20:4 n-3 and 22:5 n-3, 
#the second was 18:3 n-6 and 22:6 n-3, and §the third and last consisted of 16:0 and 18:1, precluding quantification of these FAMEs individually. 
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(data not shown).  Extracts from equilibrium-radiolabeled cultures were analyzed by 
HPLC fitted with an in-line, liquid-scintillant β-RAM detector.  In comparison to gas 
chromatography, separation of FAMEs by HPLC is not a preferred method as it 
commonly results in co-migration of some analytes.  Unfortunately, GCs require very 
low masses of analytes which are usually flame ionized.  In-line radio-detectors for 
GCs employ solid scintillants which are generally not sensitive enough to detect these 
ionized products.  In-line radio-detectors for HPLC, particularly those with a liquid 
scintillant cell, are sufficiently sensitive and can accommodate relatively large masses 
and high flow-rates.  Taking these factors into consideration, HPLC was chosen as the 
primary method of analysis for radioactive fatty acid conversions despite the 
difficulty encountered in separating certain FAME mixtures.  Some FAMEs co-
migrated in the HPLC separation, precluding distinct quantification.  Specifically, 
18:3 n-3, 20:4 n-3 and 22:5 n-3 co-migrated.  18:3 n-6 and 22:6 n-3 also co-migrated 
and so did 16:0 and 18:1.  The results shown in Table 2.3 indicate that wild-type 
Schizochytrium possesses many but not all of the activities associated with a classical 
PUFA biosynthesis pathway.  Where co-migration was an issue, total percents are 
listed in the column corresponding to the structurally simplest member of a co-
migrating group.  Retro-conversion and β-oxidation of fatty acids were not observed, 
however some fatty acids were converted to minor products which did not co-migrate 
with any of the used standards. 
 Genotyping of the Disruption Mutants of Schizochytrium 
  To verify that the observed auxotrophies were caused by a targeted 
gene disruption event, nucleic acids of the Schizochytrium mutants were compared to 
those of wild type by Southern and northern blotting.  Total gDNA was purified from 
a wild-type culture and several clones each of the ORF A, ORF B, and ORF C 
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disruption mutants, then digested with NcoI, and separated on agarose gels for 
blotting.  Blots were probed with fragments liberated from ORFs derived from the S. 
cerevisiae expression constructs described in Materials and Methods.  Maps of the 
wild-type ORFs as well as the arrangement of the disruption cassettes in each ORF 
are shown in panels A and B, respectively, of Figures 2.2, 2.3, and 2.4.  Probe 
annealing locations and predicted sizes of detectable NcoI fragments are also featured 
in these panels.  The predicted sizes of detectable, probed fragments agree well with 
what is observed in the ORF A probed Southern (Figure 2.2, panel C), for all but one 
band.  The wild-type, ORF B disruption mutant B24, and ORF C disruption mutant 
C1-46 all appear to harbor an uninterrupted copy of ORF A as indicated by the 2541 
bp band.  The 2344 and 1315 bp bands of the ORF A disruption mutant A20 agree 
well with the observed lower two bands of the corresponding Southern, however the 
higher molecular weight band shown in the A20 lane is unexpected. 
 Similar patterns are observed in the ORF C probed Southern (Figure 2.4, panel 
C).  The expected, undisrupted, ~6000 bp band is seen in the lanes containing NcoI-
digested gDNA from the wild type, A20, and B24.  While a band of similar size could 
also be seen in the lane with ORF C disrupted gDNA, the smaller 1059 bp band, 
indicating the generation of an ORF C disruption, agrees well with the migration of 
the smallest band seen in the Southern lane for C1-46.  However, as was observed 
with the ORF A disruption, this lane also displays an unexpected larger band - in this 
case larger than 10 kbp. 
 The Southern banding patterns detected with an ORF B specific probe are not 
easily interpretable.  The wild type band present in lanes containing NcoI-digested 
gDNA from the wild type and clones A20 and C1-46 are only slightly larger than the 
predicted size of 3583 bp, but no band of similar size should be detected at all in 
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A 
B 
                                                C 
Figure 2.2.  ORF A disruption.  Map of expected ORF A gDNA arrangement from a double-
crossover event in auxotrophic mutants transformed with pBSK-∆OrfA-zeoR#2 (panel A).  
Map of wild-type ORF A (panel B) and Southern blots (panel C).  The maps illustrate the 
locations of probe “A” (stroked goalposts) and detectable NcoI restriction fragments, labeled 
according to their size in base pairs, “2344” “1315” and “2541” (open boxes).  The Zeocin 
selection cassette, “zeo” is shown within the interruption of the ORF A reading frame “ORF 
A” (open arrow boxes).  Both maps are shown with a base pair ruler and positions of 
restriction sites mentioned in the text.  The Southern blot of NcoI-digested gDNA from wild 
type “wt” and three disruption mutant clones A20, B24, and C1-46 (panel C) was labeled with 
an ORF A specific probe illustrated in panels A and B.  The lane at left was probed separately 
with lambda virus specific probes and the bands are labeled according to their size in kbp. 
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 A 
B 
                                              C 
Figure 2.3.  ORF B disruption.  Map of expected ORF B gDNA arrangement from a double-
crossover event in auxotrophic mutants transformed with pBSK-∆OrfB-zeoR#6 (panel A).  
Map of wild-type ORF B (panel B) and Southern blots (panel C).  The maps illustrate the 
locations of probe “probe B” (stroked goalposts) and detectable NcoI restriction fragments, 
labeled according to their size in base pairs, “1887” “1920” and “3583” (open boxes).  The 
Zeocin selection cassette, “zeo” is shown within the interruption of the ORF B reading frame 
“ORF B” (open arrow boxes).  Both maps are shown with a base pair ruler and positions of 
restriction sites mentioned in the text.  The Southern blot of NcoI-digested gDNA from wild 
type “wt” and three disruption mutant clones A20, B24, and C1-46 (panel C) was labeled with 
an ORF B specific probe illustrated in panels A and B.  The lane at left was probed separately 
with lambda virus specific probes and the bands are labeled according to their size in kbp.  
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B 
                                               C 
Figure 2.4.  ORF C disruption.  Map of expected ORF C gDNA arrangement from a double-
crossover event in auxotrophic mutants transformed with pBSK-∆OrfC-zeoR#1 (panel A).  
Map of wild-type ORF C (panel B) and Southern blots (panel C).  The maps illustrate the 
locations of probe “C” (stroked goalposts) and detectable NcoI restriction fragments, labeled 
according to their size in base pairs, “1059” and “>5000” (open boxes).  The Zeocin selection 
cassette, “zeo” is shown within the interruption of the ORF C reading frame “ORF C” (open 
arrow boxes).  Both maps are shown with a base pair ruler and positions of restriction sites 
mentioned in the text.  The Southern blot of NcoI-digested gDNA from wild type “wt” and 
three disruption mutant clones A20, B24, and C1-46 (panel C) was labeled with an ORF C 
specific probe illustrated in panels A and B.  The lane at left was probed separately with 
lambda virus specific probes and the bands are labeled according to their size in kbp. 
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NcoI-digested gDNA from the disruption mutant B24.  Additionally, the lower band 
of the B24 lane is smaller than either 1887 bp or 1920 bp; the predicted sizes of the 
resulting bands from a “complete” homologous recombination event (i. e. a 
homologous recombination event mediated by a double-crossover). 
 In light of these results, NcoI-digested gDNA from several more 
independently generated ORF B and ORF C disruption clones were analyzed by 
Southern blotting to test the reproducibility of these banding patterns (Figure 2.5).  As 
can be seen, the banding patterns of all the ORF B disruption clones were identical, 
suggesting that the mechanism of recombination in these clones was consistent and 
reproducible.  Two of the three ORF C disruption clones tested presented identical 
banding patterns, but the third clone clearly lacked the unexpected high molecular 
weight band revealed by the other two. 
 Schizochytrium PUFA Auxotroph Transcripts 
 Total RNA was purified from a wild-type culture and from disruption mutant 
clones A20, B24, and C1-46.  This RNA was separated on agarose gels for northern 
blotting.  Blots were probed with the same fragments used for Southern blotting.  As 
shown in Figure 2.6, transcripts of the ORF A disruption mutant A20 are clearly 
fragmented into weak bands of ~2700 bp and ~1800 bp, while the size of the bands 
observed in the wild-type, B24 and C1-46 agree with expected sizes of a wild type 
ORF A transcript (<8730).  Similarly, the detected transcripts of ORFs B and C 
appear appropriately sized where they should be, but are significantly smaller among 
RNA from their corresponding disruption mutants. 
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Figure 2.5.  Southern blots of NcoI-digested gDNA from wild type (wt) and disruption mutant 
clones B7, B10, B24, C1-46, C3-2, and C5-5, labeled with the ORF B specific probe 
illustrated in panels A and B of Figure 2.3 (group at left, “B”) or with the ORF C specific 
probe illustrated in panels A and B of Figure 2.4 (group at right, “C”).  The outermost 
flanking lanes were labeled separately with lambda virus-specific probes and the bands are 
annotated according to their size in kbp. 
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Figure 2.6.  Northern blots of total RNA extracted from wild-type (wt) Schizochytrium and 
disruption mutant clones A20, B24, and C1-46.  Blots were labeled with the ORF A specific 
probe shown in Figure 2.2, panels A and B (group at left, “A”), or with the ORF B specific 
probe shown in Figure 2.3, panels A and B (group in middle, “B”), or with the ORF C 
specific probe shown in Figure 2.4, panels A and B (group on right, “C”).  The outermost 
flanking lanes were labeled separately with lambda virus specific probes and the bands are 
annotated according to their size in kbp. 
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Chapter 2 Discussion 
 
  A number of auxotrophic mutants were generated which required 
polyunsaturated fatty acids for growth.  These mutants were the result of 
recombination events in which components of the polyunsaturated fatty acid synthase 
were disrupted with a dominant selectable marker for Zeocin resistance.  Disruption 
of any one of the three genes generated auxotrophic mutants with identical 
phenotypes, indicating that each component is required for PUFA synthesis.  This 
work confirmed that of Hauvermale et al. (2006) supporting the role of the PUFA-
PKS genes, ORFs A, B, and C of Schizochytrium, in DHA biosynthesis and 
additionally demonstrated that the Schizochytrium PUFA-PKS is a critical enzyme 
component required for primary metabolism.  It also represents the first instance of a 
targeted gene disruption in any stramenopile.   
 Wild-type Schizochytrium does not accumulate any significant amounts of 
PUFA other than DHA and DPA under laboratory conditions.  However, knock-out 
mutants of the PUFA-PKS components were able to grow when supplemented with a 
variety of PUFAs, some of which were not converted to DHA or DPA.  This 
observation was somewhat surprising, as one might expect Schizochytrium to have a 
strict requirement for DHA and DPA, these being the only PUFAs Schizochytrium 
makes de novo during growth with glucose as a sole carbon source.  However, 
auxotrophs fed 20- and 22-carbon PUFAs grew better than those fed 18-carbon 
PUFAs, indicating that PUFA auxotrophs preferred supplemented PUFAs with 
greater structural analogy to DHA or DPA (Table 2.1).   
 The nature of the genetic defect in these auxotrophic mutants was analyzed by 
northern and Southern blotting.  The disruption constructs themselves were designed 
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to integrate at the loci encoding each of the three putative PUFA-PKS ORFs.  It 
appears that a single crossover event may have occurred in the ORF A disruption 
mutant A20 (Fig 2.2) and in the ORF C mutants C1-46 and C3-2 (Fig. 2.5).  In these 
cases, homologous recombination via a single crossover event would yield two copies 
of the targeted gene separated by the backbone of the vector encoding an ampicillin 
resistance gene and bacterial origin of replication (Figure 2.7).  The ORF A disruption 
construct only contained the coding regions of ORF A.  In the case of mutant clone 
A20 it seems more likely that this single crossover would have occurred upstream of 
the Zeocin resistance cassette.  The resulting ORF A locus would have a 5’ copy of 
ORF A containing the Zeocin cassette and a second, uninterrupted 3’ copy of ORF A 
without a promoter.  The aberrant, largest band of the Southern blot of A20 (Fig. 2.2) 
agrees well with the predicted size of the vector-backbone containing fragment found 
between the 3’-most NcoI site in the upstream, interrupted copy of ORF A and the 
first NcoI site found in the coding region of the downstream, uninterrupted, promoter-
less copy of ORF A.   
 In the case of the ORF C mutants C1-46 and C3-2, a similar, single crossover 
probably occurred resulting in two copies of ORF C (one interrupted by the Zeocin 
cassette and the other not) (Figure 2.7).  However the disruption construct used to 
build these clones did contain enough non-coding upstream and downstream sequence 
to encompass the predicted promoter and terminator regions.  Regardless of where the 
single crossover event occurred specifically, the migration of the larger, aberrant band 
agrees with the predicted size of a vector backbone-containing fragment between the 
two copies of ORF C.  This larger band is missing from the Southern blot of mutant 
clone C5-5 however, suggesting that this clone integrated via a double-crossover 
event and that the remainder of the disruption construct was lost.  The exact size of 
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Figure 2.7.  Diagram of the proposed mechanism of single crossover events leading to several 
of the described auxotrophic mutants.  The example specifically addresses the most likely 
scenario of recombination leading to the creation of the mutant A20 with the vector pBSK-
∆OrfA-zeoR#2 although an analogous mechanism is thought to have occurred in the creation 
of ORF C mutants C1-42 and C3-2.  A single strand break in the vector within the ORF A 
coding region and upstream of the ZEO expression cassette (“*”) could lead to a single 
crossover event at the homologous position within the genome-encoded copy of ORF A 
resulting in two copies of ORF A: one upstream copy being left with the disruptive ZEO 
cassette and the second downstream copy being left with only vector backbone sequence in 
place of a viable promoter.  Vector backbone sequences are indicated by black lines and 
genomic DNA sequences (other than ORF A) are indicated by green lines.  The vector-
encoded Zeocin resistance cassette, vector-encoded ORF A, and genome-encoded ORF A are 
shown as yellow, blue, and purple bars, respectively.  Genes are translated left to right in 
linear sequence representations and counter-clockwise in circular representations. 
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the genomic fragment upstream of ORF C could not be predicted as the location of an 
upstream NcoI site is not known, but the difference between this fragment’s size in 
the disruption mutants and the wild type should only be 63 bp and not resolvable on 
the Southern blots.  Combined with the observation that ORF C was inactivated, the 
fact that at least one copy of ORF C with an intact promoter and terminator should 
have remained in clones C1-46 and C3-2 suggests that the recombination may not 
have been perfect (introducing a frame-shift, for instance) or that Schizochytrium gene 
expression may be sensitive to structural or geographical genomic effects.   
 This speculation may be even more relevant when analyzing the fragmentation 
pattern of the ORF B Southerns (Fig. 2.3 and 2.5) which has no correspondence to 
predicted patterns of integration.  All three disruption mutants of ORF B appear to 
retain a fragment similar in size to what was observed in the wild-type indicating that 
a single-crossover mediated, ectopic integration may have occurred, but the lower 
band (<1500 bp) does not agree with any of the predicted fragments of ORF B.  
Despite these unexplained but repeatable labeling patterns among independent 
transformants, the transcripts of ORF B, as well as ORFs A and C, are clearly altered 
(Fig 2.6).  Although it is possible that the transcription of ORF B was affected by 
some mechanism not directly related to the disruption of ORF B, it seems unlikely 
due to the relatively high percentage of PUFA auxotrophs occurring among the 
Zeocin-resistant transformants and the lack of pleiotropism. 
 Taken together, these data strongly support the role of the PUFA-PKS genes 
described by Metz et al. (2001) in the production of DHA and DPA.  These results 
also indicate that in Schizochytrium, PUFAs directly participate in primary 
metabolism and that disruption of their synthesis (in the absence of an exogenous 
supply) is lethal.  This is unusual because other PUFA-producing organisms remain 
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viable after suffering mutations that interrupt PUFA biosynthesis (such as the fungus 
Mortierella alpina) (Certik et al., 1998 and Okuley et al., 1994). 
 Interestingly, the desaturases and elongase activities of Schizochytrium did not 
appear capable of producing DHA and DPA de novo, or at least not in great enough 
quantities to alleviate the auxotrophy induced by PUFA-PKS disruption or to be 
detected by radiolabeling techniques.  The apparent absence of activity for a Δ12 
desaturation of 18:1 represents a lesion in the classic pathway of Schizochytrium.  
Aside from potentially severe rate-limits in the conversions between 18:2 and 22:6, 
this lesion is the most likely cause of Schizochytrium’s inability to self-complement 
disruptions of the PUFA-PKS.  However, most biosynthetic steps expected for a 
classical pathway of PUFA biosynthesis could be identified or at least inferred by 
qualification (as summarized in Figure 2.8).  Fatty acids more complex than 18:1 all 
appeared to be converted to predictable classic pathway intermediates.  An omega-3 
desaturase activity for the conversion of ARA to EPA is seen, as are several elongase 
activities.  Specifically, Δ6 and Δ9 elongase activities for the conversion of both 
isomers of 18:3 to their 20 carbon products, and a Δ5 elongase activity for the 
conversion of EPA to 22:5 n-3, were observed.  Lastly, Schizochytrium appears to 
harbor a Δ4 desaturase activity as evidenced by the direct accumulation of DHA in 
cultures fed 22:5 n-3.  This desaturase is likely to be very similar to its counterpart in 
Thraustochytrium, discussed earlier (Qiu et al., 2001).  Although it is not known what 
other classical pathway elements Thraustochytrium may possess, it seems likely that 
its pathways of PUFA biosynthesis would be analogous to those of Schizochytrium.  It 
should be noted that in vivo feeding experiments with radiolabeled 18:3 by Metz et al. 
(2001) did not show any conversion of the fatty acid.  Similarly, Meyer et al. (2004) 
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Figure 2.8.  A summary of elongation and desaturation activities detected in wild-type and 
auxotrophic mutants of Schizochytrium.  The only “missing” activity corresponds to a ∆12 
desaturase.  “EL” - Elongase, “EL/FAS” - Elongase or Fatty Acid Synthase, “ω3” - omega-3 
desaturase activity, “∆9” delta-9 desaturase activity, “∆6” delta-6 desaturase activity, “∆5” 
delta-5 desaturase activity, “∆4” delta-4 desaturase activity.  Refer to Supplement Table 1.1 
for fatty acid naming conventions.  
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reported that Schizochytrium was not able to convert significant amounts of 
radiolabeled DPA n-3 to DHA during 24 hours incubation.  All of the Schizochytrium 
fatty acid equilibrium labeling data presented in this work were obtained using two 
day incubations, simply because preliminary experiments had established that 
equilibrium was not yet attained after just 24 hours (data not shown).  The 
Schizochytrium Δ4 desaturase activity (and most other classic pathway activities) was 
only revealed when longer incubations times were used.  Also, despite the longer 
incubation times, no obvious β-oxidation of labeled fatty acids occurred.  If the 
carboxyl carbons of any given labeled free fatty acid were in fact mobilized by β-
oxidation, one would expect to see all the fatty acids labeled in proportions more 
similar to what is observed in the unlabeled fatty acid profile (Table 2.2) rather than in 
increasingly complex PUFAs exclusively.   
 Despite certain issues with co-migrating peaks, HPLC with in-line mixing of 
liquid scintillant is the preferred method for detecting radiolabeled fatty acids.  Radio-
GC methods must use a solid scintillant which is less sensitive than liquid scintillant.  
When this lack of sensitivity is coupled with the lower sample volumes used in GC 
protocols, a situation arises where many conversion steps could be missed.  
Fortunately with the HPLC protocol used, most ambiguities imparted by a particular 
set of co-migrating fatty acids was could be clarified by observing the results from a 
different fatty acid feeding.  In a few cases however, inferences had to be made.  For 
instance, the feeding with 20:3 n6 shown in Table 2.3 shows that 1% of the label 
migrated in a peak associated with both 20:4 n3 and 22:5 n3.  It thus remains possible 
that 20:3 n6 cannot be directly desaturated to its corresponding omega-3 analog, 20:4 
n3 at all, and that peak in question (1%) is represented entirely by 22:5 n3 (and that 
the omega-3 desaturase in question is only active on 22-carbon substrates).  However, 
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if this were the case, one would not expect this omega-3 desaturase to be active on the 
substrate 20:4 n6 (ARA) either, and yet it clearly is, as 61% of the label is recovered 
in the peak corresponding to 20:5 n3 (EPA).  Therefore, one should be able to 
confidently assume that 20:4 n3 constitutes at least part of the “1% peak” found in the 
20:3 n6 labeling.  Another issue presented by these co-migration problems, and the 
fact that these observations were made by in vivo equilibrium labeling, is that rate-
limits in the classic pathway could not be unequivocally quantified.  However, for the 
purposes of this study, the qualitative analyses of fatty acid conversions served well 
enough.  Regardless, it is clear that a classic pathway of Schizochytrium desaturases 
and elongases can synthesize DHA and DPA from other PUFAs, but not from 
saturated fatty acids precursors.  Also, as previously stated, these conversions require 
extended incubation times.  Presumably, this is indicative of sluggish flux through this 
pathway, another observation implicating the classic pathway as a secondary system. 
 As noted elsewhere, the Schizochytrium PUFA-PKS is most similar to PUFA-
PKSs of proteobacterial systems.  However, the Δ4 desaturase isolated from 
Thraustochytrium (Genbank accession AAM09688) is, by BLASTP analysis, most 
similar to other “front-end” desaturases of other eukaryotes such as the Δ4 desaturase 
of Euglena (of the alveolates) and the Δ5 desaturases of the liverwort, Marchantia (of 
the viridiplantae) and the fungi, Mortierella (Genbank accessions AAQ19605, 
AAT85663, and AAR28035, respectively).  Isolation of additional classic pathway 
genes from other members of the order Labyrinthulida coupled with detailed 
phylogenetic studies may reveal that the classic pathway desaturases and elongases 
were likely present in ancestors of Thraustochytrium and Schizochytrium, and that the 
PUFA-PKS was a later, horizontally-transferred acquisition from a bacterium.  
Precedence for such bacteria-to-eukaryote horizontal gene transfers exists beyond the 
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common examples associated with the acquisition of plastids and mitochondria 
(especially among protists) (Gogarten, 2003).  Hypothetically, once the PUFA-PKS 
stabilized in this ancestral progenitor, selective pressure to retain the classic pathway 
components would be diminished to a secondary role in scavenging for environmental 
PUFAs or prematurely-released PUFA-PKS intermediates (possibly 18:5 n-3, for 
instance).  Under such conditions, one would predict that the classic pathway enzymes 
involved in conversion of PUFAs least analogous to DHA and DPA would be under 
the least selective pressure and would thus decay faster.  Analysis of other members 
of Labyrinthulida (or perhaps even other stramenopiles) may reveal classical 
pathways in greater or lesser stages of decay depending upon specific environmental 
needs and the strength of an endogenous PUFA-PKS system. 
 As an aside, it is also important to recognize the significance of the genetic 
tools developed to enable this work.  Schizochytrium now represents the only 
organism in its phylum for which homologous recombination-based transformation 
and gene disruption have been demonstrated.  Additional studies will be required to 
determine what parameters need to be changed to improve gene targeting efficiency 
and overall rates of recombination, but by any measure, these new tools should 
contribute to an expansion in research on Schizochytrium. 
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>pTUBZEO11-2 
tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggat 
gccgggagcagacaagcccgtcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcaga 
gcagattgtactgagagtgcaccatatgcggtgtgaaataccgcacagatgcgtaaggagaaaataccgcatcaggcgcc 
attcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctattacgccagctggcgaaaggg 
ggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtgaatt 
cgagctcggtacccggggatcctctagagtcgacctgcaggcatgccaattttaggccccccactgaccgaggtctgtcg 
ataatccacttttccattgattttccaggtttcgttaactcatgccactgagcaaaacttcggtctttcctaacaaaagc 
tctcctcacaaagcatggcgcggcaacggacgtgtcctcatactccactgccacacaaggtcgataaactaagctcctca 
caaatagaggagaattccactgacaactgaaaacaatgtatgagagacgatcaccactggagcggcgcggcggttgggcg 
cggaggtcggcagcaaaaacaagcgactcgccgagcaaacccgaatcagccttcagacggtcgtgcctaacaacacgccg 
ttctaccccgccttcttcgcgccccttcgcgtccaagcatccttcaagtttatctctctagttcaacttcaagaagaaca 
acaccaccaacaccatggccaagttgaccagtgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttc 
tggaccgaccggctcgggttctcccgggacttcgtggaggacgacttcgccggtgtggtccgggacgacgtgaccctgtt 
catcagcgcggtccaggaccaggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacg 
ccgagtggtcggaggtcgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagcagccgtgg 
gggcgggagttcgccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggactgacacgtgctacg 
agatttcgattccaccgccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccggctggatgatcctcc 
agcgcggggatctcatgctggagttcttcgcccaccccaacttgtttattgcagcttataatggttacaaataaagcaat 
agcatcacaaatttcacaaataaagcatttttttcactgcattctagttgtggtttgtccaaactcatcaatgtatctta 
tcatgtctgaattcccggggatcctctagagtcgacctgcaggcatgcaagcttggcgtaatcatggtcatagctgtttc 
ctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagcataaagtgtaaagcctggggtgcctaa 
tgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagctgcatta 
atgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgctcttccgcttcctcgctcactgactcgctgcgct 
cggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgca 
ggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggct 
ccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccagg 
cgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctccct 
tcgggaagcgtggcgctttctcaatgctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctg 
tgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacg 
acttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaag 
tggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaag 
agttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgca 
gaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaaggg 
attttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaaaaatgaagttttaaatcaatctaaag 
tatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgtt 
catccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatg 
ataccgcgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtgg 
tcctgcaactttatccgcctccatccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtt 
tgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcgtcgtttggtatggcttcattcagctccggttcc 
caacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcctccgatcgttgtcag 
aagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagat 
gcttttctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcg 
tcaatacgggataataccgcgccacatagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaact 
ctcaaggatcttaccgctgttgagatccagttcgatgtaacccactcgtgcacccaactgatcttcagcatcttttactt 
tcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttga 
atactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatg 
tatttagaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattatta 
tcatgacattaacctataaaaataggcgtatcacgaggccctttcgtc 
 
Supplement 2.1.  DNA sequence of the vector pTUBZEO11-2. 
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Chapter 3 - Heterologous Expression of the Polyunsaturated Fatty 
Acid Synthase from Schizochytrium in Yeast 
 
Chapter 3 Abstract 
 
 Genes encoding a polyunsaturated fatty acid (PUFA) synthase from the single 
cell oil protist, Schizochytrium sp., have previously been isolated (Metz, 2001) and 
characterized as the organism’s sole source of de novo PUFA synthesis (Hauvermale 
et al., 2006, and this study, Chapter 2).  To model their use in an oilseed crop, three 
Schizochytrium PUFA-PKS genes (ORFs A, B, and C) as well as a 4’-
phosphopantetheinyl transferase from Nostoc (hetI), were expressed in 
Saccharomyces cerevisiae.  To compare expression levels, one of the three PUFA-
PKS genes was also expressed in the methylotrophic yeast Pichia pastoris.  Two 
components of the PUFA-PKS required total codon optimization for expression of 
full-length protein in S. cerevisiae.  Yeast transformants expressing the full-length 
gene products of ORFs A, B, C, and hetI produced DHA and DPA as the only PUFAs 
found in the profile. 
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Chapter 3 Introduction  
 
 Long-chain polyunsaturated fatty acids (LCPUFAs) such as DHA and EPA 
are currently only available from three commercialized sources; fish oils, egg 
phospholipids, and single cell oils of fermentable fungi and microalgae.  Industry has 
recognized rising demand, and thus a need for LCPUFAs from cheaper sustainable 
sources; a need which can be most effectively met by developing transgenic oilseed 
crops capable of producing PUFAs.  However, before a crop plant is genetically 
engineered to produce PUFAs, it is prudent to validate PUFA biosynthesis genes in 
faster-growing model organisms such as yeasts or bacteria, to avoid some “trouble-
shooting” of gene expression problems with slow-growing plant hosts (assuming that 
the problems arise from the heterologous genes themselves and would be shared in 
any host organism).  Components of the Schizochytrium PUFA-PKS have been 
successfully expressed in Escherichia coli, and transformed clones produced DHA 
and DPA n6 (Hauvermale et al., 2006).  Bacteria most appropriately model gene 
expression in plant plastids, but yeasts are a more rational model for expression of 
heterologous genes in plant cytosol.   
 Both S. cerevisiae and P. pastoris (Macauley-Patrick, 2005) have well 
developed systems for transformation, genetics, and biochemistry and have been used 
as model eukaryotes many times.  S. cerevisiae has been the subject of a pioneering 
genome sequencing project (http://www.yeastgenome.org/cite.shtml) and has been 
used as a model specifically for plant systems several times (Dujon, 1996 and Bird, 
2005).  The feasibility of expressing heterologous genes involved in PUFA 
biosynthesis in S. cerevisiae has been well documented (Wallis, 2002), and specific 
precedence for the use of S. cerevisiae as a model for the production of EPA and 
  72
DHA has already been set by Beaudoin et al. (2000) and Meyer et al. (2004), 
respectively.  However, all of these studies used elongase and desaturase genes of the 
classic pathway to reconstitute a PUFA pathway in yeast.  As a result, these 
transgenic yeasts accumulate every intermediate fatty acid of the classic pathway in 
greater quantities than the desired, terminal fatty acid.  The highest confirmed yield of 
DHA in transgenic yeasts using classical pathway enzymes was less than 0.5% of 
total fatty acids (Meyer et al., 2004), although one group has applied for a patent 
which describes 5.6% DHA as a fraction of total fatty acids from a transgenic strain of 
Yarrowia lipolytica (Damude et al., 2006). 
 Heterologous PKS systems have also been expressed in yeast, first by Kealy et 
al. (1998), who successfully created transgenic yeast capable of synthesizing 6-
methylsalicylic acid (6-MSA) after induction of the 6-MSA synthase from Penicillium 
patulum.  This study was also the first to highlight the contribution of 4’-
phosphopantetheine transferases (PPTases) in heterologous PKS function.  Because 6-
MSA synthase is an apoenzyme, conversion to its holo-form requires esterification of 
a phosphopantetheine group to a key serine residue of an acyl-carrier protein (ACP) 
domain.  Transgenic yeasts expressing the 6-MSA synthase were only capable of 
synthesizing 6-MSA when co-transformed with an accessory 4’-phosphopantetheine 
transferase (PPTase). 
 All fatty acid synthases (FAS) and PKSs have at least one ACP domain.  
However the Schizochytrium PUFA-PKS is remarkable in that it has nine tandem 
ACP domains, all of which presumably require an esterified phosphopantetheine 
group to function.  Unfortunately, at the time of this study, no Schizochytrium 4’-
phosphopantetheinyl transferase had yet been discovered.  Therefore, heterologous 
PPTases were considered to assist in the expression of the holo-form of the 
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Schizochytrium PUFA-PKS in yeast.  This need was observed with transgenic bacteria 
expressing the Schizochytrium PUFA-PKS, which required further transformation 
with a heterologous PPTase before clones were capable of DHA production 
(Hauvermale et al., 2006).  Phylogenetically, PPTases have been generally divided 
into two families; PKS-types and FAS types (Lambalot et al., 1996).  The PPTases 
chosen to transfer the required phosphopantetheine group to the PUFA-PKS 
expressed in bacteria were HetI from Nostoc sp. and Sfp from Bacillus subtilis, both 
of which are PKS-type PPTases.   
 Nostoc also has a PKS-like fatty acid synthase, presumably involved in the 
production of hydroxy-fatty acids for the organism’s oxygen impermeable heterocyst 
(Campbell et al., 2004).  Elements of the Nostoc PKS are very similar in primary 
sequence to elements of the Schizochytrium PUFA-PKS and the order of domains in 
the Nostoc PKS locus corresponds exactly to the translated order of domains in the 
Schizochytrium PUFA-PKS (James Metz, Martek Biosciences, Boulder, CO, personal 
communication).  The Nostoc PPTase, HetI, is encoded near the end of the Nostoc 
PKS locus and is likely involved in the phosphopantetheinylation of the Nostoc PKS 
(James Metz, Martek Biosciences, Boulder, CO, personal communication and Black 
and Wolk, 1994).   
 PPTases are generally considered to be relatively specific to their 
corresponding ACPs.  An exception to this is the PPTase Sfp, which is one of two 
PPTases found in Bacillus subtilis.  B. subtilis has 43 phosphopantetheine-dependent 
ACP domains, of which it can use Sfp to convert at least 40 to a holo-ACP (Mootz et 
al., 2001).  Because of this remarkable promiscuity, Sfp has been used as a PPTase 
for several other heterologous PKS and FAS systems besides the Schizochytrium 
PUFA-PKS and the previously mentioned 6-methylsalicylic acid synthase (Kealey et 
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al., 1998), including 6-deoxyerythronolide B synthase (Pfeifer et al., 2001) and 
yersiniabactin synthase (Pfeifer et al., 2003) among others. 
 As mentioned, the compatibility of HetI and Sfp with the Schizochytrium 
PUFA-PKS has previously been demonstrated by heterologous expression in E. coli 
(Hauvermale et al., 2006).  In this study, we examine the expression of the 
Schizochytrium PUFA-PKS genes in the yeasts Saccharomyces cerevisiae and Pichia 
pastoris. 
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Chapter 3 Materials and Methods 
 
 Host strains, transformations, and culture conditions   
 All vectors and constructs were propagated in E. coli UltraMax DH5-α FT 
chemically competent cells for plasmid purification and transformation of S. 
cerevisiae, or P. pastoris. 
 Yeast cell cultures were conducted according to the manufacturer’s protocol 
(Invitrogen, Carlsbad, CA).  The haploid S. cerevisiae strain BY4734 (MATα, his3-
200, leu2-Δ0, met15-Δ0, trp1-Δ63, ura-3Δ0) (ATCC, Manassas, VA) (Brachmann et 
al., 1998) and the diploid strain InvSc1 (MATa his3-Δ1, leu2, trp1-289, ura3-52) 
(Invitrogen, Carlsbad, CA) were transformed using a method described elsewhere 
(Lippmeier et al., 2002).  The P. pastoris strains GS115 (his4) and SMD1168 (his4, 
pep4) were transformed and cultured according to the manufacturer’s protocol 
(Invitrogen, Carlsbad, CA).  All yeast media components were purchased from Q-
Biogene (Carlsbad, CA).  Plasmids were purified from small and large-scale bacterial 
cultures using the appropriate Qiagen kits (Valencia, CA).  S. cerevisiae transformants 
were grown on glucose medium (with 2% agar (w/v)) or raffinose broth and galactose 
induction medium as per the manufacturer’s instructions (cat# V8251-20, Invitrogen, 
Carlsbad, CA). 
 General vector construction 
 For all cloning procedures, restriction enzymes, alkaline phosphatase, and 
mung bean nuclease were purchased from New England Biolabs (Beverly, MA) and 
used according to the manufacturer’s instructions.  Synthetic linker and primer 
oligonucleotides were purchased from Sigma-Genosys (The Woodlands, TX).  PCR 
products were amplified with Pfu DNA polymerase (Stratagene, La Jolla, CA).  
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Restriction fragment and amplicon purifications were carried out with either PCR 
clean-up kits or Qiaex gel extraction kits from Qiagen (Valencia, CA).  agarose gels 
were made with 1% SeaKem agarose or 1% low-melt agarose (Cambrex Bio Science 
Rockland, Inc., Rockland, ME).  DNA ligations were performed with the Rapid DNA 
Ligation Kit (Roche Diagnostics Corporation, Indianapolis, IN) and 2 µL of each 
ligation were used to transform DH5-α competent cells (Invitrogen, Carlsbad, CA).  
Transformed bacterial colonies were grown in 5 mL cultures of Luria broth (LB) with 
100 µg/mL ampicillin (Sambrook and Russell, 2000).  Plasmids were extracted from 
cultures with miniprep kits (Qiagen).  All constructs were verified by DNA 
sequencing (Lark Technologies, Houston, TX).  All reagents and kits described were 
used according to the manufacturer’s instructions unless otherwise noted. 
 Codon optimization and nucleic acid analysis software 
 Initial gene design and complete gene re-synthesis of Schizochytrium ORFs A, 
B and C were conducted by Blue Heron Biotechnology, Inc. (Bothell, WA).  Codon 
optimization was based on a hybrid Saccharomyces cerevisiae/Arabidopsis thaliana 
codon table (Supplement Table 3.1).  Other software used in the design of codon-
optimized genes included NetGene2 (Hebsgaard et al., 1996, Brunak et al., 1991) and 
the “mRNA 3’-processing Site Predictor” (Graber et al., 2002).  All other DNA 
analyses were done using the Lasergene suite of applications (DNAstar, Madison, 
WI).  Each synthetic ORF was appended with sequences to facilitate ligation to 
transformation vectors: Upstream - AAG CTT GTG CAG TCA AGT GCG CAA 
AAC CAT G, Downstream - TAA CCC GGG TCT AGA (start and stop codon 
positions are underlined).  Gene and protein sequences were occasionally compared to 
locally-installed “standalone” or public sequence databases using the basic local 
alignment search tool (BLAST) (Altschul et al., 1997). 
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 S. cerevisiae and P. pastoris expression vector construction 
 Bacterial expression vectors harboring wild type Schizochytrium ORFs A 
(pJKpBR115LIpBSK:ORFA) and C (pJK501pBSK:ORFC), a modified version of 
ORF B (pJK667pBSK:ORFB), and genes encoding two different 4’-
phosphopantetheinyl transferases were kindly provided by Jerry Kuner (Martek 
Biosciences Boulder Corp., Boulder, CO).  The S. cerevisiae vectors pYES2/CT, 
pYES3/CT, pYES6/CT (Invitrogen, Carlsbad, CA), pRS423, pRS424, and pRS425 
(ATCC, Manassas, VA) (Brachmann et al., 1998) were also acquired.  Unless 
otherwise stated, all of the ligations described below were immediately used to 
transform bacteria from which plasmids were prepared for verification and subsequent 
manipulations. 
  ORF C expression constructs - The plasmid pJK501pBSK:ORFC was 
cut with EcoRI and NdeI and ligated to the oligonucleotide linkers FL5’ - AATTCAA 
and FL3’ - TATTG.  The resulting plasmid was designated pKCFL and cut with 
HindIII and XbaI to liberate a 4526 bp fragment which was ligated to HindIII/XbaI-
digested pYES2/CT to generate the plasmid pYES2/ORFCwt.  The plasmid pKCFL 
was also cut with HindIII and NheI and ligated to a similarly cut sample of 
pYES2/CT.  A plasmid resulting from this ligation was then cut with KpnI and XbaI 
to yield a fragment of 10,204 bp.  This vector fragment was ligated to a 285 bp 
fragment derived by KpnI/XbaI digestion of an amplicon created with primers, L5’ 
(GAC TGG GCC CCT ACG CCG TCA ACC TCA T) and L3’ (GAC TTC TAG 
AGA GCG CGG TTG GTG GGC TC), directed against pJK501pBSK:ORFC.  The 
product of this ligation was used to transform competent E. coli cultures and the 
resulting vector was named pYES2/ORFCxKpn.  This was linearized with KpnI alone 
  78
and ligated to a 4230 bp KpnI fragment from pYES2/ORFCwt to create the final 
construct pYES2/ORFCwt/CT.   
  ORF B expression constructs - For construction of pYES3/ORFBss/CT 
and pYES3/ORFBss, the unique ClaI site of pYES3/CT was first destroyed by the 
same method applied to pYES6/CT, but in this instance generating the vector 
pYES3/CTxCla.  The ORF B fragment, flanked by BamHI and NotI restriction sites, 
was liberated by digestion from pJK667pBSK:ORFB and subcloned to BamHI and 
NotI-digested pYES3/CTxCla to create the vector pYES3/ORFBss.  This was 
digested with NotI, purified, and digested again with ClaI and NotI to linearize the 
11,968 bp vector fragment.  Finally, this was then ligated to the linkers; B-CT-L5 
(CGA TGA CAC ATA CGT CCC GGC CGG AAG CTG C) and B-CT-L3 (GGC 
CGC AGC TTC TCG GCC GGG ACG TAT GTG TCA T) to create 
pYES3/ORFBss/CT.  ORF B was also cloned for expression in the P. pastoris vector 
pPIC3.5K.  Briefly, a 6292 bp fragment was purified from an HpaI/PmeI/BamHI 
digest of pYES3/ORFBss/CT.  This fragment was ligated to pPIC3.5K, previously 
digested with SnaBI and BamHI to create the vector pPIC3.5K/ORFBss/CT.  It is 
important to note that the sequence of ORF Bss is different from that of wild type 
ORF B in that ORF Bss has a short stretch of altered serine codons (Hauvermale et 
al., 2006).  The full sequence of ORF Bss is included in Supplement 3.2. 
    The S. cerevisiae construct for expressing the synthetic version 
of ORF B, designated pYES3/ORFBbh, was made by ligation of the fragment 
encoding ORFBbh synthetic gene from digestion of an ORFBbh synthetic gene 
construct (in a modified pUC vector, as delivered by the manufacturer, see 
Supplement 3.2) with HindIII and XbaI, to similarly digested pYES3.  Properly 
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ligated constructs were used for bacterial transformations, screened, and isolated 
according to standard procedures described. 
  ORF A expression constructs - A new S. cerevisiae transformation 
vector was constructed for carrying ORF A.  First, the ClaI site of pYES6/CT was 
destroyed by restriction digestion, fill-in blunting with Pfu polymerase, and ligation to 
create the vector pYES6/CTxCla which was purified from subsequent bacterial 
transformants of the ligation mix.  Second, a 1753 bp PCR amplicon generated with 
the primers PO-Leu5’Nhe (GAC TGC TAG CTT AAG CAA GGA TTT TCT TAA 
C) and PO-Leu3’Bam (GAC TGG ATC CTC CTG ATG CGG TAT TTT CTC C), 
specific to the vector template pRS425, was digested with BamHI and NheI and 
ligated to the 4913 bp fragment of a pYES6/CTxCla BglII/NheI digest.  The vector 
resulting from subsequent bacterial transformations, pYES-Leu/CT, was digested with 
KpnI and XbaI and ligated to a 8812 bp fragment encoding ORF A liberated from 
pJKpBR115LIpBSK:ORFA by digestion with KpnI and XbaI.  The vector from this 
step was verified by restriction digests after being purified from a specific 
transformant of the ligation mix.  This vector was then digested with EcoRI and NdeI 
and ligated to the linkers ORFA-FL-5 (AAT TCG GTA CCA A) and ORFA-FL-3 
(TAT TGG TAC CG), cloned, linearized with KpnI, and re-ligated to produce the 
vector pYES-Leu/ORFAwt.  An amplicon-linker was then prepared by PCR with the 
primers ORFA-CT.L-5 (GAC TAT CGA TGA CGT GCT CTC GTG CAC C) and 
ORFA-CT.L-3 (GAC TTC TAG AGA AGG CAA GGC TGT CCG T), using 
pJKpBR115LIpBSK:ORFA as a template.  The resulting 403 bp amplicon-linker, 
ORFA-CT.L, was digested with ClaI and XbaI and ligated to the 14,960 bp fragment 
of a ClaI/XbaI digest of pYES-Leu/ORFAwt to yield the construct pYES-
Leu/ORFAwt/CT.   
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   The S. cerevisiae construct destined to express the synthetic 
version of ORF A, designated pYES-Leu/ORFAbh, was generated by digestion of the 
ORFAbh synthetic gene (in pUC, as delivered by the manufacturer) with HindIII and 
XbaI and ligation of the purified ORFAbh fragment to similarly digested pYES3.  
Properly cloned constructs were screened and isolated according to standard 
procedures described. 
  4’-Phosphopantetheinyl transferase constructs - The 4’-
phosphopantetheinyl transferases (PPTases), Sfp and HetI, were cloned into a 
customized vector, pYES-His/CT.  Specifically, a 1221 bp amplicon was obtained 
from pRS423 by PCR using the primers PO-HIS3.5’SPE (GAC TAC TAG TCT AAG 
AAA CCA TTA TTA TCA T) and PO-HIS3.3’BAM (GAC TGG ATC CAG CTT 
TAA ATA ATC GGT GTC A).  This amplicon was digested with SpeI and BamHI 
while the vector pYES6/CTxCla was digested with NheI and BglII.  The resulting 
4913 bp fragment of pYES6/CTxCla was ligated to the compatible cohesive ends of 
the pRS423-derived amplicon to create the basic vector pYES-His/CT, which was 
used for expression of the PPTases.   
   (A) Sfp from Bacillus subtilis (genbank accession X63158) was 
PCR-amplified from a construct provided by Jerry Kuner (Martek Biosciences, 
Boulder, CO) with the 5’ primer SFP5’BAMHI (GAC TGG ATC CAA AAA TGA 
AGA TTT ACG GAA TTT AT) and one of two 3’ primers; either SFP3’XBAI-
NOTAG (GAC TTC TAG ATT AAA GCT CTT CGT ACG A) or SFP3’XBAI-TAG 
(GAC TTC TAG ATA AAA GCT CTT CGT ACG A) to create fragments of 685 bp 
and 682 bp, respectively.  These two amplicons and pYES-His were digested with 
BamHI and XbaI and ligated separately to produce the vectors pYES-His/Sfp and 
pYES-His/Sfp/CT. 
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   (B) HetI from Nostoc sp. PCC 7120 (accession L22883) was 
PCR amplified from a construct provided by Jerry Kuner (Martek Biosciences, 
Boulder, CO) with the 5’ primers HetI5’Bam (GAC TGG ATC CGC CAC CAT GTT 
GCA GCA TAC TTG GCT ACC AAA ACC C) and one of two 3’ primers; either 
HetI3’Xba-tag (GAC TTC TAG AAT AAT GCC AGA ATT TTG GCT GC) or 
HetI3’XbaI (GAC TTC TAG ATC AAT AAT GCC AGA ATT TTG GCT GC) to 
create fragments of 737 bp and 740 bp, respectively.  These two amplicons and 
pYES-His were digested with BamHI and XbaI and ligated separately to produce the 
vectors pYES-His/Het and pYES-His/Het/CT. 
 Fatty acid derivitization and analysis 
 Free fatty acids were extracted from freeze-dried pellets and converted to fatty 
acid methyl esters (FAMEs) as described in Morrison and Smith (1964) but at 1/10th 
scale to accommodate the lower biomass yields when 10 mL culture volumes were 
used.  Specifically, dry pellets were boiled for 5 minutes with 0.3 mL of 1 mM 
butylated hydroxy toluene (BHT) in toluene and 0.8 mL of 0.5 N NaOH in methanol.  
This mixture was then treated with a mixture of BF3 in methanol (Alltech Assoc., 
Deerfield, IL) and boiled for an additional 30 minutes.  The reactions were allowed to 
cool before extracting FAMEs with 2 mL of hexane.  Fame preparations were reduced 
to dryness under N2 and resuspended in a buffer appropriate for HPLC.  FAMEs 
destined for analysis by gas chromatography (GC) were doped with 25 mg of 19:0 to 
serve as an internal standard. 
  Gas Chromatography - One microliter injections of FAMEs were 
separated on a gas chromatogram fitted with a flame-ionizing detector and a 
FAMEWAX 30-meter column (0.25 mm id, 0.25 df).  FAME separations were 
performed as described by Arterburn et al. (2000).  Eluted FAMEs were identified by 
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comparison to authentic standards and quantified by comparison to the internal 
standard. 
 RNA isolation and Northern Blotting 
 Extracts of total RNA from induced and non-induced logarithmic-phase 
cultures of S. cerevisiae transformants were prepared using the RNAeasy midiprep kit 
(Qiagen, Carlsbad, CA).  RNA preparations were electrophoresed using gels of 2.2 M 
formaldehyde and 1% agarose (Sambrook and Russell, 2000) and transferred to 
Nytran-N membranes with a Turboblotter according to the manufacturer’s protocols 
(Schliecher and Schuell, Keene, NH).  
 Three probes directed against PUFA-PKS genes were prepared from: (i) a 
fragment containing the entire reading frame of ORF A (which was gel purified after 
digestion from pJKpBR115LIpBSK:ORFA with KpnI and XbaI), (ii) a fragment 
containing all of ORF B from pJK667pBSK:ORFB (which was similarly isolated 
after digestion with BamHI), and (iii) a fragment containing all of ORF C (liberated 
from pJK501pBSK:ORFC by digestion with NdeI and NheI).  RNA Millennium™ 
markers (Ambion, Austin, TX) were electrophoresed and blotted with total RNA 
samples, but were probed with lambda phage DNA.  Probes were synthesized using 
either the Random Primer Probe Labeling kit (Invitrogen, Carlsbad, CA) or the 
Proligo Probe kit from Promega (Madison, WI) and dCT[32P] (ICN, Costa Mesa, CA).  
Probe hybridizations were performed as described by Sambrook and Russell (2000).  
After drying, blots were wrapped in cellophane and imaged on a BioRad Personal 
Molecular Imager FX (BioRad, Hercules, CA). 
 Western Blots 
 Total protein lysates were prepared from induced and non-induced cultures of 
yeast transformants using the manufacturer’s protocol (cat# V8251-20, Invitrogen, 
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Carlsbad, CA).  Lysates were electrophoresed with the Mini-Protean II SDS-PAGE 
gel apparatus fitted with 4-20% Tris-HCl or 4-12% bis-tris acrylamide gels in glycine 
buffer or 10x MOPS buffer (respectively) as recommended by the manufacturer 
(BioRad, Hercules, CA).  Proteins were transferred to PVDF membranes using a 
Criterion Blotter apparatus (BioRad, Hercules, CA).  Western blots were probed with 
either a monoclonal anti-6xHis epitope antibody (Invitrogen, Carlsbad, CA) or ORF-
specific rabbit antisera provided by Jerry Kuner and Brad Rosenzweig (Martek 
Biosciences Boulder Corp.), which were then bound with alkaline phosphatase-
conjugated, goat anti-rabbit, or alkaline phosphatase-conjugated goat anti-mouse 
secondary antibodies as appropriate  (Sigma Chemical, St. Louis, MO).  Antibody 
binding was conducted using standard protocols (Sambrook and Russell, 2000).  For 
signal development, blots were washed in 1x TBS three times before applying 
BCIP/NBT reagent (KPL, Gaithersburg, MD) 
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Chapter 3 Results 
 
 Construction of Saccharomyces cerevisiae and Pichia pastoris expression 
vectors 
  S. cerevisiae - Ten constructs were made for expression of wild-type 
PUFA-PKS genes from Schizochytrium in S. cerevisiae (Table 3.1).  Of these, six 
required two or more cloning steps.  The genes involved in the PUFA-PKS were large 
and consequently difficult to clone.  All three ORFs were individually sub-cloned into 
a construct alone and as a fusion with a C-terminal V5 epitope/6xHis tag.  The genes 
encoding two accessory proteins (Sfp and HetI), encoding 4’-phosphopantetheinyl 
transferases, were sub-cloned in a similar manner.  Several S. cerevisiae strains were 
considered for their suitability as a host for a heterologous biochemical pathway.  
Two strains were selected for having four or more auxotrophic selectable markers and 
good growth characteristics; InvSc1 (Invitrogen) and BY4734 (Brachmann et al., 
1998).  Both of these strains carry at least four auxotrophy-inducing mutations 
requiring supplementation with histidine, leucine, tryptophan, and uracil.  Each 
auxotrophy is the result of an engineered gene disruption or deletion and consequently 
never presents “leaky” phenotypes.  The pYES vectors were chosen to mediate 
expression of these genes primarily for their facile multiple cloning sites and epitope 
tags.  Unfortunately the pYES suite of vectors only employ selectable markers that 
confer tryptophan or uracil prototrophy.  Therefore, two additional vectors were 
constructed in which the histidine and leucine prototrophy-conferring selectable 
markers (from the pRS vectors) were imported to the pYES backbone (Figure 3.1).  In 
summary, tagged and untagged constructs were made for each ORF: ORF A was 
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Vector name Expressed protein of 
interest 
C-terminal 
6xHis/V5 tag 
fusion? 
Source 
pYES2/CT n/a n/a Invitrogen 
pYES3/CT n/a n/a Invitrogen 
pRS423 n/a n/a Brachmann et al., 
1998 
pRS425 n/a n/a Brachmann et al., 
1998 
pYES-Leu/CT n/a n/a this study 
pYES-His/CT n/a n/a this study 
pYES-Leu/ORFAwt ORF A (wild type) - this study 
pYES-
Leu/ORFAwt/CT 
ORF A (wild type) + this study 
pYES-Leu/ORFAbh ORF A (synthetic) - this study 
pYES3/ORFBss ORF Bss (wild type*) - this study 
pYES3/ORFBss/CT ORF Bss (wild type*) + this study 
pYES3/ORFBbh ORF B (synthetic) - this study 
pYES2/ORFCwt ORF C (wild type) - this study 
pYES2/ORFCwt/CT ORF C (wild type) + this study 
pYES-His/Sfp Sfp  - this study 
pYES-His/Sfp/CT Sfp + this study 
pYES-His/Het HetI - this study 
pYES-His/Het/CT HetI + this study 
pPIC3.5K/ORFBss/CT ORF Bss (wild type*) + this study 
 
Table 3.1.  Relevant yeast expression vectors described in this work.  *Note that ORF Bss 
differs from the true wild type ORF B due to the codon optimization of a short stretch of 
serine residues (see text), otherwise, the rest of this gene is as wild-type. 
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Figure 3.1.  Plasmid map of pYES-Leu/ORFAwt/CT: one of the Schizochytrium ORF 
expression vectors used in this study.  Uncolored elements such as the ampicillin resistance 
cassette (Amp), the URA3 terminator, the GAL1 promoter, the CYC terminator, and the 
bacterial and yeast origins of replication (ori); f1, 2µm, and pUC were common to each 
pYES-based expression vector  The GAL1 promoter and the CYC terminator were used to 
drive expression of each ORF or PPTase (in red).  Features in blue and the URA3 terminator 
correspond to elements involved in expression of a given selectable marker, in this example, 
Leucine auxotrophy (Leu).   
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carried on vectors with the leucine marker, ORF B with the tryptophan marker, and 
ORF C with uracil.  The genes encoding the 4'-phosphopantetheinyl transferases Sfp 
and HetI were carried on vectors with the histidine marker.  Each of these genes was 
expressed by the glucose-repressible and galactose-inducible GAL1 promoter. 
 P. pastoris - The Pichia pastoris expression system is ideally suited for over-
expression of a single protein.  The Pichia vector pPIC3.5K uses the inducible alcohol 
oxidase (AOX) promoter to drive gene expression when the cultures are grown in the 
presence of methanol.  This promoter is more efficient than GAL1 of S. cerevisiae 
and provided a comparison of available promoters between yeasts.  Only ORF B was 
selected for expression analysis in Pichia (Table 3.1) (see discussion). 
 Wild type PUFA-PKS gene expression 
 C-Terminally tagged and untagged versions of each native PUFA-PKS gene 
(ORFs A, B and C) as well as an accessory 4’-phosphopantetheinyl transferase 
(PPTase) gene (sfp or hetI) were used alone or in series to transform both InvSc1 and 
BY4734.  Operating under the assumption that the appropriate start ATG codons of 
each heterologous gene could be recognized by the yeast host, C-terminally tagged 
versions of each ORF and PPTase were constructed to specifically determine if they 
could be expressed as full-length proteins, even if subsequent proteolysis affected 
their observed size.  Two sets of quadruple-transformants (ORFs A, B, C, and a 
PPTase) were made and several colonies from each set were grown, induced, and 
screened for PUFA production.  None was observed.  Potential causes for this result 
were investigated.  Protein extracts of S. cerevisiae transformants expressing the 
native and epitope tagged ORFs were analyzed by western blot (Figure 3.2).  Western 
blots of protein extracts from induced cultures of the transformants indicated 
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Figure 3.2.  Western blot detection of Schizochytrium ORFs A, B, C and two 4’-
phosphopantetheinyl transferases expressed in induced S. cerevisiae transformant cultures.  
Whole protein extracts were separated by SDS-PAGE and blotted to PVDF membranes.  The 
blot in Panel A was probed with an anti-V5 antibody-Alkaline Phosphatase conjugate.  
Extracts from S. cerevisiae transformants of  pYES2/ORFCwt/CT - “C”, pYES-His/Sfp/CT - 
“Sfp” and the manufacturer’s pYES2/LacZ/CT - “LacZ” positive control (left to right).  Full-
length ORF C is indicated by the black arrow.  “Lane 1” of each of the three blots (one blot in 
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each panel) of Panel B was loaded with extracts of pYES-His/Het/CT transformants.  Each 
“Lane 2” was loaded with extracts of an S. cerevisiae triple transformant; pYES-
Leu/ORFAwt, pYES3/ORFBss, and pYES2/ORFCwt/CT.  The blot shown on the first panel 
was probed with a rabbit anti-ORF C antisera “ScC1-A” (kindly provided by Brad 
Rosenzweig, Martek Biosciences, Boulder CO).  The blot shown in the middle panel was 
probed with a rabbit anti-ORF B antisera “ScB1-B” (Brad Rosenzweig, Martek Biosciences, 
Boulder, CO).  These blots were then probed with a secondary goat-anti-rabbit, alkaline 
phosphatase-conjugated antibody for signal amplification.  The blot shown in the right-most 
panel was probed with an anti-V5 antibody-alkaline phosphatase conjugate, “anti-V5”.  
Extracts from transformants of C-terminal tagged or untagged ORF A (pYES-
Leu/ORFAwt/CT and pYES-Leu/ORFAwt) (data not shown) and ORF B (pYES3/ORFBss) 
(middle panel, “ScB1-B” lane 2) did not display any detectable signals beyond non-specific 
background.  The signals for full-length tagged Het I and ORF C are clear (anti-V5 lanes 1 
and 2, respectively).  Non-specific background signals are also seen in lane 1 of the first and 
second blots.  Extracts from transformants of untagged ORF C probed with ORF C -specific 
anti-sera (ScC1-A, Lane 2) were similar to that of tagged ORF C (anti-V5, Lane 2).  Arrows 
indicating full-length ORF C (~165.5 kDa) and HetI (~27 kDa) are shown. 
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that ORFs A and B were not expressed well enough to be detected as full-length 
proteins.  Several weakly-staining low-molecular weight bands could be discriminated 
among the non-specific background staining of these blots, but they were not clear 
enough to be resolved in digital images (negative results for ORF B blotting are 
shown in Figure 3.2, Panel B).  This result was interpreted as an indication that ORF 
A and ORF B proteins were both poorly expressed and additionally suffering 
proteolysis.  Full-length ORF C was highly expressed but also suffered from 
proteolysis (Figure 3.2).  Sfp (Figure 3.2A) and HetI (Figure 3.2B and Figure 3.6, 
discussed below) were expressed well enough to detect and were not degraded.  
Before the apparent proteolysis could be addressed or corrected, the efficiency of 
ORF gene transcription and translation had to be verified.  The inadequacy of S. 
cerevisiae as a host for high-level protein expression was also considered. 
 To determine if poor transcription was contributing to the lack of expressed 
PUFA-PKS components, northern blots were performed with RNA extracted from 
induced cultures of S. cerevisiae transformants.  Transcript levels of all three ORFs 
were detected suggesting that transcription was not limiting production of the 
corresponding proteins.  The transcript of ORF B was less abundant than that of ORFs 
A and C, but not so much as to suspect that it wasn’t abundant enough to allow a 
translated product (Figure 3.3).   
 The alcohol oxidase promoter (AOX) of the Pichia pastoris system is 
generally considered to be stronger than any promoters available in S. cerevisiae 
transformation systems.  To test if higher transcript levels could overcome limitations 
in translation, transformants of Pichia constructs harboring an epitope-tagged fusion 
of ORF B with expression driven by AOX, were also generated.  These transformants 
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Figure 3.3.  Northern blot of total RNA extracted from S. cerevisiae transformants of pYES-
Leu/ORFAwt/CT - lane “A”, pYES3/ORFBss/CT - lane “B”, and pYES2/ORFCwt/CT - lane 
“C”.  An RNA ladder ranging from 9.0 - 1.0 kb is shown at left.  Each ORF lane was probed 
with a randomly-primed, radiolabeled oligonucleotide preparation made from excised 
portions of each corresponding ORF gene.  The RNA ladder was probed with radiolabeled 
lambda-phage DNA.  PUFA-PKS ORF transcripts are expressed in S. cerevisiae at detectable 
levels and predicted sizes. 
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were selected for high-copy numbers of integrated plasmid by secondary selection in 
increased concentrations of Geneticin® (G418 sulfate).  Of 192 randomly selected 
primary transformants, eight were resistant to the highest concentration of antibiotic 
(4 mg/mL).  Three of these eight clones expressed detectable levels of full-length 
ORF B (Figure 3.4) suggesting that problems in expression of this gene could be 
overcome by improved transcription.  However as mentioned, promoters of similar 
strength to that of AOX in P. pastoris do not exist for S. cerevisiae.  Therefore, other 
means to improve expression of ORFs A and B proteins in S. cerevisiae were 
investigated.  Specifically, codon-optimized versions of these two Schizochytrium 
PUFA-PKS genes were created. 
 Synthetic PUFA-PKS gene expression   
 The codon use of each Schizochytrium PUFA-PKS gene was compared to the 
codon bias of all known S. cerevisiae coding regions.  ORFs A and B were found to 
contain a number of codons that are used only rarely in S. cerevisiae, the arginine 
codon CGC and the leucine codon CTC being the most extreme examples (Figure 
3.5).  To eliminate the possibility that codon usage issues were preventing efficient 
heterologous expression of these ORFs in S. cerevisiae, fully synthetic PUFA-PKS 
genes encoding identical protein products, but with idealized codon composition, 
were designed.  Since S. cerevisiae was found capable of expressing full-length ORF 
C, codon optimization and gene synthesis was restricted to ORFs A and B.  Because 
of the high cost of gene synthesis and the potential for these genes to be used in future 
higher plant transformations, we chose to base our codon optimization on a hybrid S. 
cerevisiae/Arabidopsis thaliana codon table (Supplement Table 3.1).   A number 
of conceptual sequences, codon optimized for S. cerevisiae (and A. thaliana) 
expression, were created for both genes.  These conceptual sequences were selected 
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A   
B     
Figure 3.4.  Western blots of SDS-PAGE separated protein extracts from six P. pastoris 
transformants of pPIC3.5K/ORFBss/CT and untransformed, wild-type cells “wt”.  Cultures 
were grown in methanol induction medium before harvesting.  The first blot (Panel A) was 
probed with an anti-V5 antibody-alkaline phosphatase conjugate.  The second blot (Panel B) 
was probed with the primary anti-ORF B rabbit anti-sera ScB1-B and a monoclonal, alkaline 
phosphatase-conjugated, goat anti-rabbit, secondary antibody.  The top-most visible bands of 
the blot in Panel A are ORF B (~228 kDa with the fused epitope tag).  In Panel B, the band 
corresponding to ORF B is marked with a black arrow. 
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Figure 3.5.  Codon usage comparison between the S. cerevisiae genome and Schizochytrium 
ORF A (Panel A) and ORF B (Panel B).  Codon frequencies of Schizochytrium ORFs are 
represented by red bars, codon frequencies of all known S. cerevisiae coding regions are 
represented by black bars.  Mean differences between the total codon frequencies of the S. 
cerevisiae genome and each ORF were calculated: ORF A - 31.41% and ORF B - 28.56%.  
The data was generated using the “Graphical Codon Usage Analyzer” which can be found at: 
http://gcua.schoedl.de/ 
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 for low levels of predicted secondary structure to reduce potential impediments to 
protein translation such as hairpin stem-loops and other self-complimentary structures 
(Katz, 2003).  Cryptic S. cerevisiae transcription terminators and higher plant intron 
splice sites in the conceptual sequences were identified and removed or appropriately 
modified using publicly available tools (Hebsgaard et al., 1996, Brunak et al., 1991, 
and Graber et al., 2002).  Yeast terminators and plant splice sites are composed of 
several semi-degenerate, position-specific sequence elements.  Attempts to remove 
these elements by changing the specific nucleotide sequence (while retaining the 
protein sequence and preferred codon bias) would often inadvertently create new 
cryptic terminators or splice sites.  Therefore all sequence modifications were made in 
a step-wise fashion where each change was checked for its desired effect.  The 
conceptual sequences were considered complete only when they did not generate 
scores above software-defined, default threshold values.  The final sequences of each 
optimized gene are shown in Supplement 3.2.   
 S. cerevisiae transformants harboring synthetic ORF A and B, with wild-type 
ORF C and HetI were generated.  A transgenic yeast carrying the vectors pYES-
LEU/ORFAbh, pYES3/ORFBbh, pYES2/ORFCwt, and pYES-His/Het/CT was 
designated BRY 4.5.  A negative control strain transformed with pYES3/ORFBbh, 
pYES2/ORFCwt, and pYES-His/Het/CT, but lacking pYES-LEU/ORFAbh was also 
prepared and designated BRY 3.3.  Both strains were grown at 30 °C in induction 
medium.  Analysis of protein extracts from induced transformants by western blot 
indicated that the gene optimization was successful and that synthetic ORFs A and B 
and wild-type C and HetI were expressed as full-length products (Figure 3.6).  As 
previously observed with wild-type ORF C, synthetic ORFs A and B appeared to 
suffer proteolysis but not enough to obscure detection of the full-length PUFA-PKS 
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proteins.  Transformant clones BRY 4.5 and BRY 3.3 were also grown under 
inducing conditions at 30 °C so lipid extracts from these cultures could be used to 
derive FAMEs for analysis by GC.  As shown in Figure 3.7, BRY 4.5 was capable of 
producing both DHA and DPA in small amounts. 
 Because of this success, because codon preferences between S. cerevisiae and 
P. pastoris are similar (data not shown), and because selected strains of S. cerevisiae 
possessed enough selectable markers to easily import all the PUFA-PKS genes, 
further development of the P. pastoris system was abandoned (four selectable markers 
were needed; the Pichia system can only conveniently accommodate two).  Also, at 
the time of this study, strategies for pathway reconstruction in Pichia involving 
successive disruption and complementation of auxotroph-associated loci had not yet 
become commonly available (Nett et al., 2005). 
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Figure 3.6.  Western blot of SDS-PAGE-separated extract of S. cerevisiae clone BRY4.5 
grown at 30 °C (transformed with pYES-LEU/ORFAbh, pYES3/ORFBbh, pYES2/ORFCwt, 
and pYES-His/Het/CT).  The culture was grown in medium containing galactose for 
induction of gene expression except for a negative control culture which was grown in the 
presence of the non-inducing sugar, raffinose (data not shown).  Blots were probed with rabbit 
antisera “ScA2” (anti-ORF A, lane “A”), “ScB1” (anti-ORF B, lane “B”), “ScC1” (anti-ORF 
C, lane “C”), or Anti-6xHis monoclonal (anti-HetI-tag, lane “Het”).  Before signal detection, 
lanes A, B and C were additionally probed with a secondary goat-anti-rabbit, alkaline 
phosphatase-conjugated antibody or a goat-anti-mouse, alkaline phosphatase-conjugated 
antibody.  Each primary antiserum was as diluted for use 1:500 (v/v), secondary antibodies 
and the anti-6xHis monoclonal were diluted 1:1000 (v/v).  Numbers listed on the right 
correspond to the migration of molecular weight markers, in kDa.  The migration of each 
intact protein agrees well with their predicted size (ORF A - 307 kDa, ORF B - 224 kDa, 
ORF C - 165 kDa.  HetI-tag was expected to form a band migrating at approximately 30.3 
kDa.  Protein extracts from negative control transformants and wild type did not produce any 
signals in western blots when treated identically (data not shown).  Lane “Het” and “C” 
contained 20 µg of BRY 4.5 protein extract.  Lanes “B” and “A” contained 40 and 60 µg of 
this same protein extract, respectively.  
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Figure 3.7.  Gas Chromatograms of FAMEs of lipids from cultured yeast transformant BRY4.5 (top) and BRY3.3 (bottom) grown at 30 °C.  BRY 4.5 harbors 
all three Schizochytrium PUFA-PKS ORFs and the 4’-phosphopantetheine transferase HetI (transformed with pYES-LEU/ORFAbh, pYES3/ORFBbh, 
pYES2/ORFCwt, and pYES-His/Het/CT).  BRY3.3 is identical to BRY4.5, except that it lacks a copy of Schizochytrium ORFA (pYES-LEU/ORFAbh).  As 
can be seen in the magnified panels at right, the only two fatty acids unique to BRY4.5 are the PUFAs DHA and DPA.  Levels of 26:0, 24:0 and all other non-
PUFAs are similar.  The fatty acid profiles of BRY3.3 and wild type, untransformed yeast are not significantly different (data not shown).  *19:0 was added 
to FAMEs as an internal standard. 
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Chapter 3 Discussion 
 
 Genes encoding the Schizochytrium sp. PUFA-PKS were expressed in the 
yeast, S. cerevisiae and the complex was capable of producing PUFA but only after 
two of the three PUFA-PKS genes were synthesized with improved codon 
composition.  The ultimate intent of this work is to produce PUFA in a crop plant, but 
the yeast model was initially used to diagnose potential problems with heterologous 
eukaryotic expression.  Among eukaryotes, yeasts possess the most well developed 
molecular biological systems, they grow quickly, and they transcribe and translate 
DNA and RNA in ways common to most eukaryotes.  It was hoped that technical 
issues that might prevent success in an expensive, long-term, heterologous expression 
project in higher plants would be identified and solved more quickly, and at lower 
cost, in yeast. 
 Appropriate yeast host strains were chosen for having a large number of 
auxotrophic marker genes.  The strain BY4734 harbored 5 auxotrophic mutations and 
the strain InvSc1 harbored 4 (all 4 of the InvSc1 auxotrophic phenotypes were also 
possessed by BY4734).  For maximum flexibility, each Schizochytrium ORF gene and 
PPTase gene was carried on a separate expression vector with a unique selectable 
marker.  Two of the needed vectors were commercially available but two others had 
to be custom made.  To ensure uniform expression of the PUFA-PKS complex, each 
gene was paired with the same yeast promoter from the inducible GAL1 gene. 
 This promoter is repressed in the presence of glucose but is expressed 
normally in the presence of galactose (Johnston, 1987).  The system provides an 
excellent means for controlling potentially toxic gene products but is not necessarily 
well suited for high-level protein expression.  This issue has been addressed more 
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effectively with the Pichia pastoris system.  P. pastoris is a methylotrophic yeast, 
capable of using methanol or methylamine as a primary carbon source.  P. pastoris 
also grows to high densities using either glycerol or glucose as a carbon source.  The 
Pichia expression system typically employs the alcohol oxidase promoter, which is 
strongly induced when the cells are grown on methanol.  In fact, the AOX promoter 
serves as the strongest available in a yeast system  This promoter is never fully 
“repressed” as is the case with the GAL1 promoter of S. cerevisiae grown on glucose, 
but when high-level expression is desired, uninduced, “leaky” expression is usually 
inconsequential.  The Pichia system also benefits from the capacity for multiple 
integrations of a single copy of the target gene which can be selected with increased 
concentrations of G418 sulfate and allows further improvements in gene product 
accumulation (for reviews see: Cregg and Higgins, 1995, Nico-Farber et al., 1995, 
and Romanos, 1995). 
 Unfortunately, at the time of this study, the Pichia system was disadvantaged 
by a lack of diversity in selectable markers and the lack of any known episomal 
elements, making it largely unsuitable for the multiple gene transfers involved in 
pathway reconstructions of the sort attempted in this study (PUFA biosynthesis).  
Because Pichia transformation is mediated by homologous recombination, the easy 
application of the AOX promoter is limited to just one gene.  For these reasons and 
those discussed below, the obstacles presented by the S. cerevisiae system were 
judged more tractable than those presented by the P. pastoris system and so efforts 
toward total reconstruction of the PUFA-PKS pathway were focused on 
Saccharomyces. 
 Two of the wild-type genes of the Schizochytrium PUFA-PKS, ORFs A and B, 
could not be expressed as full-length proteins in S. cerevisiae, despite clearly 
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detectable levels of transcript RNA.  Surprisingly, one of these, ORF B, could be 
expressed in P. pastoris.  It was concluded that there may be a number of issues 
contributing to the expression problems in S. cerevisiae.  Transcription of the ORF 
genes in S. cerevisiae did not appear to be impaired although the mRNA signal for 
ORF B may have been somewhat less robust than that of ORF A or ORF C.  
However, the codon usage of the PUFA-PKS genes could have been dissimilar 
enough to yeast codon preferences to partially or completely prevent mRNA 
translation to protein.  In Pichia, this hypothetically reduced rate of translation may 
have been overcome by the elevated rate of AOX promoter-mediated transcription; so 
that abundant mRNAs are “forced” through protein translation despite their imperfect 
codon composition (the codon usage of Pichia is similar to that of S. cerevisiae).  It is 
also possible that, if translation of the ORFs in S. cerevisiae was only partially 
inhibited, proteolysis of the heterologous proteins may represent a second impediment 
to detectable accumulation of protein.  This proteolysis was considered a secondary 
issue and so initial efforts focused on improving the translation of ORF A and B in S. 
cerevisiae. 
  As detailed in the results, these potential translation issues were addressed by 
the design of fully synthetic versions of two of the PUFA-PKS genes, optimized for 
expression in yeasts and plants.  Obviously, the hybrid codon table chosen for this 
optimization was not ideal for either organism; however the theoretical difference in 
codon use between the two genomes was not so great as to expect significant 
contradictory biases.  It was understood that improved expression of the PUFA-PKS 
genes would not directly address secondary problems with proteolysis, but the 
possibility was considered that the PUFA-PKS subunits might be better shielded from 
degradation when assembled as a full complex.  Egner et al. (1993) established 
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precedence for this phenomenon when they reported that mutation or deletion of one 
of the two subunits of yeast FAS resulted in proteolysis of the other unmodified 
subunit.   
 As hoped, the synthetic PUFA-PKS genes were indeed expressed as full-
length proteins (Figure 3.6).  This success was further supported by the observation 
that simultaneous expression of the synthetic PUFA-PKS genes and a PPTase 
conferred an ability to produce the PUFAs DHA and DPA (Figure 3.7).  However, the 
observed ratio of DHA to DPA in yeast transformants was higher than what is 
observed in wild type Schizochytrium or in E. coli strains transformed with this 
PUFA-PKS system (Hauvermale et al., 2006).  In those organisms, the ratio is about 
3:1 (DHA:DPA) but in the yeasts transformed with the PUFA-PKS and a PPTase, the 
ratio is closer to 1:1.  It is not clear why this is so but some hypotheses can be 
established. 
 In many FAS and PKS systems, a thioesterase is required to liberate the acyl 
chain from the enzyme complex to create a free fatty acid destined for secondary 
esterification to CoA or some lipid species (see reviews by Voelker, 1996 and Hunt 
and Alexson, 2002).  In other instances, an acyl transferase may mediate direct acyl 
transfer to a lipid group, without creating a free fatty acid intermediate (Pollard and 
Ohlrogge, 1999, Bayan and Therisod, 1989).  No thioesterase domain has been 
identified in the Schizochytrium PUFA-PKS and the final product (free fatty acid or 
CoA ester) of the synthase is not yet known.  It is possible that some protein, 
endogenous to E. coli but not S. cerevisiae, is capable of performing this unidentified 
last step of PUFA biosynthesis efficiently and promiscuously enough to produce a 
ratio of PUFAs in the organism determined primarily by the flux of DHA and DPA 
from the PUFA-PKS.  The corollary to this hypothesis is that the enzymes involved in 
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acyl transfer in yeast either have a preference for ω-6 over ω-3 PUFA, or that the 
endogenous yeast enzymes are too inefficient to move free fatty acids into esterified 
pools to inhibit any feedback mechanisms the PUFA-PKS may have.  One possible 
way to correct the ratio might include expression of a fifth gene involved in acyl 
transfer, or other aspects of lipid biosynthesis (such as the enzymes of the Kennedy 
pathway) (Kennedy and Weiss, 1956).  If pursued, such an experiment might have the 
added benefit of increasing total PUFA yield in transgenic yeast, as was demonstrated 
by Tonon et al. (2005) with an acyl-CoA synthetase from the diatom Thalassiosira 
pseudonana. 
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Chapter 3 Supplementary Data 
 
1   # /1000 fraction  # /1000 fraction    /1000 fraction    yeast_plant table 
   S. cerevisiae  A. thaliana  difference*100  Hybrid genome    Codon Fraction 
Ala GCA  91967 16.1 0.29  427842 17.6 0.27  2  16.85 0.28 GCA Ala   GCA 0.28 
Ala GCC  71233 12.5 0.22  253877 10.4 0.16  6  11.45 0.19 GCC Ala   GCC 0.19 
Ala GCG  34942 6.1 0.11  217886 8.9 0.14  3  7.5 0.125 GCG Ala   GCG 0.13 
Ala GCT  120208 21.1 0.38  697575 28.6 0.44  6  24.85 0.41 GCT Ala   GCT 0.41 
                                   
Arg AGA  121292 21.3 0.48  457927 18.8 0.35  13  20.05 0.415 AGA Arg   AGA 0.42 
Arg AGG  52441 9.2 0.21  266406 10.9 0.2  1  10.05 0.205 AGG Arg   AGG 0.21 
Arg CGA  17099 3 0.07  152537 6.3 0.12  5  4.65 0.095 CGA Arg   CGA 0.10 
Arg CGC  14638 2.6 0.06  91869 3.8 0.07  1  3.2 0.065 CGC Arg   CGC 0.07 
Arg CGG  9848 1.7 0.04  117195 4.8 0.09  5  3.25 0.065 CGG Arg   CGG 0.07 
Arg CGT  36777 6.5 0.15  220192 9 0.17  2  7.75 0.16 CGT Arg   CGT 0.16 
                                   
Asn AAC  141737 24.9 0.41  508277 20.9 0.48  7  22.9 0.445 AAC Asn   AAC 0.45 
Asn AAT  206516 36.3 0.59  543539 22.3 0.52  7  29.3 0.555 AAT Asn   AAT 0.56 
                                   
Asp GAC  115047 20.2 0.35  420193 17.2 0.32  3  18.7 0.335 GAC Asp   GAC 0.34 
Asp GAT  215249 37.8 0.65  895566 36.7 0.68  3  37.25 0.665 GAT Asp   GAT 0.67 
                                   
Cys TGC  26534 4.7 0.37  171924 7.1 0.41  4  5.9 0.39 TGC Cys   TGC 0.39 
Cys TGT  45462 8 0.63  254179 10.4 0.59  4  9.2 0.61 TGT Cys   TGT 0.61 
                                   
Gln CAA  156586 27.5 0.69  470475 19.3 0.56  13  23.4 0.625 CAA Gln   CAA 0.63 
Gln CAG  69006 12.1 0.31  371091 15.2 0.44  13  13.65 0.375 CAG Gln   CAG 0.38 
                                   
Glu GAA  261115 45.8 0.71  836077 34.3 0.52  19  40.05 0.615 GAA Glu   GAA 0.62 
                                                 
1 Supplement Table 3.1 (continuing) 
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Glu GAG  108666 19.1 0.29  786970 32.3 0.48  19  25.7 0.385 GAG Glu   GAG 0.39 
                                   
Gly GGA  62176 10.9 0.22  592219 24.3 0.37  15  17.6 0.295 GGA Gly   GGA 0.30 
Gly GGC  55103 9.7 0.19  223041 9.2 0.14  5  9.45 0.165 GGC Gly   GGC 0.17 
Gly GGG  34032 6 0.12  249165 10.2 0.15  3  8.1 0.135 GGG Gly   GGG 0.14 
Gly GGT  136434 24 0.47  546544 22.4 0.34  13  23.2 0.405 GGT Gly   GGT 0.41 
 2                                  
His CAC  44112 7.7 0.36  211635 8.7 0.39  3  8.2 0.375 CAC His   CAC 0.38 
His CAT  78282 13.7 0.64  334012 13.7 0.61  3  13.7 0.625 CAT His   CAT 0.63 
                                   
   # /1000 fraction  # /1000 fraction    /1000 fraction    yeast_plant table 
   S. cerevisiae  A. thaliana  difference*100  Hybrid genome    Codon Fraction 
Ile ATA  101628 17.8 0.27  305594 12.5 0.24  3  15.15 0.255 ATA Ile   ATA 0.26 
Ile ATC  97055 17 0.26  452968 18.6 0.35  9  17.8 0.305 ATC Ile   ATC 0.31 
Ile ATT  173137 30.4 0.47  528593 21.7 0.41  6  26.05 0.44 ATT Ile   ATT 0.44 
                                   
Leu CTA  75972 13.3 0.14  240784 9.9 0.11  3  11.6 0.125 CTA Leu   CTA 0.13 
Leu CTC  30538 5.4 0.06  391502 16.1 0.17  11  10.75 0.115 CTC Leu   CTC 0.12 
Leu CTG  59114 10.4 0.11  240472 9.9 0.11  0  10.15 0.11 CTG Leu   CTG 0.11 
Leu CTT  69114 12.1 0.13  589767 24.2 0.26  13  18.15 0.195 CTT Leu   CTT 0.20 
Leu TTA  151850 26.7 0.28  308336 12.6 0.13  15  19.65 0.205 TTA Leu   TTA 0.21 
Leu TTG  153619 27 0.28  508909 20.9 0.22  6  23.95 0.25 TTG Leu   TTG 0.25 
                                   
Lys AAA  240515 42.2 0.58  749448 30.7 0.48  10  36.45 0.53 AAA Lys   AAA 0.53 
Lys AAG  174597 30.7 0.42  798966 32.8 0.52  10  31.75 0.47 AAG Lys   AAG 0.47 
                                   
Met ATG  119008 20.9 1  594807 24.4 1  0  22.65 1 ATG Met   ATG 1.00 
                                   
Phe TTC  103686 18.2 0.41  505253 20.7 0.49  8  19.45 0.45 TTC Phe   TTC 0.45 
Phe TTT  148716 26.1 0.59  534456 21.9 0.51  8  24 0.55 TTT Phe   TTT 0.55 
                                   
Pro CCA  103680 18.2 0.41  393957 16.2 0.33  8  17.2 0.37 CCA Pro   CCA 0.37 
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Pro CCC  38522 6.8 0.15  129838 5.3 0.11  4  6.05 0.13 CCC Pro   CCC 0.13 
Pro CCG  29915 5.3 0.12  207684 8.5 0.17  5  6.9 0.145 CCG Pro   CCG 0.15 
Pro CCT  77417 13.6 0.31  455638 18.7 0.38  7  16.15 0.345 CCT Pro   CCT 0.35 
                                   
Ser AGC  54958 9.7 0.11  273815 11.2 0.13  2  10.45 0.12 AGC Ser   AGC 0.12 
Ser AGT  80728 14.2 0.16  339903 13.9 0.16  0  14.05 0.16 AGT Ser   AGT 0.16 
Ser TCA  106932 18.8 0.21  440264 18.1 0.2  1  18.45 0.205 TCA Ser   TCA 0.21 
Ser TCC  80799 14.2 0.16  270545 11.1 0.13  3  12.65 0.145 TCC Ser   TCC 0.15 
Ser TCG  48582 8.5 0.1  223500 9.2 0.1  0  8.85 0.1 TCG Ser   TCG 0.10 
Ser TCT  134028 23.5 0.26  610403 25 0.28  2  24.25 0.27 TCT Ser   TCT 0.27 
                                   
Thr ACA  101336 17.8 0.3  381774 15.7 0.3  0  16.75 0.3 ACA Thr   ACA 0.30 
Thr ACC  71608 12.6 0.22  252577 10.4 0.2  2  11.5 0.21 ACC Thr   ACC 0.21 
Thr ACG  45120 7.9 0.13  186589 7.7 0.15  2  7.8 0.14 ACG Thr   ACG 0.14 
Thr ACT  115551 20.3 0.35  431031 17.7 0.34  1  19 0.345 ACT Thr   ACT 0.35 
   # /1000 fraction  # /1000 fraction    /1000 fraction    yeast_plant table 
   S. cerevisiae  A. thaliana  difference*100  Hybrid genome    Codon Fraction 
Trp TGG  58581 10.3 1  304101 12.5 1  0  11.4 1 TGG Trp   TGG 1.00 
                                   
Tyr TAC  83397 14.6 0.44  337738 13.9 0.48  4  14.25 0.46 TAC Tyr   TAC 0.46 
Tyr TAT  107653 18.9 0.56  359583 14.8 0.52  4  16.85 0.54 TAT Tyr   TAT 0.54 
                                   
Val GTA  67408 11.8 0.21  242644 10 0.15  6  10.9 0.18 GTA Val   GTA 0.18 
Val GTC  65876 11.6 0.21  312848 12.8 0.19  2  12.2 0.2 GTC Val   GTC 0.20 
Val GTG  60537 10.6 0.19  423929 17.4 0.26  7  14 0.225 GTG Val   GTG 0.23 
Val GTT  125255 22 0.39  668037 27.4 0.41  2  24.7 0.4 GTT Val   GTT 0.40 
                                   
End TAA  5692 1 0.45  22128 0.9 0.36  9  0.95 0.405 TAA End   TAA 0.41 
End TAG  2682 0.5 0.23  12250 0.5 0.2  3  0.5 0.215 TAG End   TAG 0.22 
End TGA  3804 0.7 0.32  26304 1.1 0.44  312  0.9 0.38 TGA End   TGA 0.38 
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Supplement Table 3.1.  A hybrid S. cerevisiae / A. thaliana codon table.  Columns marked, "#" represent the total number of codon occurrences in the 
indicated genome (because the "hybrid genome" is artificial, no codon occurrence data is listed).  Columns marked, "/1000" list the frequency of that codon 
per thousand codons.  Columns marked "fraction" indicate the fraction of occasions on which that codon is used for the corresponding amino acid.  The codon 
frequency values "/1000" and "fraction" from A. thaliana and S. cerevisiae were independently averaged to create the corresponding values for the Hybrid 
Genome.  The second column of the "yeast_plant table" lists the codon usage fractions of the Hybrid Genome adjusted to three significant digits.  These 
yeast_plant table codon usage fractions were used to guide gene re-synthesis efforts. 
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aagcttgtgcagtcaagtgcgcaaaaccatggctgctaggttgcaagaacaaaaaggtggtgagatggatactagaattgctatca
ttggaatgtctgctattttgccatgtggtactactgttagagaatcttgggaaactattagagctggtattgattgtttgtctgat
ttgcctgaagatagagttgatgttactgcttactttgatccagttaaaactactaaagataaaatctattgtaagagaggtggttt
cattccagaatatgattttgatgctagagaatttggtttgaatatgtttcagatggaagattctgatgctaatcaaactatttctt
tgttgaaagttaaagaagcattgcaagatgctggcatcgatgctttgggtaaagagaagaagaatattggttgtgttttgggtatt
ggtggtggtcaaaaatcttctcatgaattttactcaagattgaattatgttgttgttgagaaggtattgagaaaaatgggtatgcc
agaagaagatgttaaagttgctgttgaaaaatacaaagctaattttccagagtggagattggattcttttccaggtttcttgggaa
atgttactgcaggaagatgtactaatacttttaatcttgatggCatgaattgtgttgttgatgctgcttgtgcttcttctttgatt
gctgttaaagttgctattgatgaattgttgtacggtgattgtgatatgatggttactggtgctacttgtactgataattctattgg
aatgtacatggctttttctaaaactccagttttctctactgatccatctgttagagcttatgatgaaaaaactaaaggaatgttga
ttggtgaaggttctgctatgttggttttgaaaagatatgctgatgctgttagagatggtgatgaaattcatgctgttattagaggt
tgtgcttcttcttctgatggtaaagctgctggtatctatactccaactatttctggtcaagaagaagcattgagaagagcttataa
tagagcttgtgttgatccagctactgttactttggttgaaggtcatggtactggtactccagttggtgatagaattgaattgactg
ctttgagaaatttgtttgataaagcatatggtgaaggtaatactgaaaaagttgctgttggttctattaaatcttctattggtcat
ttgaaagctgttgctggtttggctggaatgattaaagttatcatggctttgaaacataaaactttgccaggaactattaatgttga
taatccaccaaacttgtacgataatactccaattaacgaatcttctttgtacattaatactatgaatagaccttggtttccaccac
caggtgttccaagaagagctggtatttcttcttttggttttggtggtgctaattatcatgctgttttggaagaagctgaaccagaa
catactactgcttataggttgaacaaaagaccacaaccagttttgatgatggctgctactccagctgctttgcaatctttgtgtga
agctcaattgaaagaatttgaagctgctattaaagaaaacgaaactgttaaaaatactgcttatattaaatgtgttaaatttggtg
aacaattcaaattccctggtagtattccagctactaatgctaggttgggtttcttggttaaagatgctgaagatgcttgttctact
ttgagagctatttgtgctcaatttgctaaagatgttactaaagaagcatggagattgccaagagaaggtgtttcttttagagctaa
aggtattgctactaatggtgctgttgctgctttgttttctggtcaaggtgctcaatatactcatatgttttctgaagttgctatga
attggccacaattcagacaatctattgctgctatggatgctgctcaatctaaagttgctggttctgataaagattttgaaagagtt
tctcaagttttgtatccaagaaaaccatacgagagagaaccagagcaagatcataagaagatttctttgactgcttattctcaacc
atctactttggcttgtgctttgggtgcttttgaaatttttaaagaagctggttttactccagattttgctgctggtcattctttgg
gtgaatttgctgctttgtacgctgctggttgtgttgatagagatgaattgtttgaattggtttgtagaagagctagaattatgggt
ggtaaagatgctccagctactccaaaaggttgcatggctgctgttattggtccaaatgctgaaaatattaaagttcaagctgctaa
tgtttggttaggaaattctaattctccatctcaaactgttattactggttctgttgaaggtattcaagctgaatctgctaggttgc
aaaaagaaggttttagagttgttccattggcttgtgaatctgcttttcattctccacagatggaaaatgcttcttctgcttttaaa
gatgttatctctaaagtttcttttagaactccaaaagctgaaactaaattgttttctaatgtttctggtgaaacttatccaactga
tgctagagaaatgttgactcaacatatgacttcttctgttaaatttttgactcaagttagaaatatgcatcaagctggtgctagaa
tttttgttgaattcggtccaaaacaagttttgtctaaattggtttctgaaactttgaaagatgatccatctgttgttactgtttct
gttaatccagcttctggtactgattctgatattcaattgagagatgctgctgttcaattggttgttgctggtgttaatttgcaagg
ttttgataaatgggatgctccagatgctactagaatgcaagctattaaaaaaaaaagaactactttgagattgtctgctgctactt
atgtttctgataaaactaagaaagttagagatgctgctatgaatgatggtagatgtgttacttacttgaaaggtgctgctccattg
attaaagctccagaaccagttgttgatgaagctgctaaaagagaagctgaaagattgcaaaaagaattgcaagatgctcaaagaca
attggatgatgctaaaagagctgctgctgaagctaattctaaattggctgctgctaaagaagaagctaaaactgctgctgcttctg
ctaaaccagctgttgatactgctgttgttgaaaaacatagagctattttgaaatctatgttggctgaattggatggttatggttct
gttgatgcttcttctttgcaacaacaacaacaacaacaaactgctccagctccagttaaagctgctgctccagctgctccagttgc
ttctgctccagcacccgcagttagcaacgaactcttagaaaaagccgagacagtagtgatggaagttcttgcagctaaaacggggt
acgaaacagatatgattgaagcagatatggaacttgaaactgaactgggcattgattcgattaaacgcgtggaaattctgtcagaa
gtgcaagctatgttaaatgttgaagcgaaagatgttgatgcactgtcacgcacacgcaccgtgggcgaagtagtgaacgccatgaa
agcagaaattgcaggctcctcagcacccgcgccggccgcagcagcaccagcccccgcaaaagccgcccccgcagcggcggctccag
ccgtttcaaacgaattactcgaaaaagcagaaaccgtagtgatggaagtccttgccgccaaaacgggttatgagaccgatatgatc
gaaagcgatatggaattagaaaccgaattagggattgatagtattaaacgcgtagaaattctgtccgaagtacaagctatgctgaa
tgtagaagcaaaagatgtagatgcgttaagccgcacacgcactgttggtgaagttgtgaatgctatgaaagctgaaattgcaggag
gttcagcaccggccccagcagccgcagccccaggtccagcagcagccgcaccggcccccgccgccgccgcaccggcagtatcaaac
gagttgttagagaaagcggaaaccgttgtgatggaagtacttgccgcgaagacaggttacgagaccgatatgatcgaaagtgacat
ggaattagaaaccgaattgggcattgatagcattaaacgcgtagaaattttatccgaagttcaagccatgttaaatgttgaagcca
aagatgtggatgcgttatcccgcacgcgtaccgtcggagaagtagtggacgctatgaaagcagagattgcaggaggaagtgcaccg
gctccagcagcagcagcacccgccccagcggcagcggcgccggcaccggccgctccggccccagccgttagttcagaactcctcga
aaaagcagaaactgttgtcatggaagtattagctgcaaaaacaggttacgagacggatatgattgaaagcgatatggaattagaaa
ccgaattaggcattgattcaattaaacgtgttgaaatcttaagtgaagtccaagccatgcttaatgttgaagccaaagatgtagat
gcattatctcgcacgcgtacagtgggtgaagttgtcgatgcgatgaaagcagaaatcgcgggaggatcagcgccagccccggcagc
agcagcccccgcgcccgccgcggcCgcacctgcgccggccgccccagcccctgcagcaccggccccagcagtgtcgtcggaattac
tcgaaaaagctgaaacggtcgttatggaagtacttgctgcaaagacgggctatgaaacggatatgattgaatcggatatggaatta
gaaacagaacttggtattgactctattaaacgcgtggaaattctgagcgaagtacaggcaatgttaaacgtagaagccaaagatgt
agacgctttgtcacgcacacggacggtaggagaagttgtggatgcgatgaaagctgaaattgccggttcaagtgctagcgcccctg
ctgccgccgcccctgcccctgccgccgcagcaccggccccggcagccgcagctccagcagttagtaacgaattactcgaaaaagca
gaaacggtggtcatggaagtgttagcagcaaaaactggatatgaaacggacatgattgaaagcgatatggaattagaaacagaact
gggaattgatagtattaaacgtgttgagattttatctgaggttcaagctatgctgaatgttgaagcgaaagatgtagacgcactgt
ctcggacccgcacagtaggtgaagtggtggacgcgatgaaagcagaaatcgcaggtggaagtgctccggccccggcggcagccgca
cccgcgcccgcggccgcagccccagcagttagcaacgaattactcgagaaagcagaaactgtagtgatggaagtgttagccgcaaa
aacgggttatgaaacggatatgattgaaagcgatatggaactggaaaccgaactgggcattgattctattaaacgtgtcgaaatct
tatcggaagtccaagcaatgctgaacgtagaggcaaaggatgttgatgccctgtcacgtacccgtaccgtaggtgaagttgtagat
gccatgaaagctgaaatcgcaggcagtagcgccccggcaccagccgccgccgcccccgcgccggcagccgcCgcacccgcgccagc
cgcagctgctccagctgtatctagtgagctgctcgaaaaagcagaaaccgtggttatggaagtgctcgccgctaaaacaggatatg
aaaccgatatgattgaaagcgatatggaattagaaaccgaactgggtattgatagtattaagcgtgttgaaattttgtcagaagtt
caagctatgttgaatgtagaagccaaagatgtagacgctttaagtcggacgcgtactgttggagaagtcgtagacgccatgaaagc
agagattgcaggcggaagtgcaccggccccggcagcagcagccccagcaccagcggccgccgctcctgcagtgtcaaacgaacttc
tggaaaaagctgaaaccgtcgtcatggaagtgctggctgcaaaaactggatatgaaacagacatgattgaatcagatatggaactc
gaaaccgaactggggattgatagcattaaacgtgtggaaattttatcggaggtacaagcaatgttaaatgtggaagcaaaagatgt
ggatgcactgagccgtactcgtactgttggtgaggtcgtggatgcgatgaaagcagaaattgctggagggagtgcgcctgccccgg
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ccgccgccgcacccgcgtctgccggtgctgcccccgctgtcaaaattgattctgttcatggtgctgattgtgatgatttgtctttg
atgcatgctaaagttgttgatattagaagaccagatgaattgattttggaaagaccagaaaatagaccagttttggttgttgatga
tggttctgaattgactttggctttggttagagttttgggtgcttgtgctgttgttttgacttttgaaggtttgcaattggctcaaa
gagctggtgctgctgctattagacatgttttggctaaagatttgtctgctgaatctgctgaaaaagctattaaagaagctgaacaa
agatttggtgctttgggtggttttatctctcaacaagctgaaagatttgaaccagctgaaattttgggttttactttgatgtgtgc
taaatttgctaaagcatctttgtgcactgctgttgctggtggtagaccagctttcattggtgttgctaggttggatggtaggttgg
gttttacttctcaaggaacttctgatgctttgaaaagagctcaaagaggtgctatttttggtttgtgcaagactattggtttggaa
tggtctgaatctgatgttttctcaagaggtgttgatattgctcaaggtatgcatccagaagatgctgctgttgctattgttagaga
aatggcttgtgctgatattagaattagagaagttggtattggtgctaatcaacaaagatgtactattagagctgctaaattggaaa
ctggaaatccacaaagacaaattgctaaagatgatgttttgttggtttctggtggtgctagaggaattactccattgtgcattaga
gaaattactagacaaattgctggtggaaagtatattttgttgggtaggtctaaagtttctgcttctgaaccagcttggtgtgctgg
tattactgatgaaaaagctgttcaaaaagctgctactcaagaattgaaaagagctttttctgctggtgaaggtccaaaaccaactc
caagagctgttactaaattggttggttctgttttgggtgctagagaagttaggtcttctattgctgctattgaagcattgggtgga
aaagctatctattcttcttgtgatgttaattctgctgctgatgttgctaaagctgttagagatgctgaatctcaattgggtgctag
agtttctggtattgttcatgcttctggtgttttgagagataggttgattgaaaaaaaattgccagatgaatttgatgctgtttttg
gtactaaagttactggtttggaaaatttgttggctgctgttgatagagctaatttgaaacatatggttttgttttcttctttggct
ggttttcatggtaatgttggtcaatctgattatgctatggctaacgaagcattgaacaaaatgggtttggaattggctaaagatgt
ttctgttaaatctatttgttttggtccttgggatggtggtatggttactccacaattgaaaaaacaatttcaagaaatgggtgttc
aaattattccaagagaaggtggtgctgatactgttgctagaattgttttgggttcttctccagctgaaattttggttggtaattgg
agaactccatctaaaaaagttggttctgatactattactttgcacagaaaaatttctgctaaatctaatccatttttggaagatca
tgtcattcaaggtagaagagttttgccaatgactttggctattggttctttggctgaaacttgtttgggtttgtttcctggatatt
ctttgtgggctattgatgatgctcaattgtttaaaggtgttactgttgatggtgatgttaattgtgaagttactttgactccatct
actgctccttctggtagagttaatgttcaagctactttgaaaactttttcttctggtaaattggttccagcttatagagctgttat
tgttttgtctaatcaaggtgctccaccagctaatgctactatgcaaccaccatctttggatgctgatccagctttgcaaggttctg
tttatgatggaaagactttgtttcatggtccagcttttagaggtattgatgatgttttgtcttgtactaaatctcaattggttgct
aaatgttctgctgttccaggttctgatgctgctagaggtgaatttgctactgatactgatgctcatgatccatttgttaatgattt
ggcttttcaagctatgttggtttgggttagaagaactttgggtcaagctgctttgccaaattctattcaaagaattgttcaacaca
gaccagttccacaagataaaccattttatattactttgagatctaatcaatctggtggtcattctcaacataaacatgctttgcaa
tttcataacgaacaaggtgatttgttcattgatgttcaagcatctgttattgctactgattctttggctttttaacccgggtctag
a 
 
5>ORFBbh 
aagcttgtgcagtcaagtgcgcaaaaccatggctgctagaaatgtttctgctgctcatgaaatgcatgatgaaaaaagaattgctg
ttgttggtatggctgttcaatatgctggttgtaagactaaagatgaattttgggaagttttgatgaatggtaaagttgaatctaaa
gttatctctgataaaagattgggttctaattaccgagctgaacattacaaGgctgaaagatcCaaatacgctgatactttttgtaa
cgaaacttatggtactttggatgaaaacgaaattgataacgaacatgaattgttgttgaatttggctaaacaagcattggctgaaa
cttctgttaaagattctactagatgtggtattgtttctggttgtttgtcttttcctatggataatttgcaaggtgaattgttgaat
gtctatcaaaatcatgttgagaagaaattgggtgctagagtttttaaagatgcttctcattggtctgaaagagaacaatctaacaa
accagaagctggtgatagaagaattttcatggacccagcttcttttgttgctgaagaattgaatttgggtgctttgcattattctg
ttgatgctgcttgtgctactgctttatacgttttgagattggctcaagatcatttggtttctggtgctgctgatgttatgttgtgt
ggtgctacttgtttgccagaaccattctttatcttgtctggtttttctacttttcaagctatgccagttggtactggtcaaaatgt
ttctatgccattgcataaagattctcaaggtttgactccaggtgaaggtggttctatcatggttttgaaaagattggatgatgcta
ttagagatggtgatcatatctatggtactttgttgggtgctaatgtttctaattctggCactggtttgccattgaaaccattgttg
ccatctgaaaaaaaatgtttgatggatacttatactagaattaatgttcatccacataaaattcaatatgttgaatgtcatgctac
tggtactccacaaggtgatagggttgaaattgatgctgttaaagcatgttttgaaggaaaagttccaagatttggtactactaaag
gaaactttggtcatactttggttgctgctggttttgctggaatgtgcaaagttttgttgtctatgaaacatggtatcattccacca
actccaggtattgatgatgaaactaagatggacccattggttgtttctggtgaagctattccttggccagaaactaatggtgaacc
aaaaagagctggtttgtctgcttttggttttggtggtactaatgctcatgctgtttttgaagaacatgatccatctaatgctgctt
gtactggtcatgattctatttctgctttgtctgctagatgtggtggtgaatctaatatgagaattgctattactggtatggatgct
acttttggtgctttgaaaggtttggatgcttttgaaagagccatctacactggtgctcatggtgctattccattgccagaaaagag
atggagatttttgggCaaagataaagatttcttggatttgtgtggtgttaaagctactccacatggttgttatattgaagatgttg
aagttgattttcaaagattgagaactccaatgactccagaagatatgttgttgccacaacaattgttggctgttactactattgat
agagctattttggattctggtatgaaaaaaggtggtaatgttgctgtttttgttggtttgggtaccgatttggaattgtacagaca
tagagctagagttgctttgaaagaaagagttagaccagaagcatctaaaaaattgaatgatatgatgcaGtacattaatgattgtg
gcacctctacttcttatacttcttatattggtaatttggttgctactagagtttcttctcaatggggttttactggtccatctttt
actattactgaagggaataactctgtttatagatgtgctgaattgggaaagtatttgttggaaactggtgaagttgatggtgttgt
tgttgctggtgttgatttgtgtggttctgctgaaaacttatacgttaaatcaagaagattcaaagtttctacttctgatactccaa
gagcttcttttgatgctgctgctgatggttactttgttggtgaaggttgtggtgcttttgttttgaaaagagaaacttcttgtact
aaagatgatagaatctatgcttgcatggatgctattgttccaggtaatgttccatctgcttgtttgagagaagcattggatcaagc
tagagttaaaccaggtgatattgaaatgttggaattgtctgctgattctgctagacatttgaaagatccatctgttttgccaaaag
aattgactgctgaagaagaaattggtggtttgcaaactattttgagagatgatgataaattgccaagaaatgttgctactggttct
gttaaagctactgttggtgatactggttatgcttctggtgctgcttctttgattaaagctgctttgtgcatctataataggtattt
gccatctaatggtgatgattgggatgaaccagctccagaagctccttgggattctactttgtttgcttgtcaaacttcaagagctt
ggttgaaaaatcctggagagagaagatatgctgctgtttctggtgtttctgaaactaggtcttgttattctgttttgttgtctgaa
gctgaaggtcattatgaaagagaaaatagaatttctttggatgaagaagctccaaaattgattgttttgagagctgattctcatga
agaaattttgggtaggttggataaaattagagaaagatttttgcaaccaactggtgctgctccaagagaatctgaattgaaagctc
aagctagaagaattttcttggaattgttgggtgaaactttggctcaagatgctgcttcttctggttctcaaaaaccattggctttg
tctttggtttctactccatctaaattgcaaagagaagttgaattggctgctaaaggtattccaagatgtttgaaaatgagaagaga
ttggtcttctccagctggttcaagatatgctccagaaccattggcttctgatagagttgctttcatgtacggtgaaggaaggtctc
catactatggaatcactcaagatattcatagaatttggccagaattgcatgaagttattaacgaaaaaactaataggttgtgggct
gaaggtgatagatgggttatgccaagagcttcttttaaatctgaattggaatctcaacaacaagaatttgatagaaatatgattga
aatgtttaggttgggtattttgacttctattgcttttactaatttggctagagatgttttgaatattactccaaaagctgcttttg
gtttgtctttgggtgaaatttctatgatttttgctttttctaaaaaaaatggtttgatttctgatcaattgactaaagatttgaga
gaatctgatgtttggaacaaagcattggctgttgaattcaatgctttgagagaagcatggggtattccacaatctgttccaaaaga
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tgaattttggcaaggttatattgttagaggtactaaacaagatattgaagctgctattgctccagattcCaaatacgttaggttga
ctatcattaatgatgctaatactgctttgatttctggtaaaccagatgcttgtaaagctgctattgctaggttgggtggtaatatt
ccagctttgccagttactcaaggaatgtgtggtcattgtccagaagttggtccatatactaaagatattgctaaaattcatgctaa
tttggaatttccagttgttgatggtttggatttgtggactactattaatcaaaaaagattggttccaagagctactggtgctaaag
atgaatgggctccatcttcttttggtgaatatgctggtcaactttacgaaaaacaagctaattttccacaaattgttgaaactatc
tacaaacaaaattatgatgtttttgttgaggttggtccaaacaaccataggtctactgctgttagaactactttgggtccacaaag
aaatcatttggctggtgctattgataaacaaaacgaagatgcttggactactattgttaaattggttgcttctttgaaagctcatt
tggttccaggtgttactatttctccattgtatcattctaaattggttgctgaagctgaagcatgttatgctgctctgtgcaaagga
gaaaaacctaagaagaacaaatttgttagaaaaattcaattgaatggtaggttcaattctaaagctgatccaatttcttctgctga
tttggcttcttttccaccagctgatccagctattgaagctgctatttcttcaagaattatgaaaccagttgctccaaaattttatg
ctaggttgaatattgatgaacaagacgaaacaagagatccaattttgaacaaagataatgctccatctagttcatctagttcctct
tcatctagttcttcatctagttctccatctccagctccttctgctccagttcaaaaaaaagctgctccagctgctgaaactaaagc
tgttgcttctgctgatgctttgagatctgctttgttggatttggattctatgttggctttgtcttctgcttctgcttctggtaatt
tggttgaaactgctccatctgatgcttctgttattgttccaccatgtaatattgctgatttgggttcaagagcttttatgaaaact
tatggtgtttctgctccattgtacactggtgctatggctaaaggtattgcttctgctgatttggttattgctgctggtagacaagg
Cattttggcttcttttggtgctggtggtttgccaatgcaagttgttagagaatctattgaaaaaattcaagctgctttgccaaatg
gtccatatgctgttaatttgattcattctccatttgattctaatttggaaaaaggtaatgttgatttgtttttggaaaaaggtgtt
acttttgttgaagcatctgcttttatgactttgactccacaagttgttaggtacagagctgctggtttgactagaaatgctgatgg
ttctgttaatattagaaatagaattatcggaaaggtttcaagaactgaattggctgaaatgtttatgagacctgccccagaacact
tgttgcaaaaattgattgcttctggtgaaattaatcaagaacaagctgaattggctagaagagttccagttgctgatgatattgct
gttgaagctgattctggtggtcatactgataatagaccaattcatgttatcttgccattgattattaatttgagagaCagattgca
tagagaatgtggttatccagctaatttgagagttagagttggtgctggtggtggtattggttgtccacaagctgctttggctactt
ttaatatgggtgcttctttcattgttactggCactgttaatcaagttgctaaacaatctggtacttgtgataatgttagaaaacaa
ttggctaaagctacttattctgatgtttgcatggctccagctgctgatatgtttgaagaaggtgttaaattgcaagttttgaagaa
agggacAatgtttccatcaagagctaataagttatacgaattgttttgcaagtatgattcttttgaatctatgccaccagctgaat
tggctagagttgaaaaaagaattttctcaagagctttggaagaagtttgggatgaaactaaaaatttttacattaataggttgcac
aatccagaaaaaattcaaagagctgaaagagatccaaaattgaaaatgtctttgtgttttagatggtatttgtctttggcttcaag
atgggctaatactggtgcttctgatagagttatggattatcaagtttggtgtggtccagctattggttcttttaatgatttcatta
aaggcacctacttggacccagctgttgctaacgaatatccatgcgttgttcaaattaacaaacaaattttgagaggtgcttgtttc
ctcagaagattggaaattttgagaaatgctaggttgtctgatggtgctgctgctttggttgcttctattgatgatacttatgttcc
agctgaaaaattgtaacccgggtctaga 
 
6>ORFBss 
atggccgctcggaatgtgagcgccgcgcatgagatgcacgatgaaaagcgcatcgccgtcgtcggcatggccgtccagtacgccgg
atgcaaaaccaaggacgagttctgggaggtgctcatgaacggcaaggtcgagtccaaggtgatcagcgacaaacgactcggctcca
actaccgcgccgagcactacaaagcagagcgcagcaagtatgccgacaccttttgcaacgaaacgtacggcacccttgacgagaac
gagatcgacaacgagcacgaactcctcctcaacctcgccaagcaggcactcgcagagacatccgtcaaagactcgacacgctgcgg
catcgtcagcggctgcctctcgttccccatggacaacctccagggtgaactcctcaacgtgtaccaaaaccatgtcgagaaaaagc
tcggggcccgcgtcttcaaggacgcctcccattggtccgaacgcgagcagtccaacaaacccgaggccggtgaccgccgcatcttc
atggacccggcctccttcgtcgccgaagaactcaacctcggcgcccttcactactccgtcgacgcagcatgcgccacggcgctcta
cgtgctccgcctcgcgcaggatcatctcgtctccggcgccgccgacgtcatgctctgcggtgccacctgcctgccggagccctttt
tcatcctttcgggcttttccaccttccaggccatgcccgtcggcacgggccagaacgtgtccatgccgctgcacaaggacagccag
ggcctcaccccgggtgagggcggctccatcatggtcctcaagcgtctcgatgatgccatccgcgacggcgaccacatttacggcac
ccttctcggcgccaatgtcagcaactccggcacaggtctgcccctcaagccccttctccccagcgagaaaaagtgcctcatggaca
cctacacgcgcattaacgtgcacccgcacaagattcagtacgtcgagtgccacgccaccggcacgccccagggtgatcgtgtggaa
atcgacgccgtcaaggcctgctttgaaggcaaggtcccccgtttcggtaccacaaagggcaactttggacacaccctsgycgcagc
cggctttgccggtatgtgcaaggtcctcctctccatgaagcatggcatcatcccgcccaccccgggtatcgatgacgagaccaaga
tggaccctctcgtcgtctccggtgaggccatcccatggccagagaccaacggcgagcccaagcgcgccggtctctcggcctttggc
tttggtggcaccaacgcccatgccgtctttgaggagcatgacccctccaacgccgcctgcacgggccacgactccatttctgcgct
ctcggcccgctgcggcggtgaaagcaacatgcgcatcgccatcactggtatggacgccacctttggcgctctcaagggactcgacg
ccttcgagcgcgccatttacaccggcgctcacggtgccatcccactcccagaaaagcgctggcgctttctcggcaaggacaaggac
tttcttgacctctgcggcgtcaaggccaccccgcacggctgctacattgaagatgttgaggtcgacttccagcgcctccgcacgcc
catgacccctgaagacatgctcctccctcagcagcttctggccgtcaccaccattgaccgcgccatcctcgactcgggaatgaaaa
agggtggcaatgtcgccgtctttgtcggcctcggcaccgacctcgagctctaccgtcaccgtgctcgcgtcgctctcaaggagcgc
gtccgccctgaagcctccaagaagctcaatgacatgatgcagtacattaacgactgcggcacatccacatcgtacacctcgtacat
tggcaacctcgtcgccacgcgcgtctcgtcgcagtggggcttcacgggcccctcctttacgatcaccgagggcaacaactccgtct
accgctgcgccgagctcggcaagtacctcctcgagaccggcgaggtcgatggcgtcgtcgttgcgggtgtcgatctctgcggcagt
gccgaaaacctttacgtcaagtctcgccgcttcaaggtgtccacctccgataccccgcgcgccagctttgacgccgccgccgatgg
ctactttgtcggcgagggctgcggtgcctttgtgctcaagcgtgagactagctgcaccaaggacgaccgtatctacgcttgcatgg
atgccatcgtccctggcaacgtccctagcgcctgcttgcgcgaggccctcgaccaggcgcgcgtcaagccgggcgatatcgagatg
ctcgagctcagcgccgactccgcccgccacctcaaggacccgtccgtcctgcccaaggagctcactgccgaggaggaaatcggcgg
ccttcagacgatccttcgtgacgatgacaagctcccgcgcaacgtcgcaacgggcagtgtcaaggccaccgtcggtgacaccggtt
atgcctctggtgctgccagcctcatcaaggctgcgctttgcatctacaaccgctacctgcccagcaacggcgacgactgggatgaa
cccgcccctgaggcgccctgggacagcaccctctttgcgtgccagacctcgcgcgcttggctcaagaaccctggcgagcgtcgcta
tgcggccgtctcgggcgtctccgagacgcgctcgtgctattccgtgctcctctccgaagccgagggccactacgagcgcgagaacc
gcatctcgctcgacgaggaggcgcccaagctcattgtgcttcgcgccgactcccacgaggagatccttggtcgcctcgacaagatc
cgcgagcgcttcttgcagcccacgggcgccgccccgcgcgagtccgagctcaaggcgcaggcccgccgcatcttcctcgagctcct
cggcgagacccttgcccaggatgccgcttcttcaggctcgcaaaagcccctcgctctcagcctcgtctccacgccctccaagctcc
agcgcgaggtcgagctcgcggccaagggtatcccgcgctgcctcaagatgcgccgcgattggagctcccctgctggcagccgctac
gcgcctgagccgctcgccagcgaccgcgtcgccttcatgtacggcgaaggtcgcagcccttactacggcatcacccaagacattca
ccgcatttggcccgaactccacgaggtcatcaacgaaaagacgaaccgtctctgggccgaaggcgaccgctgggtcatgccgcgcg
ccagcttcaagtcggagctcgagagccagcagcaagagtttgatcgcaacatgattgaaatgttccgtcttggaatcctcacctca
attgccttcaccaatctggcgcgcgacgttctcaacatcacgcccaaggccgcctttggcctcagtcttggcgagatttccatgat
ttttgccttttccaagaagaacggtctcatctccgaccagctcaccaaggatcttcgcgagtccgacgtgtggaacaaggctctgg
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ccgttgaatttaatgcgctgcgcgaggcctggggcattccacagagtgtccccaaggacgagttctggcaaggctacattgtgcgc
ggcaccaagcaggatatcgaggcggccatcgccccggacagcaagtacgtgcgcctcaccatcatcaatgatgccaacaccgccct
cattagcggcaagcccgacgcctgcaaggctgcgatcgcgcgtctcggtggcaacattcctgcgcttcccgtgacccagggcatgt
gcggccactgccccgaggtgggaccttataccaaggatatcgccaagatccatgccaaccttgagttccccgttgtcgacggcctt
gacctctggaccacaatcaaccagaagcgcctcgtgccacgcgccacgggcgccaaggacgaatgggccccttcttcctttggcga
gtacgccggccagctctacgagaagcaggctaacttcccccaaatcgtcgagaccatttacaagcaaaactacgacgtctttgtcg
aggttgggcccaacaaccaccgtagcaccgcagtgcgcaccacgcttggtccccagcgcaaccaccttgctggcgccatcgacaag
cagaacgaggatgcttggacgaccatcgtcaagcttgtggcttcgctcaaggcccaccttgttcctggcgtcacgatctcgccgct
gtaccactccaagcttgtggcggaggctcaggcttgctacgctgcgctctgcaagggtgaaaagcccaagaagaacaagtttgtgc
gcaagattcagctcaacggtcgcttcaacagcaaggcggaccccatctcctcggccgatcttgccagctttccgcctgcggaccct
gccattgaagccgccatctcgagccgcatcatgaagccggttgctccgaagttctacgcgcgtctcaacattgacgagcaggacga
gacccgtgatccgatcctcaacaaggacaacgcgccgtcttccagctctagctcctcttccagctcttccagctcttccagcccgt
cgccagctccgtccgccccagtgcaaaagaaggctgctccggccgcggagaccaaggctgttgcttcggctgacgcacttcgcagt
gccctgctcgatctcgacagtatgcttgcgctgagctctgccagtgcctccggcaaccttgttgagactgcgcctagcgacgcctc
ggtcattgtgccgccctgcaacattgcggatctcggcagccgcgccttcatgaaaacgtacggtgtttcggcgcctctgtacacgg
gcgccatggccaagggcattgcctctgcggacctcgtcattgccgccggccgccagggcatccttgcgtcctttggcgccggcgga
cttcccatgcaggttgtgcgtgagtccatcgaaaagattcaggccgccctgcccaatggcccgtacgctgtcaaccttatccattc
tccctttgacagcaacctcgaaaagggcaatgtcgatctcttcctcgagaagggtgtcacctttgtcgaggcctcggcctttatga
cgctcaccccgcaggtcgtgcggtaccgcgcggctggcctcacgcgcaacgccgacggctcggtcaacatccgcaaccgtatcatt
ggcaaggtctcgcgcaccgagctcgccgagatgttcatgcgtcctgcgcccgagcaccttcttcagaagctcattgcttccggcga
gatcaaccaggagcaggccgagctcgcccgccgtgttcccgtcgctgacgacatcgcggtcgaagctgactcgggtggccacaccg
acaaccgccccatccacgtcattctgcccctcatcatcaaccttcgcgaccgccttcaccgcgagtgcggctacccggccaacctt
cgcgtccgtgtgggcgccggcggtggcattgggtgcccccaggcggcgctggccaccttcaacatgggtgcctcctttattgtcac
cggcaccgtgaaccaggtcgccaagcagtcgggcacgtgcgacaatgtgcgcaagcagctcgcgaaggccacttactcggacgtat
gcatggccccggctgccgacatgttcgaggaaggcgtcaagcttcaggtcctcaagaagggaaccatgtttccctcgcgcgccaac
aagctctacgagctcttttgcaagtacgactcgttcgagtccatgccccccgcagagcttgcgcgcgtcgagaagcgcatcttcag
ccgcgcgctcgaagaggtctgggacgagaccaaaaacttttacattaaccgtcttcacaacccggagaagatccagcgcgccgagc
gcgaccccaagctcaagatgtcgctgtgctttcgctggtacctgagcctggcgagccgctgggccaacactggagcttccgatcgc
gtcatggactaccaggtctggtgcggtcctgccattggttccttcaacgatttcatcaagggaacttaccttgatccggccgtcgc
aaacgagtacccgtgcgtcgttcagattaacaagcagatccttcgtggagcgtgcttcttgcgccgtctcgaaattctgcgcaacg
cacgcctttccgatggcgctgccgctcttgtggccagcatcgatgacacatacgtcccggccgagaagctgtaa 
 
Supplement 3.2 (continued).  Codon optimized sequences of genes used in this study. 
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Chapter 4 - Standard Pathway Characterization and Disruption of 
Polyunsaturated Fatty Acid Synthesis in Crypthecodinium cohnii 
 
Chapter 4 Abstract 
 
 Crypthecodinium cohnii is a heterotrophic dinoflagellate used commercially 
for the production of docosahexaenoic acid (DHA) by fermentation.  Two types of 
auxotrophic mutants of C. cohnii were generated.  One auxotrophic phenotype was 
defined by a requirement for supplemented saturated fatty acids and the other was 
defined by a requirement for supplemented polyunsaturated fatty acids (PUFA).  
Equilibrium and pulse labeling experiments with 14C-fatty acids and 14C-acetate with 
the auxotrophic mutants and wild type established that de novo biosynthesis of DHA 
by C. cohnii does not depend on simpler PUFA substrates or saturated fatty acid 
biosynthesis.  These experiments also show that the “standard” desaturase and 
elongase-mediated pathway of PUFA biosynthesis in C. cohnii contains several 
lesions that preclude de novo biosynthesis of any PUFA via this pathway.  An 
alternate system, like the PUFA-PKS system of Schizochytrium (Metz et al., 2001) is 
therefore the most likely mechanism of DHA biosynthesis in C. cohnii. 
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Chapter 4 Introduction 
 
 Crypthecodinium cohnii is a unicellular, heterotrophic dinoflagellate.  It is 
used commercially for the production of the nutritionally important fatty acid DHA, 
and is the most widely used source of DHA for inclusion in infant formulas.  Unlike 
most dinoflagellates, C. cohnii can be grown in large-scale fermentors and may 
accumulate more than half of its dry cell weight as triglyceride.  Very little is known 
about dinoflagellate biochemistry and genetics and even less about C. cohnii 
specifically.  This chapter describes the creation of PUFA-requiring, auxotrophic 
mutants and their use as tools to investigate the mechanism of PUFA biosynthesis in 
C. cohnii. 
 Photosynthetic dinoflagellates are primary producers of fixed carbon in the 
ocean, second only to diatoms in abundance (Tappan, 1980, Hallegraeff, 1981).  They 
are found in a variety of habitats and survive by several strategies: predation, 
parasitism, symbiosis, and autotrophy (Hackett et al., 2004).  Dinoflagellates are 
usually encased by tough, cellulosic, thecal plates which are often complex in design.  
They are also known for possessing unusually large haploid genomes on the order of 
1010 to 1011 base pairs (Veldhuis et al., 1997).  The dinoflagellate life cycle has 
several stages, but under nutrient replete conditions, they exist primarily as bi-
flagellated, motile, haploid schizonts which replicate by vegetative fission.  Under 
certain conditions, schizonts will act as gametes where one of a pair of cells will shed 
its theca permitting sexual fusion (Bhaud et al., 1991, Beam and Himes, 1974).  C. 
cohnii has all the features typical of dinoflagellates, aside from its lack of 
photosynthetic ability and its simple unadorned theca.   
  121
 C. cohnii can be mutated to produce stable and crossable phenotypes that obey 
rules of classical genetics (Beam and Himes, 1974, Hackett, 2005).  This observation 
is somewhat surprising as dinoflagellates are known to excessively duplicate genes 
(Le et al., 1997) which should reduce the probability of generating recessive point 
mutations that result in the inactivation of a given gene product. 
 As discussed in Chapter 1, several studies on the biochemistry of C. cohnii 
fatty acid biosynthesis have been reported.  The earliest such study by Beach et al. 
(1974) used 14C-labeled acetate and fatty acids as anticipated precursors to 18:1 and 
22:6.  They found that “biosynthesis of 18:1 was compartmentalized from that of 22:6 
(n-3) and that known pathways to the (n-3) polyunsaturated fatty acids were either 
inaccessible to exogenous intermediates or did not operate in C. cohnii.”  A later 
study by Henderson and Mackinlay (1991) confirmed the finding of Beach et al. by 
observing that while “…extracellular 18:0 and 18:1(n-9) were extensively 
incorporated into glycerolipids, they were not converted to 22:6(n-3), or any other 
PUFA, despite a net increase in the absolute amount of 22:6(n-3) over the growth 
cycle of the cultures.  In contrast, 22:6(n-3) was actively synthesized de novo from 
acetate by the cultures of C. cohnii and esterified into both triacylglycerols and 
phospholipids.”  The authors went on to assert that “[t]he manner in which this 
selectivity is implemented remains to be established.”  Neither study conducted a 
comprehensive analysis of fatty acid conversion so the possibility remained that 
certain precursors were simply too diluted among downstream products to allow clear 
detection of the entire pathway. 
 The observation that 18:1 was not converted to DHA in C. cohnii (made by 
Beach et al., 1974 and Henderson and Mackinlay, 1991) was also supported in a 
report by de Swaaf et al. (2003) on the effects of desaturase inhibitors on C. cohnii.  
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However, the authors of this study additionally suggested that oxygen-dependent 
desaturases may contribute to the lipid content of C. cohnii.  The authors qualify this 
observation by stating that enzymes other than desaturases may have been inactivated 
by the inhibitors used in the study.   
 In 1996 Kazunaga Yazawa reported the discovery of a novel gene cluster in 
the marine bacterium Shewanella, the products of which were capable of synthesizing 
the long-chain polyunsaturated fatty acid EPA.  The gene cluster was subsequently 
shown to encode a polyketide synthase-like protein complex (Metz et al., 2001) and 
has since been commonly referred to as the PUFA-PKS.  Homologs of the Shewanella 
PUFA-PKS system were identified in Moritella marina for synthesis of DHA (Morita 
et al. 2000) and in Schizochytrium sp. for synthesis of DPA (n-6) and DHA (Metz et 
al., 2001, Hauvermale et al., 2006).  The evidence implicating the PUFA-PKS genes 
of Schizochytrium in their involvement with PUFA biosynthesis, and the ancillary 
nature of the standard pathway, were presented in Chapters 2 and 3 of this study.  
Prior to the current work, no genes encoding analogs of PUFA-PKS systems have 
been detected in C. cohnii (see Chapter 5), adding to speculation about the mechanism 
of PUFA biosynthesis employed by the organism. 
 Before the discovery of the first PUFA-PKS system in 2001, no other 
mechanisms of LCPUFA biosynthesis, other than those mediated by desaturases and 
elongases, were known.  In this chapter, data supporting a saturated fatty acid (SFA), 
desaturase- and elongase-independent mechanism of DHA biosynthesis in C. cohnii 
are presented.  Also detailed are data supporting the presence of an incomplete 
desaturase- and elongase-mediated pathway for conversion of exogenous PUFA to 
DHA in C. cohnii.  The data indicate that the standard pathway is not capable of 
producing LCPUFA de novo in C. cohnii, but instead likely represents a secondary 
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scavenging mechanism, or a remnant of the standard PUFA synthesis system, similar 
to the vestigial standard pathway observed in Schizochytrium. 
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Chapter 4 Materials and Methods 
 
 Strains and culture conditions 
  C. cohnii strain KO was selected from a single “wet-looking” colony 
of an ATCC stock culture (ATCC# 30340) for its ability to stick to sterile velveteen, 
thereby facilitating replica-plating.  All C. cohnii cultures were grown in “50:6 
medium” consisting of 50 g/L glucose and 6 g/L Tastone™ 154 yeast extract 
(Sensient Flavors, Indianapolis, IN) in 100% reconstituted Instant Ocean™ salt 
mixture (Aquarium Systems, Mentor, OH).  For cultivation of either wild-type or 
mutants of C. cohnii, the following ingredients were added alone or in combinations 
where indicated or appropriate; 20 g/L agar (VWR, West Chester, PA), and 0.5 mM 
DHA or myristic acid (NuChekPrep, Elysian, MN) complexed with randomly 
methylated beta-cyclodextrins (Cyclodextrin Technologies Development, Inc., High 
Springs, FL).  All other media ingredients were purchased from Sigma Chemical (St. 
Louis, MO).   
 For genetic crosses, auxotrophic mutants of differing phenotypes were co-
inoculated to wells filled with 50:6 medium supplemented with cyclodextrin/fatty acid 
complexes as appropriate, and allowed to incubate at 27 °C for 2-4 weeks.  If cells 
grew, they were taken from wells and their phenotypes were verified by sub-culturing 
on solid media. 
 Random Mutagenesis 
  Cultures of C. cohnii strain KO were harvested after 2-3 days of 
growth from an inoculum diluted 1:50 (v/v) and applied to solid medium 
supplemented with 0.5 mM DHA and myristic acid at a density of 5-50 x 105 cells.  
Cells on these “master plates” were then subjected to 30,000 μJ/cm2 of ultraviolet 
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radiation with an UVC 515 Ultraviolet Multilinker (Ultra-Lum, Carson, CA), 
wrapped in foil, and incubated at 27 ºC for 7-14 days until colonies began to appear.  
Plates were then unwrapped and “replica-plated” to solid media lacking fatty acid 
supplements by transfer to sterile velveteen squares.  Colonies were permitted to 
grown an additional 7-14 days at 27 ºC before correlations between master and replica 
plates were made.  Colonies growing on the master plate, but not the replica plate, 
were picked and re-plated to solid media, with and without fatty acid supplements.  
To verify phenotypes, colonies that grew on supplemented solid medium, but not un-
supplemented solid medium, were re-plated to both media again, and the phenotype 
also confirmed by sub-culture in liquid media with and without fatty acid 
supplements. 
 Fatty acid labeling, derivitization and analysis 
  To determine the experimental rate kinetics of fatty acid uptake, cell 
numbers in 2 day old cultures of C. cohnii were determined and the cultures were fed 
varying concentrations (and specific activities) of radiolabeled fatty acid.  Aliquots of 
1 mL were drawn from these cultures at intervals and collected cells were 
immediately washed with distilled water on a vacuum manifold fitted with fiberglass 
filters, which were then immersed in liquid scintillation fluid for quantifying 
incorporated radiolabel.  To serve as a negative control in one experiment, cells were 
killed by incubation in 50:6 liquid medium supplemented with 10 mM KCN for 1 
hour, washed, and resuspended in 50:6 medium before addition of radiolabeled free 
fatty acid. 
  For equilibrium labeling, freshly inoculated cultures of C. cohnii were 
fed cold and α-14C radiolabeled fatty acids.  Cultures were grown for 3-4 days before 
cells were harvested by centrifugation and freeze-dried.  For equilibrium labeling, all 
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radiolabeled fatty acids were added as 1.0 µCi doses in 10 mL of 50:6 medium and 
inoculated with 100 µL of a saturated culture.  All radiochemicals were acquired from 
American Radiolabeled Chemical (St. Louis, MO), except for [1-14C] 20:4 n-3 
(Cayman Chemical, Ann Arbor, MI).  Free fatty acids were extracted from freeze-
dried cell pellets and converted to fatty acid methyl esters (FAMEs) as described in 
Morrison and Smith (1964). 
 A 2-3 day old culture, originally inoculated 1:50 (v/v) with a saturated culture 
of wild-type C. cohnii (KO), was pulsed with 10 µCi of [1,2-14C] acetate.  Three 
aliquots (2 of 1 mL and 1 of 5 mL) were removed from this culture 1, 10, 100, 500, 
1000, and 2000 minutes after addition of the pulsed radiolabel.  The 1 mL aliquots 
were either mixed with scintillation fluid immediately or applied to a 0.2 μm glass 
filter and washed three times with 100% Instant Ocean reconstituted salt mix prior to 
transferring both the filter and retained cells to scintillant for quantifying radioactive 
emission in counts per minute (cpm or “counts”).  Cells in the 5 mL aliquots were 
harvested by centrifugation at 5000 x g for 5 minutes and the resulting cell pellets 
were washed once in distilled water before being freeze-dried.  FAMEs were then 
derivitized from non-polar solvent extracts of the freeze-dried pellets and subjected to 
high pressure liquid chromatography (HPLC) separation and analysis as described 
below. 
  Gas Chromatography - One microliter injections of FAMEs were 
separated on a Gas Chromatograph (GC) fitted with a flame-ionizing detector and a 
FAMEWAX 30-meter column (0.25 mm id, 0.25 df) (Restek, Bellefonte, PA).  
FAME separations were essentially performed as described by Arterburn et al. 
(2000).  Eluted FAMEs were identified and quantified by comparison to authentic 
standards. 
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  High Pressure Liquid Chromatography - HPLC separations of FAMEs 
were performed essentially as described by Özcimder and Hammers (1980).  
Specifically, 5-20 μL injections of FAMEs were separated by HPLC with a glass 
Chromsep LiChrosorb 7 RP18 (reverse phase) column (Varian, Palo Alto, CA) into 
which a 15-0% (v/v) water gradient in acetonitrile was channeled over 40 minutes.  
Alternately, 14C-radiolabeled FAMEs were separated on a 250 x 4.6 mm Taxsil 
pentafluorophenyl analytical column (Varian Inc., Walnut Creek, CA, USA) of 3 μm 
particle size.  The column was maintained at 30 °C.  The binary mobile phase 
consisted of acetonitrile and water at a flow rate of 1.00 mL/min., initially delivering 
linear a gradient of 0-40% water over 35 minutes, then 40-30% water from 35-40 
minutes, isocratic at 30% water from 40-60 minutes, then another linear gradient back 
to a ratio of 40% water (each by vol.), which was maintained an additional 10 
minutes.  Eluted radioactive FAMEs were mixed in-line with Scintiverse LC (Fisher, 
Hampton, NH) liquid scintillant (1:2, v/v) for detection of beta-particle emissions 
with a β-RAM Model 2B in-line HPLC scintillation detector (IN/US, Tampa, FL) and 
ultimately identified and quantified by comparison to authentic standards. 
 Total lipid injections of 5-20 µL, extracted from freeze-dried biomass 
according to the protocol of Bligh and Dyer (1959), were separated on a gradient of 
water in methanol:acetonitrile (9:1; v/v) (isocratic at 20% water for 0-1 min., linear 
gradient to 5% water from 1-10 min., isocratic at 5% water for 10-20 min., linear 
gradient to 0% water from 20-30 min., then isocratic 0% water for 30-85 min., and 
then a final linear gradient to 20% water from 85-90 minutes) over a glass, 
LiChrosorb 7 RP18, 100x3 m column (Varian, Palo Alto, CA).  Eluted radioactive 
lipids were also mixed in-line with scintillation fluid and analyzed with an HPLC 
scintillation detector.  Biomass used for these total lipid preparations were previously 
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fed radiolabeled free fatty acids according to the equilibrium radiolabeling protocol 
described above. 
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Chapter 4 Results 
 
 Free Fatty Acid Uptake by Crypthecodinium 
  A single fatty acid, eicosapentaenoic acid (EPA), was chosen as a 
model to evaluate C. cohnii’s capacity to import and internalize fatty acids under the 
rationale that if no EPA import was observable, comprehensive investigation of a 
classic pathway in C. cohnii would be impossible.  Incubation of C. cohnii cells in 10 
mM of KCN was found to be sufficient to kill cultures in preliminary experiments 
(data not shown), and cultures treated in this way were used as negative controls to 
distinguish what levels of uptake might be due to passive processes.  The rate of EPA 
uptake by C. cohnii followed Michaelis-Menten kinetics: Km = 0.53 mM EPA, Vmax 
= 0.06 nM/cell/second.  Additionally, uptake velocity of 1 mM EPA into living cells 
was greater than twice that of dead cells (42 vs. 19 pmol/cell/sec.) 
 Crypthecodinium Auxotrophic Mutants 
  Several groups of cultures were U/V irradiated before 5 individual 
fatty acid auxotrophs were obtained.  All irradiated cultures were immediately 
thereafter shielded from light to prevent possible SOS pathway-mediated mutation 
repair (although the existence of this mechanism has not been investigated in C. 
cohnii).  Irradiation consistently resulted in 97-99% cell death, leaving well-spaced 
survivors for replica-plating.  Nearly 1 in 1000 of the surviving colonies was found to 
represent a true fatty acid auxotroph, although several more were initially picked from 
the master plates due to poor replica-plating colony transfers.  Of the five confirmed 
auxotrophs, two (designated KO-24 and KO-18) were capable of growth only with 
supplied PUFAs and three (designated KO-1, KO-5, and KO-147) were capable of 
growth only with supplied saturated fatty acids.  To determine if these mutations were 
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allelic, sexual crosses were performed.  C. cohnii is capable of sexual fusion but does 
not possess mating types (Beam and Himes, 1974).  Sexual crosses revealed that the 
mutations were allelic as none of the PUFA-requiring clones could complement one 
another and none of the saturate-requiring clones could complement one another but 
when the saturate-requiring and PUFA-requiring auxotrophic clones were mixed, 
prototrophic progeny with the wild type phenotype were generated. 
 PUFA Auxotrophic Mutant Characterization 
  The PUFA-requiring auxotroph, KO-24, was selected for detailed 
phenotype analysis.  Liquid cultures of this mutant were grown in the presence of the 
fatty acids indicated in Table 4.1.  As shown, the PUFA-requiring auxotroph, C. 
cohnii strain KO-24, can be rescued by several PUFAs, particularly 20 and 22-carbon 
omega-3 LCPUFAs.  It should be noted that free fatty acids are slightly toxic to C. 
cohnii.  This toxicity was somewhat alleviated when PUFAs were fed to C. cohnii in 
combination with saturated fatty acids (data not shown).  Supplementation of KO-24 
with 14:0 alone did not complement the growth defect and only served to better reveal 
the phenotype conveyed by the other supplemented PUFAs.  In addition to subjective 
growth analysis, the distribution of fatty acids in the PUFA-auxotroph was also 
analyzed (Table 4.1).  It is important to note that exogenous fatty acids do not need to 
be converted to DHA to complement the phenotype (best illustrated with the example 
of exogenous 20:4 n3).  Similar experiments were performed with the other PUFA-
requiring mutant (KO-18) to find that its phenotype was essentially identical (data not 
shown).  
 C. cohnii Free Fatty Acid Radiolabeling 
  Several [1-14C] free fatty acids were fed to the wild type parent (KO), a 
PUFA-requiring mutant (KO-18), and a saturate-requiring mutant (KO-1).  Fatty acid 
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% FAMEs of harvested biomass 
Strain fats fed Growth % Fat 14:0 14:1 16:0 16:1 18:0 18:1 n9 
18:3 
n6 
18:4 
n3 20:0 
20:3 
n3 
20:4 
n6 
20:4 
n3 
20:5 
n3 22:0 
22:3 
n6 
22:4 
n6 
22:5 
n6 
22:5 
n3 22:6 24:1 
KO (wt) none (+++) 11 20   20 13 2 8     0.4                   44   
none* (-) 14 26 0.9 26 10.5 0.3 30     0.2       0.5 0.3         1   
18:3 n6/14:0 (+/-) 18 32 0.6 24 5 0.2 24.5 9   0.3       0.5 0.5         0.8   
20:4 n6/14:0 (+) 5 23   8 0.8 1 6         16        34  8     3 
20:4 n3/14:0 (+++) 18 22   4 0.8 0.4 5   0.6   1   63§ 2         1.5     
20:5 n3/14:0 (+++) 6 27   8 0.7 1 7             10         7 36 4 
22:5 n3/14:0 (+++) 5 24   12 1 1 9                       44 6 1 
KO-24 
22:6 n3/14:0 (+++) 5 23   12 0.8 1 8                       2 50   
Table 4.1.   Purified free fatty acids were supplemented as a complex with randomly methylated beta-cyclodextrin to LCPUFA-requiring, auxotrophic mutant 
KO-24 cultures.  Before harvesting, all cultures were grown for 3-4 days in the presence of the indicated fatty acid except for “KO-24, none*”, which was 
instead grown in a mixture of 14:0 and 22:6 for 3 days, washed and cultured in medium without supplemented fatty acids for an additional 3 days, and then 
harvested.  Cultures were harvested by centrifugation and pellets were freeze-dried before oil extraction and fatty acid methyl ester (FAME) derivation.  
FAMEs were separated by gas chromatography and qualified and quantified by comparison to authentic standards.  Free fatty acids are known to be slightly 
toxic.  This toxicity was somewhat alleviated when PUFAs were fed in combination with saturated fatty acids.  Supplementation of KO-24 with 14:0 alone 
had no effect, so complementing fatty acids were fed in combination with 14:0 to better reveal the KO-24 phenotype.  As shown in the table, slight 
complementation was observed with 18:3 n6 (GLA) and 20:4 n6 (ARA).  Full complementation of the phenotype was only achieved with omega-3 PUFA 
supplementation.  It is important to note that conversion of a supplemented fatty acid to DHA was not required for full complementation of the growth defect.  
This phenomenon is best observed in the KO-24 feeding with 20:4 n3.  The FAME profile of the wild-type parent strain (KO) is also shown for comparison.  
Harvested FAMEs corresponding to fed fatty acids are shown in bold.  §Assignment based on calculated retention time of 20:4 n3.  Each of the following 
fatty acids was fed in combination with 14:0 to KO-24 (except saturated fatty acids, which were fed alone to KO-24) and none were capable of 
complementing the auxotrophic defect of KO-24: 14:0, 16:0, 18:0, 18:2 n6, 18:3 n6, 18:3 n3, 18:4 n3, 20:0, 20:1 n9, 20:2 n6, 20:3 n6, 22:0, 22:1 n9, 22:2 n6, 
22:3 n3, and 22:4 n6. 
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conversions were inferred from the resulting 14C label distribution.  Table 4.2 
demonstrates that wild-type C. cohnii is not capable of converting fatty acids less 
complex than 20:4 n6 (ARA) to more complex PUFA, but is capable of converting 
ARA and more complex PUFA to DHA.  Fatty acids that were significantly converted 
by the wild type were also used in equilibrium labeling of the relevant auxotrophic 
mutants.  No meaningful qualitative differences were observed between the 
conversions carried out by the mutants versus the wild-type, indicating that 
auxotrophy-inducing mutations were not detectably associated with standard 
desaturases or elongases.   
 C. cohnii Acetate Radiolabeling 
  A 2-3 day old culture of wild-type C. cohnii (KO) was pulsed with 
[1,2-14C] acetate and aliquots were removed over time and analyzed.  The results of 
this analysis are shown in Figures 4.1 and 4.2.  Specifically, a sharp initial uptake of 
label between 10 and 100 minutes was observed.  After 100 minutes, the total amount 
of label in the cell pellet established equilibrium in a range between 60 and 75% of 
the total counts present in the culture (at each time point) (Figure 4.1).  However, 
during the course of the experiment, absolute radioactivity of the culture steadily 
decreased, presumably due to respiration of the label as 14CO2.  The distribution of 
cell-associated label into two different classes of fatty acids (PUFAs versus saturated 
FA and monounsaturated FA taken together) over the experimental time course, is 
shown in Figure 4.2.  The minimal cellular uptake of label one minute after the pulse 
resulted in undetectable levels of label incorporation into fatty acids.  Therefore, 
relative levels of label incorporation are first presented at ten minutes.  The saturated 
and monounsaturated fatty acids were placed in a single group due to the established 
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Percent of label recovered in: 
Strain Added 
14:0 16:0 18:0 18:1 18:2n6 18:3n6 18:3n3 18:4n3 20:2n6 20:3n9 20:3n6 20:4n3 20:4n6 20:5n3 22:4n6 22:5n3 22:5n6 22:6 ? 
14:0 76 14  10                
16:0  67  28               5* 
18:0   27 68               5* 
18:2n6     100               
18:3n6      100              
18:3n3       98.5     0.5       1 
18:4n3        100            
20:2n6         100           
20:3n9          100          
20:3n6           44 56        
20:4n3            100        
20:4n6             19 61  14  5 1 
20:5n3              60  27  13  
22:4n6               35 50 4 12  
22:5n3                84  16  
22:5n6                 38 51 11** 
KO 
22:6                  80 20** 
14:0 51 22 4 17               6* 
16:0  53 10 28               9* KO-1 
18:0   13 73               14* 
20:3n6           58 41        
20:4n6             32 62  6    
20:5n3              77  18  5  
22:4n6               46 39 5 10  
22:5n3                89  11  
KO-18 
22:5n6                 41 55 4** 
Table 4.2. 
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Table 4.2 (continued).  Radio-labeled fatty acid methyl esters (FAMEs) derived from total lipids of wild-type Crypthecodinium cohnii cultures grown in 
liquid media supplemented with the indicated [1-14C]-labeled free fatty acids.  All values are expressed as percent of total counts per minute in the FAME 
preparations.  In both the wild type and the auxotrophic mutants, conversions of exogenously supplied 18-carbon to 20-carbon fatty acids were not observed.  
The slight conversion of 18:3 n3 to 20:4 n3 (presumably through an undetectable 20:3 n3 intermediate) is considered insignificant due to the low activity and 
the fact that 20:4 n3 cannot be converted to any other products.  *Most of the unknown values represent single peaks which did not migrate at the same rate of 
authentic standards and therefore are unlikely to represent any other known standard pathway intermediates, but may represent non-standard desaturation 
events.  One unknown peak may represent 28:8** (as determined by the comparison of this peak’s retention time to the retention time calculated for 28:8), a 
fatty acid shown previously to accumulate in C. cohnii in very low levels (Van Pelt et al., 1999).  All values marked “*” or “**” correspond to single peaks 
which did not co-migrate with any of the authentic standards used and no authentic standards for 28:8 were available at the time of this study. 
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[1,2-14C] Acetate Uptake by C. cohnii  (strain KO)
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Figure 4.1.   Total radioactivity of a 14C-acetate-pulsed culture of C. cohnii (KO).  Aliquots 
were removed from the culture at 1, 10, 100, 500, 1000, and 2000 minutes after being pulsed 
with label.  Total cpm of the whole culture and washed cell pellets were determined and 
plotted.  Total cpm/mL of culture is shown as triangles (▲) and the percentage of these totals 
that were associated with the cell pellet is shown as squares (■). 
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Relative [1,2-14C] Acetate Incorporation 
into C. cohnii  Fatty Acids
0
10
20
30
40
50
60
70
1 10 100 1000 10000
Minutes
%
 c
pm
% in saturated and monounsaturated fatty acids
% in DHA
 
 
Figure 4.2.  Relative incorporation of radio-labeled acetate in C. cohnii fatty acids.  Lipids 
were extracted from biomass of additional aliquots from the culture described in Figure 4.1.  
Lipid extracts were converted to FAMEs and analyzed by radio-HPLC.  The sums of 
integrated peak areas are expressed as percents of total FAME-associated cpm for two acyl 
classes.  Percent of counts associated with DHA are shown as squares (■) and percent of 
counts associated with all saturated and monounsaturated fatty acids are shown as triangles 
(▲). 
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 product-precursor relationship between these fatty acids (Beach et al., 1974).  The 
same logic was of course applied to the grouping of all PUFAs in a single class, even 
though ~99% of this fraction was composed of DHA (as discussed above and shown 
in Table 4.2).  The relative incorporation of acetate into PUFAs (primarily DHA) and 
the saturate/monounsaturate groups remained constant throughout the experiment, 
indicating a nearly instantaneous equilibrium and more significantly, the absence of a 
product/precursor relationship between the two groups.    
 Radiolabeled fatty acid incorporation into C. cohnii lipids 
  To determine if those fatty acids which were not significantly 
converted to more complex, known PUFAs (Table 4.2) were incorporated into lipid 
pools after being fed to C. cohnii cultures, total lipids from cultures fed these 
radiolabeled fatty acids were extracted, separated into polar and non-polar lipid 
classes by HPLC and analyzed by scintillation detection.  The results of these 
analyses are shown in Figure 4.3.  In this case, 20:5 n3 (EPA) was used as a positive 
control because it was readily converted by elongation to DPA n3 which in turn was 
desaturated to DHA, a process indicative of incorporation into polar lipid classes 
(which typically serve as substrates for desaturases and elongases).  Unfortunately, 
the interpretation of these results was limited by the absence of commercially 
available radiolabeled lipids which could be used as comparative standards.  For this 
reason, non-radioactive lipids were previously applied to the column and detected by 
U/V absorption to determine the general ranges in which given lipid classes eluted.  
Polar lipids eluted from the column before 40 minutes of the HPLC run had elapsed, 
and all non-polar lipids eluted after this time.  Free fatty acids and CoA esters nearly 
co-migrated as the initial peaks detected.   
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Figure 4.3.  Chromatograms of scintillation intensities (in cpm) of lipid extracts from biomass 
samples equilibrium-labeled with the indicated [1-14C] free fatty acids.  Specific activities of 
each [1-14C] free fatty were approximately equal when initially added to each culture.  
Radiolabeled lipid class standards were not available, but preliminary experiments using 
unlabeled lipids indicated that all polar lipids migrated before 40 minutes run time (indicated 
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by the arrow at bottom).  Neutral lipids were found to migrate after this point in the run 
protocol.  The “FFA std” was pure [1-14C]-eicosapentaenoic acid (EPA).  Every other 
chromatogram represents separations of lipid extracts of biomass fed with[1-14C] 20:5 n3 
(EPA), 20:4 n3 (eicosatetraenoic acid), 20:3 n9 (mead acid), 20:1 n9 (eicosaenoic acid), 20:0 
(arachidic acid), 18:4 (stearidonic acid), 18:3 n6 (γ-linolenic acid) 18:3 n3 (α-linolenic acid), 
18:2 n6 (linoleic acid), 18:1 n9 (oleic acid), or 16:3 n6 (hexadecatrienoic acid). 
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 Surprisingly, EPA was not extensively distributed among many polar lipids 
classes although the major peak in this chromatogram is broader than the sharp peak 
of the pure radiolabeled EPA free fatty acid standard (“FFA std”) suggesting that it 
may exist as a CoA ester.  It should also be noted that while each culture was fed an 
approximately equivalent radioactive dosage of FFA, and was grown, harvested, 
extracted, and analyzed identically, the radioactivity recovered from certain extracts 
differed significantly (from ~120 cpm to ~1200 cpm per injection).  In this protocol, 
polar glycerolipid species elute from the column in a range between 10 and 45 
minutes.  The only fatty acids that appear to have incorporated into these species in a 
significant way are 20:4 n3, 20:3 n9, 20:0, 18:2 n6, and 18:1.  Some species of lipid 
did appear to harbor label from fed 20:1 n9 and 16:3 n6, but the overall levels of 
incorporation were fairly low.  The more complex 18-carbon species, like 18:4 and 
both isomers of 18:3, distributed their label in a pattern more similar to that seen with 
the EPA control, where the major peak is slightly broader than the free fatty acid 
standard. 
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Chapter 4 Discussion 
 
 Saturated and fatty acid-requiring auxotrophic mutants of C. cohnii were 
generated by random U/V mutagenesis.  In these auxotrophs, the biosynthesis of DHA 
was apparently not dependent upon saturated fatty acid biosynthesis in a manner 
reminiscent to the auxotrophic mutants of Schizochytrium described in Chapter 2.  
Several independently isolated C. cohnii mutants of each class of auxotrophy 
(saturated fatty acids or PUFAs) were generated and each mutant of an auxotrophic 
class was found to be identical in phenotype and allelic by sexual crosses.  With 
Schizochytrium, DHA biosynthesis is performed by a PUFA-PKS complex which 
synthesizes DHA and DPA de novo by a mechanism similar to that of saturated fatty 
acid biosynthesis with canonical fatty acid synthases (Metz, et al., 2001).  The data 
presented here do not demonstrate if C. cohnii possesses its own PUFA-PKS system, 
but they do demonstrate that C. cohnii lacks a functional standard pathway for the 
synthesis of DHA, leaving an alternate PUFA-PKS-like system as the most likely 
mechanism for DHA biosynthesis.  This hypothesis is discussed further in Chapter 5. 
 As shown in Table 4.2 and summarized in Figure 4.4, wild-type C. cohnii is 
not capable of converting fatty acids less complex than 20:4 n6 (ARA) to DHA, 
confirming the results of Beach et al. that C. cohnii is not capable of de novo DHA 
biosynthesis by known desaturase- and elongase-mediated pathways.  Limited 
conversion of homo-γ-linolenic acid (20:3 n6) to eicosatetraenoic acid (20:4 n3) was 
observed.  However, neither of these products could be elongated or further 
desaturated indicating that C. cohnii lacks a functional ∆5 desaturase.  C. cohnii also 
appears to lack activities for a ∆12 desaturase, ∆8 desaturase, ∆6 elongase, or ∆11 
elongase.  Taken together, these five “missing” activities represent a minimum of four 
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14:0 16:0 18:0
18:1
20:3n6
20:4n6
22:4n6
22:5n6
20:4n3
20:5n3
22:5n3
22:6n3
EL/FAS EL
Δ9
n-3
EL
Δ4
Figure 4.4.  A summary of elongation and desaturation activities found in wild-type and 
auxotrophic mutants of C. cohnii. 
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lesions in the standard pathway to DHA.  Not shown in Figure 4.4 is the fatty acid 
28:8 n3, which may have been produced in certain cultures (Table 4.2).  This finding 
is discussed further in Chapter 6. 
 These lesions alone do not provide evidence of a PUFA-PKS-like mechanism 
for DHA biosynthesis in C. cohnii.  For that purpose, a pulse-labeling experiment was 
performed with 1,2-[14C]-acetate (Figure 4.2).  If saturated and monounsaturated fatty 
acids served as precursors to DHA, acetate would incorporate into these fatty acids 
successively, rather than simultaneously as observed.  The rationale for this 
experiment was borrowed from Metz et al. (2001) who performed it with cultures of 
Schizochytrium to get strikingly similar results.  Keeping in mind that Schizochytrium 
is known to use a PUFA-PKS system as its sole mechanism of de novo PUFA 
biosynthesis, the case for a similar PUFA-PKS-like mechanism of DHA biosynthesis 
in C. cohnii becomes fairly convincing.  The argument is bolstered even further when 
one considers that both Schizochytrium and C. cohnii have lesions in the classic 
PUFA pathway that make de novo DHA biosynthesis by this route impossible. 
 Previously, Drexler et al. (2003) speculated that “C. cohnii is a candidate for 
using [a PUFA-PKS system].”  The authors go on to speculate that 
desaturase/elongase systems and PUFA-PKS systems may operate in parallel in 
several organisms, presumably to account for this same group’s observation that C. 
cohnii is capable of converting DPA n3 to DHA (Meyer et al., 2003). 
 This hypothesis is based on previously published data (Beach et al., 1974, 
Henderson and Mackinlay, 1991, de Swaaf et al., 2003), which show that 18-carbon 
fatty acids cannot be converted to DHA.  The data presented here support Drexler’s 
hypothesis.  Although, alternate explanations for the observations of Beach et al. 
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(1974), Henderson and Mackinlay (1991), and de Swaaf et al. (2003) have been made 
and should be addressed. 
 First, the argument has been made by Infante and Huszagh et al. (1998) that 
the “channeled” synthesis of DHA in C. cohnii is due to a mitochondrial 
compartmentalization of the necessary enzymes.  This hypothesis is not supported by 
our in vivo, fatty acid equilibrium labeling results, which should have detected any 
classic pathway regardless of its compartmentalization. 
 Also, de Swaaf et al., (2003) noted that “...the lipid content of the [C. cohnii] 
cells, strongly decreased with both desaturase inhibitors [norflurazon and propyl 
gallate,] does indicate that in C. cohnii, desaturases are involved [in the synthesis of 
DHA]”.  Nevertheless, the authors did not explicitly conclude that desaturases were 
responsible for de novo synthesis of DHA.  In the de Swaaf study, the lipid content of 
both saturated and unsaturated fats decreased nearly proportionally when C. cohnii 
cultures were exposed to desaturase inhibitors, suggesting that the inhibitors had a 
more global physiological effect on lipid accumulation rather than one that was 
specific to desaturases or to DHA biosynthesis in particular.  The work presented in 
this thesis indicates that some desaturation steps can lead to DHA biosynthesis, but 
only from PUFA substrates which cannot be synthesized de novo by C. cohnii, a 
distinction not addressed by de Swaaf et al. (2003). 
 Lastly, it is generally accepted that fatty acids are not desaturated and 
elongated directly, but rather are first esterified to a lipid or carrier molecule (like 
CoA or ACP).  It is also possible that the enzymes responsible for these reactions (for 
example, acyl-CoA ligase, glycerol-3-phosphate acyltransferase, etc.) have some acyl-
chain substrate specificity.  Thus, some fatty acids could be cell associated by passive 
uptake, but never converted to other fatty acids simply because they were never 
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esterified to molecules that would serve as adequate substrates for desaturation or 
elongation.  Before any equilibrium labeling experiments were performed with C. 
cohnii, the ability of the cell to incorporate an exogenous fatty acid was tested.  Live 
cells were approximately twice as capable of internalizing EPA as cells killed with 
potassium cyanide.  Cells killed in this way remained intact and visually similar to 
live cells, but were no longer swimming.  Presumably, EPA was incorporated more 
efficiently in live cells because of the contribution of an energy-dependent mechanism 
like the esterification of acyl groups to lipid or CoA.  The relevant chromatogram of 
Figure 4.3 suggests that esterification of EPA may have been primarily limited to 
products more or equally polar than a free fatty acid, like an acyl-CoA.  
Unfortunately, no further conclusion can be made by these analyses as to whether the 
[1-14C]-fatty acid, after equilibrium labeling and consequent desaturation and 
elongation, remained as a free fatty acid or a CoA ester.   
 The most curious aspect of the results shown in Figure 4.3 may be the 
diversity of lipid species in which the fatty acid label associated.  The presumption 
that the fatty acids which are converted by C. cohnii to larger or more unsaturated 
products (Table 4.2) are done so in association with polar lipid species may need to be 
revised.  In any case, many of the free fatty acids that are not converted by C. cohnii 
are clearly associated with lipid classes to some degree (18:2 n6 and 20:4 n3 being the 
most notable examples as these are two potential substrates for the “missing” 
reactions in the classic pathway to DHA).  Thus, the cause of certain supplied fatty 
acids not being converted to more complex products in C. cohnii can be most likely 
attributed to an absence of, or defect within, corresponding desaturases and elongases, 
rather than to an inability to import and esterify these fatty acid substrates.  However, 
the reduced levels of radiolabel incorporation associated with 20:1 n9 and 16:3 n6 
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indicate that C. cohnii may indeed possess a system of active free fatty acid uptake 
which is capable of discriminating against some free fatty acids, although this 
discrimination did not seem to apply to any of the key fatty acid substrates of the 
classical pathway. 
 Like the targeted gene disruption mutants of Schizochytrium, our randomly 
generated mutants of C. cohnii are unable to grow without supplied PUFAs.  If PUFA 
synthesis in C. cohnii were mediated by a desaturase/elongase mechanism, some 
qualified difference in the fatty acid equilibrium labeling between the wild type and 
the mutants should have been apparent, and yet this pathway was not significantly 
affected.  The relative kinetics of acetate label incorporation into fatty acids of 
Schizochytrium extracts and C. cohnii cells were also very similar, strongly implying 
independent mechanisms for de novo PUFA and saturated fatty acid synthesis.   
 Also like Schizochytrium, C. cohnii possesses a primary pathway for DHA 
biosynthesis and a relict, secondary pathway presumably for the conversion of 
exogenous or environmentally scavenged PUFAs.  This secondary pathway is 
mediated by standard desaturases and elongases.  However, the primary pathway of 
de novo biosynthesis of DHA is probably performed by a PUFA-PKS-like system. 
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Chapter 5 - Identification of Genes from Crypthecodinium cohnii 
Encoding Homologs of Fatty Acid and Polyketide Synthase 
Domains 
 
Chapter 5 Abstract 
 
 Expressed sequence tag databases of cDNAs from the heterotrophic 
dinoflagellate Crypthecodinium cohnii were generated.  These databases were mined 
for sequences with significant similarity to known genes of fatty acid or polyketide 
biosynthesis, of which several were found.  Specifically, five sequences similar to 
ketoacyl synthase domains of type I polyketide and fatty acid synthases were 
identified.  Additional transcripts with sequences similar to a ketoacyl reductase, a 
malonyl-CoA:ACP transacylase, and an acyl carrier protein were identified.  Each of 
these transcripts appeared to encode proteins with only one catalytic domain.  The 
only transcript which appeared to encode fusions of catalytic domains of fatty acid or 
polyketide synthases possessed sequence similar to malonyl-CoA:ACP transacylases 
followed by two domains with similarity to acyl carrier proteins.  The potential for 
these gene products to be involved in PUFA biosynthesis in C. cohnii is discussed. 
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Chapter 5 Introduction 
 
 As a source of the nutritionally important docosahexaenoic acid (DHA), 
Crypthecodinium cohnii is uncommon in that its DHA is the only polyunsaturated 
fatty acid (PUFA) accumulated.  In Chapter 4, the possibility of a PKS or PKS-like 
system for making DHA in C. cohnii was presented.  To date, only three C. cohnii 
genes have been found which are implicated in PUFA biosynthesis, and each of these 
appears to encode a classical-pathway elongase (Heinz et al., 2001, Zank et al., 2005, 
Cirpus et al., 2005).  Genes encoding domains associated with polyketide synthases 
from dinoflagellates of photosynthetic, toxin-producing genera have also been 
isolated (Snyder et al., 2005, Kubota et al., 2006).  These studies have primarily 
targeted type I PKS domains in these dinoflagellates, presumably under the 
assumption that similar domains related to fatty acid synthesis would be associated 
with type II FAS systems (which are targeted to plastids and are the exclusive source 
of medium- to long-chain fatty acids in nearly all photosynthetic eukaryotes) and that 
any type I FAS-like or PKS-like systems should be associated with polyketide toxin 
biosynthesis.  In two instances, a DNA sequence similar to PKS-like β-ketoacyl-
synthase (KS) domains was isolated from dinoflagellates of genera which were not 
known to produce toxins: Gymnodinium catenatum and Amphidinium carterae 
(Synder et al., 2003).  Unfortunately, the partial sequence of only three PKS-like 
domains from a dinoflagellate have been published (each from Karenia brevis, 
accessions: AAX39748, AAX39747 and AAX39746).  C. cohnii has never been 
reported to produce toxins and its raw biomass has been demonstrated as safe in 
toxological studies (Stefano, 1999). 
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 Like all dinoflagellates, C. cohnii has chromosomes (108 in all, Allen et al., 
1975) which stay condensed except during cell division (Dodge, 1966), which lack 
histones (Rizzo, 2003), and which harbor long stretches of highly repetitive DNA 
sequence (Hinnebusch et al., 1980).  Dinoflagellate genomes are also typically very 
large.  Measurements of the genome mass of C. cohnii have been found to range 
between 23.3 pg/cell (~2 x 1010 bp) (Veldhuis et al., 1997) and 6.9 pg/cell (~6 x 1010 
bp) (Soyer and Haapla, 1974).  Although the majority of C. cohnii chromosomal DNA 
apparently does not encode transcripts but is instead possibly structural in purpose 
(Anderson et al., 1992).  Lastly, dinoflagellate DNA is often methylated and contains 
varying degrees of the unusual nucleic acid hydroxymethyl uracil, which functions as 
thymine when recognized by RNA polymerase (Rae, 1976). 
 For these reasons, dinoflagellate genomics has focused primarily on Expressed 
Sequence Tag (EST) approaches whereby random plasmids from a cDNA library are 
sequenced en masse from one end of the cloned cDNA.  Prior to the work presented 
here and elsewhere (Sanchez-Puerta et al., 2006), four dinoflagellate EST projects 
have been reported.  The first was essentially a pilot set of C. cohnii ESTs from which 
several phylogenetically important sequences were derived (Fast et al., 2002).  The 
second two EST projects were small in scale (1012 and 2143 unique sequences) and 
focused on identification of genes encoding plastid proteins of Lingulodinium 
polyedrum and Amphidinium carterae (Bachvaroff et al., 2004).  The third 
dinoflagellate EST project, on Alexandrium tamarense, was larger (6,723 unique 
sequences) and more general in scope (Hackett et al., 2005). 
 In this study, a new EST survey of C. cohnii is presented.  General features of 
C. cohnii’s expressed gene set are described as a whole, followed by specific analysis 
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of gene sequences which appear to encode likely candidates for components of FAS-, 
PUFA-PKS-, or PKS-like systems. 
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Chapter 5 Materials and Methods 
 
 Strains, Media, and Culture Conditions 
  A C. cohnii strain adapted for growth in low salinity was grown in a 
fermentor (Martek Biosciences, Columbia, MD) essentially as described by Behrens 
et al. (2005).  The culture was harvested after 3 days for isolation of RNA.  C. cohnii 
strain KO and C. cohnii mutant KO-18 were grown in 1 L of IO 50:6 medium 
supplemented with cyclodextrins and DHA as needed (described in Chapter 4) at 27 
°C for 4 days before harvesting for RNA isolations. 
 RNA Isolations 
  Cultures were centrifuged at 5,000 x g for 10 minutes, and the pellets 
were flash-frozen in liquid nitrogen.  Approximately 10 g of each frozen pellet was 
ground to a fine powder using an oven-sterilized mortar and pestle (also cooled in 
liquid nitrogen).  The ground pellets were transferred to a 50 mL centrifuge tube 
containing 30 mL cetyl trimethyl ammonium bromide (CTAB) Buffer (0.1 M Tris-
HCl (pH 7.5), 1.5 M  NaCl, 50 mM EDTA (pH 8.0), 2% CTAB, 8 mg/mL fresh DTT) 
and gently mixed into a uniform suspension.  The suspensions were then passed 
through a French pressure cell at 5000 lbs./in.2 and the resulting lysates were mixed 
with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1, by vol.).  After 
centrifugation at 10,000 x g for 20 minutes, the aqueous layers were removed and re-
extracted with phenol/chloroform/isoamyl alcohol twice more before being mixed 
with an equal volume of isopropanol.  After overnight incubation at 4 °C, a precipitate 
was collected by centrifugation at 5,000 x g for 20 minutes, washed in 80% ethanol 
(v/v), and dried in air for 30 min.  The pellet was then resuspended in molecular 
biology grade water and stored at -80 °C. 
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 Construction of cDNA Libraries, Isolation, and Sequencing 
  Libraries of cDNA were constructed by Marligen Biosciences Inc. 
(Ijamsville, MD) as detailed.  Purification of mRNA from total RNA was conducted 
using standard protocols with oligo-dT conjugated resin (Marligen Biosciences Inc., 
Ijamsville, MD), and complimentary DNA was synthesized by reverse transcription 
with oligo-dT primers containing a NotI restriction site, except for the oligo-dT 
primer used to make cDNA inserts for the library “cli” (below) which instead 
contained a PacI site.  Complimentary DNA made from RNA of low-salinity C. 
cohnii cultures were either fractionated by size to create an average cDNA insert size 
of 3.3 kbp (cDNA library “cli”) or normalized (cDNA library “cn”) by standard 
protocols before ligation to the carrier vector pExpress-1.  Alternately, first-strand, 
target cDNA made from C. cohnii strain KO was used to create three different 
subtraction libraries by initially hybridizing it with RNA extracted from the C. cohnii 
mutant KO-18 at 42 °C.  Three Cot values (10, 50, and 500) were obtained under 
different hybridization conditions: cDNA library “cot10” was created using 11.8 µg 
of RNA driver to hybridize with the target for 35 h, cDNA library “cot50” was 
created using 59 µg of RNA driver to hybridize with the target for 3.5 h, and cDNA 
library “cot500” used 43 µg of RNA driver to hybridize with the target for 48 h.  The 
non-hybridizing cDNAs were collected and used for second-strand synthesis and 
insertion to the carrier vector pExpress-1.  The pExpress-1 vector used for each 
library had previously been mutated at the unique EcoRI site to enable digestion 
instead with EcoRV.  All cDNAs were digested with either PacI or NotI before 
ligation to pExpress-1 which had previously been digested with EcoRV and NotI or 
PacI as appropriate. 
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 Mass clone isolation, growth, plasmid extraction, and cDNA insert sequencing 
was performed by MWG (Ebersberg, Germany) using standard dye-terminator 
procedures and kits.  Inserts were initially sequenced using a primer specific to the 
SP6 promoter.  Selected clones were further sequenced by walking strategies.  Where 
mentioned, the 5’ ends of certain cDNAs were isolated with the GeneRacer™ RACE 
Ready cDNA Kit (Invitrogen, Carlsbad, CA) for rapid mmplification of cDNA ends 
(RACE).  Resulting amplicons were cloned for sequencing by standard procedures. 
 Sequence Assembly and Analysis 
  Raw sequences were assembled into contiguous reads (“contigs”) by 
MWG (Ebersberg, Germany) before being installed as searchable datasets on a stand-
alone basic local alignment search tool (BLAST) server according to provided 
instructions (National Center for Biotechnology Information, Bethesda, MD).  
Additional assemblies were made with SeqMan (Lasergene, Madison, WI) using the 
following assembly parameters: “minimum overlap” - 12 bp, “% match” - 99, 
“minimum sequence length” - 100 bp, “gaps/kbp/contig” - 5, “gaps/kbp/sequence” - 
5, “register shift” - 2.  Assembled and non-assembled EST datasets were also 
automatically annotated by blastall comparisons against the Genbank dataset “nr” and 
by retrieval of gene ontologies of high-scoring subjects with BLAST2GO (Conesa et 
al., 2005).  Output files were parsed and imported to a relational database.  Specific 
sequences were identified by simple text searches of the relational database as well as 
by querying public databases by BLAST searches with protein and gene sequences 
related to fatty acid synthases, polyketide synthases, and lipid biosynthesis. 
  159
Chapter 5 Results 
 
 EST Statistics 
  From the combined subtraction libraries (“cot10”, “cot50”, and 
“cot500”), 4879 usable sequences were made representing 3,027,380 bp.  Separately, 
these usable sequences were composed of: 1821 reads from “cot10” totaling 
1,166,817 bp, 1777 reads from “cot50” totaling 1,164,403 bp, and 1281 reads from 
“cot500” totaling 696,160 bp.  When assembled, these collapsed to 2650 unique, 
contiguous sequences (contigs) of 1,955,363 total bp.  The “long insert” (“cli”) and 
normalized (“cn”) libraries were used to generate a total of 15,261 usable ESTs 
(10,303,807 bp) which collapsed to 5,513 unique contigs after assembly (4,392,822 
bp) (note that this assembly was done independently of the one reported by Sanchez-
Puerta et al. (2006), which produced 5505 unique sequences and included an 
additional set of pilot sequences which were excluded from the current assembly).  
Individually, 7331 sequences, totaling 4,848,912 bp were made from the “cli” library 
and 7930 sequences, totaling 5,454,895 bp were made from the “cn” library.  The two 
sets of assembled contigs (“cot” and “cli+cn”) were then further assembled to each 
other to form a single composite set of contigs consisting of 6932 unique sequences 
(5,587,750 bp). 
 When the composite contigs were compared to the Genbank non-redundant 
sequence database by BLASTx, 43% produced an e-value lower than the threshold of 
9. 9  x 10-3 (Figure 5.1, Panel A).  Of these, most were about 50% similar to other 
known genes (Figure 5.1 Panel B).  Only 17% (1,176) could be cataloged in the Gene 
Ontological (GO) database (Figure 5.2) and Enzyme Commission (EC) numbers 
could be assigned to just 235 sequences, which were then used to populate pathway 
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    A 
 
    B 
 
Figure 5.1.  6,933 unique sequences, assembled from various C. cohnii ESTs, were compared 
to the non-redundant Genbank dataset by BLASTx.  2,991 query sequences matching subjects 
(“hits”) with e-value scores lower than the arbitrary threshold of 9. 9  x 10-3 were analyzed 
further.  (Panel A) e-value score distribution of all hits scoring lower than threshold e-values.  
(Panel B) Distribution of percent similarity between translated query and subject protein 
sequence matches with e-values lower than threshold of 9. 9  x 10-3.  
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A.  Cellular Component 
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B. Biological Process 
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C. Molecular Function 
Figure 5.2.  Gene Ontologies of assembled C. cohnii ESTs.  1,176 unique sequences of C. cohnii transcripts are classified by Gene Ontologies (Level 3).  
Top-level ontologies are “Cellular Component” (Panel A), “Biological Process” (Panel B), and “Molecular Function (Panel C). 
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maps provided by Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa 
and Goto, 2000).  At least six of the ten genes described in the following sections 
appear to be encoded only partially by complimentary DNA.  Of these, two were the 
subject of successful RACE, which was used to retrieve the missing 5’ ends 
(described below). 
 Sequences Similar to FAS and PKS: ketoacyl synthase (KS) 
  Through text and BLAST searches, five contigs were identified with 
sequences similar to those of β-ketoacyl synthase (KS) domains from other PUFA-
PKS, FAS, and PKS systems.  Alignments of the 4 characteristic KS motifs are shown 
in Figure 5.3.  Generally, KS is the most well conserved FAS or PKS domain.  
Catalytic KS domains have a specifically located cysteine residue for covalent 
attachment of the growing acyl chain (Figure 5.3, Panel A).  Non-catalytic KS 
domains which lack these cysteine residues are also known.  KS domains usually exist 
as dimers and in cases where a catalytic KS domain is paired with a non-catalytic 
domain, the non-catalytic domain is thought to contribute to overall chain length of 
the formed acyl groups and is often referred to as a “chain length factor” (CLF) 
(Keatinge-Clay et al., 2004).  Two other domains are best characterized by catalytic 
histidines which interact with acyl intermediates derived from acyl-acyl carrier 
protein (ACP) esters (Figure 5.3; Panels B and C).  Lastly, many KS domains have 
what has been called an “ending” domain which does not serve any apparent catalytic 
function but may be important for overall KS structure (Jim Metz, Martek 
Biosciences Boulder Corp., Boulder, CO, personal communication). 
 Two cDNA clones formed the contig encoding KS1 (one from the cot500 
library and the other from the “cli” library).  The N-terminal region of the KS1 gene 
product was truncated from these cDNA clones but was later isolated by 5’ RACE.  
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A) 
       T V D T A C S S S L V                    Majority 
       ------------------+--- 
                         10   
       ------------------+--- 
  959  T I D T A C S S S L V                    T. gondii FAS KS CAJ20333 
 5431  T I D T A C S S S L V                    C. parvum FAS KS AAC99407 
  200  T V D T A C S S S L V                    P. cellulosum epoC KS AAF26921 
  204  T L D T A C S S S L V                    Nostoc punctiforme PKS ZP_00108795 
  205  T V D T A C S A S L L                    Stigmatella aurantiaca stiG CAD19091 
  167  A V D T A C S S S L V                    Gloeobacter violaceus PKS NP_925775 
  189  C I D A A C S S A F Y                    Anabaena hglD KS AAA93154 
  191  A L D A A C A S S C Y                    Moritella marina ORF 10 BAA89384 
  210  V V D A A C A S S L I                    Schizochytrium ORF A KS AAK72879 
  191  S V D A A C A T A L Y                    Schizochytrium ORF B KS AAK72880 
  176  G M L S A C A T S G N                    Plasmodium yoelii KSI.II EAA16317 
11121  T V D T A C S S S L V                    C. parvum PKS KS AAN60755 
  153  T V D T A C S S G L S                    KS1 (cot500_003c_b09+RACE) 
    1  - - - - - - - - - - -                    KS2 (cot10_001d_g05) 
   81  S H D T A C S S T L M                    KS3 (cot500_001c_d11) 
  455  S I D C E M S S A S V                    KS5/CLF1 (cli_018d_h06) 
  145  A L D A H G A T A W A                    KS4/CLF2 (cot10_002c_c08) 
  651  T I T E G N N S V Y R                    Schizochytrium ORF B CLF AAK72880 
  251  V V D A A W P S S F G                    Nostoc punctiforme hglE CLF AAB82059 
  170  V V A A D E A G G L D                    S. coelicolor ORF IV CLF CAA39409 
 
B) 
 
       I D Y V E C H G T G - T P L G            Majority 
       ------------------+----------- 
                         10           
       ------------------+----------- 
 1108  I Y F V E T H G T G - T S L G            T. gondii FAS KS CAJ20333 
 5565  I D Y L E S H G T G - T P L G            C. parvum FAS KS AAC99407 
  334  V D Y V E T H G T G - T S L G            P. cellulosum epoC KS AAF26921 
  338  V S Y V E A H G T G - T P L G            Nostoc punctiforme PKS ZP_00108795 
  339  V G Y V E A H G T G - T S L G            Stigmatella aurantiaca stiG CAD19091 
  301  I D Y V E A H G T G - T P L G            Gloeobacter violaceus PKS NP_925775 
  323  I D Y M E C H A T G - T L L G            Anabaena hglD KS AAA93154 
  325  V D Y I E C H A T G - T P K G            Moritella marina ORF 10 BAA89384 
  344  V T L V E G H G T G - T P V G            Schizochytrium ORF A KS AAK72879 
  327  I Q Y V E C H A T G - T P Q G            Schizochytrium ORF B KS AAK72880 
  316  I K Y I N A H G T S - T K L N            Plasmodium yoelii KSI.II EAA16317 
11266  I S I I E A H G T G - T Q L G            C. parvum PKS KS AAN60755 
  293  I T T Q E C H G T G - T A L G            KS1 (cot500_003c_b09+RACE) 
   79  I T V A E C H G T G - T A L G            KS2 (cot10_001d_g05) 
  217  V G A A E C H G T G - N R P R            KS3 (cot500_001c_d11) 
  601  V D A V E C H G I G - G A L E            KS5/CLF1 (cli_018d_h06) 
  283  I E V V E C F A D G - D A M S            KS4/CLF2 (cot10_002c_c08) 
  782  A R H L K D P S V L P K E L T            Schizochytrium ORF B CLF AAK72880 
  385  V G L M E A H G T G - T M A G            Nostoc punctiforme hglE CLF AAB82059 
  305  V D V V F A D A L G - V P E A            S. coelicolor ORF IV CLF CAA39409 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. 
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C) 
 
        K T N I G H L E A A A                    Majority 
        ------------------+--- 
                          10   
        ------------------+--- 
  1185  K T N I G H L E G A A                    T. gondii FAS KS CAJ20333 
  5608  K T N I G H L E G A A                    C. parvum FAS KS AAC99407 
   375  K T N I G H L E A A A                    P. cellulosum epoC KS AAF26921 
   379  K T N I G H L E S A A                    Nostoc punctiforme PKS ZP_00108795 
   380  K T N V G H L E G A A                    Stigmatella aurantiaca stiG CAD19091 
   342  K T N I G H L E A A A                    Gloeobacter violaceus PKS NP_925775 
   361  K A N V G H L L V A A                    Anabaena hglD KS AAA93154 
   363  K S N L G H L L T A A                    Moritella marina ORF 10 BAA89384 
   387  K S S I G H L K A V A                    Schizochytrium ORF A KS AAK72879 
   363  K G N F G H T L X A A                    Schizochytrium ORF B KS AAK72880 
   354  K S M T G H C I G A A                    Plasmodium yoelii KSI.II EAA16317 
 11305  K T N I G H L E G A S                    C. parvum PKS KS AAN60755 
   333  K S N L G H Q E P N A                    KS1 (cot500_003c_b09+RACE) 
   118  K A N F G H M E A C A                    KS2 (cot10_001d_g05) 
   259  R S T S A T Q K P M Q                    KS3 (cot500_001c_d11)* 
   643  K T H V G A Q C E A C                    KS5/CLF1 (cli_018d_h06) 
   325  M S N I G F M R E V A                    KS4/CLF2 (cot10_002c_c08) 
   824  K A T V G D T G Y A S                    Schizochytrium ORF B CLF AAK72880 
   426  K S Q I G H T K A A A                    Nostoc punctiforme hglE CLF AAB82059 
   343  K T G T G R A Y C A A                    S. coelicolor ORF IV CLF CAA39409 
 
D) 
 
        G V S S F G F G G T N A H                Majority 
        ------------------+------- 
                          10       
        ------------------+------- 
  1261  G V S S F G F G G A N G H                T. gondii FAS KS CAJ20333 
  5674  G V S S F G F G G C N S H                C. parvum FAS KS AAC99407 
   441  G V S S F G M S G T N A H                P. cellulosum epoC KS AAF26921 
   445  G V S S F G F S G T N A H                Nostoc punctiforme PKS ZP_00108795 
   446  G V S S F G L S G T N V H                Stigmatella aurantiaca stiG CAD19091 
   408  G V S S F G F G G T N A H                Gloeobacter violaceus PKS NP_925775 
   427  A L S A F G F G G T N S H                Anabaena hglD KS AAA93154 
   434  G V S V F G F G G S N A H                Moritella marina ORF 10 BAA89384 
   457  G I S S F G F G G A N Y H                Schizochytrium ORF A KS AAK72879 
   425  G L S A F G F G G T N A H                Schizochytrium ORF B KS AAK72880 
   414  L N T N L G F G G H N T A                Plasmodium yoelii KSI.II EAA16317 
 11367  G V S S F G F G G T N A H                C. parvum PKS KS AAN60755 
   397  G V S S F G V S G T N A H                KS1 (cot500_003c_b09+RACE) 
   182  G V S S F G V G G T N A R                KS2 (cot10_001d_g05) 
   322  W E C L L S V S E V R T D                KS3 (cot500_001c_d11)* 
   707  S F S S R G L G G T T V H                KS5/CLF1 (cli_018d_h06) 
   390  G A T S R G L G G T V T H                KS4/CLF2 (cot10_002c_c08) 
   891  A V S G V S E T R S C Y S                Schizochytrium ORF B CLF AAK72880 
   494  G V S S F G F G G T N Y H                Nostoc punctiforme hglE CLF AAB82059 
   399  L V L A R G L M G S N S A                S. coelicolor ORF IV CLF CAA39409 
Figure 5.3 (continued).  Relevant motifs of KS and CLF domains of selected type I and type 
II FAS and PKS systems.  Positions of residues conserved in KS domains are highlighted in 
red.  Sequences detailed in this work are in bold.  Residue numbers are indicated at left and 
corresponding KS or CLF protein sequence identifiers are shown at right by organism, gene, 
and accession number (or other specific reference designator).  The consensus majority 
sequence is shown at the top of the alignment.  All sequences listed above KS1 have been 
documented as KS domains.  All sequences listed below KS4/CLF have been documented as 
CLF domains.  A) KS Catalytic site 1: elongating acyl chains are bound as a thioester at the 
“C” residue.  Note the absence of this residue in each of the CLF domains.  B) KS Catalytic 
site 2.  C) KS Catalytic site 3.  D) KS/CLF “Ending Domain”.  *Possible artifact (see text). 
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Like KS1, the only clone encoding KS2 was truncated before the area encoding the 
first canonical KS motif.  The sequence of KS5/CLF1 was the only other KS derived 
from a contig composed of more than a single sequence: three from the “cn” library 
and one from “cli”.  Each of the other sequences encoding proteins similar to KS 
domains were found to be composed of a single sequence: KS2 and KS4/CLF2 each 
from a different clone of the cot10 library and KS3 from a clone of the cot500 library.  
Every KS cDNA clone possessed a poly-A tail varying in length from 10 to 85 bases. 
 Basic features of the conceptually translated protein products of each KS gene 
sequence are described in Table 5.1.  The first half of KS1 exhibited strong similarity 
to KS domains from FASs and PKSs of many different organisms (39-1190 bp) (type 
I FAS from T. gondii, PKS from Nostoc punctiforme PCC 73102, type I FAS from 
Cryptosporidium parvum, StiG from Stigmatella aurantiaca, etc.), yet the last half 
(base pairs 1190-2276) had only weak similarities to a handful of unrelated proteins.  
The 3’ untranslated region (UTR) of the assembled transcript of KS1 is 228 bp.  
Because the 5’ end of this transcript was acquired by RACE, the length of the 5’ UTR 
was determined to be just 11 bp but a small segment (~5 bp) of the 5’ RACE primer 
sequence did not agree with the confirmed sequence of the resulting amplicon.  KS1 
also appears to encode cysteine and histidine residues in the appropriate positions 
(Figure 5.2, Panels A-C), enabling its classification as a KS domain. 
 The single cDNA clone encoding KS2 was apparently truncated.  Like KS1, 
the gene encoding KS2 was very similar to the same PKS and FAS associated KS 
domains, and this similarity was only found to the first half of the KS2 conceptual 
translation (2-529 bp).  The last half of the KS2 conceptual translation (amino acids 
529-859) had no significant similarity to any known proteins.  The 3’ UTR of KS2 is 
200 bp.  The cDNA encoding KS2 was unfortunately truncated at a point after the 
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Gene Name Pred. cds Calc. MW  Best Hit Description (BLASTx) % Ident. % Pos. % Gaps Hit Range 
KS1 12-2276 
(754 aa) 
82.1  type I fatty acid synthase, putative [Toxoplasma 
gondii] (CAJ20333) 
40 52 10 39-1190 
KS2 2-859 
(286 aa) 
truncated type I fatty acid synthase, putative [Toxoplasma 
gondii] (CAJ20333) 
48 62 1 2-529 
KS3 2-1036 
(345 aa) 
truncated type I fatty acid synthase, putative [Toxoplasma 
gondii] (CAJ20333) 
45* 58* 3* 2-679* 
672-716 
748-915 
KS4/CLF2 3-1400 
(466 aa) 
truncated type I fatty acid synthase, putative [Toxoplasma 
gondii] (CAJ20333) 
34 53 3 9-1133 
KS5/CLF1 98-3169** 
(1024 aa) 
111.4** type I fatty acid synthase, putative [Toxoplasma 
gondii] (CAJ20333) 
32 50 10 773-2323 
 
MAT 20-1699** 
(560 aa) 
62.6** malonyl CoA-acyl carrier protein transacylase 
containing protein, expressed [Oryza sativa 
(japonica cultivar-group)] (ABF95452) 
40 56 3 785-1672 
KR 17-1711 62.8 Polyketide synthase modules and related proteins 
[Nostoc punctiforme PCC 73102] (ZP_00107887) 
34 50 6 686-1528 
MAT2xACP 198-2372 78.5 unnamed protein product [Aspergillus oryzae] 
(BAE64602) 
28 44 12 306-1262 
ACP 1-1341 truncated polyketide synthase [Polyangium cellulosum] 
(CAD43450) 
41 61 0 1108-
1332 
ELO4 107-1039 35.0 unnamed protein product [Crypthecodinium cohnii] 
(CAC69358) 
99 99 0 404-1033 
DES1 50-790 partial seq delta 5 fatty acid desaturase [Dictyostelium 
discoideum AX4] (BAA81814) 
26 41 15 134-748 
 
Table 5.1.  Selected properties of C. cohnii EST sequences similar to FAS and PKS domains.  Predicted coding region (“Pred. cds”) refers to the positions (in 
bp position relative to the known cDNA sequence) of the most likely coding region of the gene and, in parentheses, the expected protein product size in amino 
acids (“aa”).  The calculated molecular weight of the conceptual protein product is given in kDa, except for genes from cDNAs which appeared to be 
truncated or for which only partial sequence (“partial seq”) was available.  The Best Hit Description column displays the Genbank definition line (and 
accession number) of the top-scoring hit resulting from a BLASTx search of the “nr” database using the indicated gene sequence as a query (excluding poly-
A tails).  BLASTx parameters were set to defaults.  Percentage of Identity (“% Ident.”), Positives (“%Pos.”), and Gaps (“% Gaps”) are values derived from 
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the top-scoring, BLASTx hit from “nr” relative to the indicated gene sequence query.  The range (in bp position relative to the known cDNA sequence) of a 
given cDNA sequence query producing an alignment with a sequence from “nr” is shown in the column labeled “Hit Range”.  In many cases, the query 
sequence may have aligned with multiple domains of the highest-scoring, BLASTx hit.  In these examples, only the statistics for the domain producing the 
highest bit score are shown.  (*Frame 2 only; see text)  (**Longest potential ORF; see text).  All BLAST scores were determined without complexity 
filtering. 
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position where the cysteine of the acyl binding site would normally be found (Figure 
5.3, Panel A).  Classification of KS2 as a true KS domain (as opposed to a chain 
length factor (CLF)) will depend on later isolation and identification of this upstream 
region. 
 The cDNA encoding the gene for KS3 appears to have one or more frame-
shifting point mutations as BLASTx comparisons of the sequence from the lone 
cDNA associated with KS3 to other KS domains generated alignments in all three 
plus-strand frames.  For instance, the best hit, to a type I FAS KS domain of 
Toxoplasma gondii, matched conceptual translations of the KS3 query between base 
pairs 2 and 679 (frame 2), between base pairs 672 and 716 (frame 3), and between 
base pairs 748 and 915 (frame 1).  These likely frame-shifts make 3’ UTR prediction 
difficult.  However, if it is assumed that frame 1 represents the true coding frame of 
the gene from base pair 916 onwards, a stop codon appears later in the transcript at 
base pair number 2043 leaving a 3’ UTR of 93 bp.  When compared to “nr” by 
BLASTx, the nucleotide sequence of this region between base pairs 916 and 2043 
reveals only weak hits to unrelated proteins, similar to what was observed when the 
regions downstream of the high-scoring regions of KS1 and KS2 were compared to 
“nr” in the same way.  While the acyl-binding cysteine and the first histidine motif are 
encoded in the appropriate position of KS3 (Figure 5.3, Panels A and B), the 
remaining two domains (Figure 5.3, Panels C and D) are obscured by these putative 
frame-shift mutations, allowing only provisional classification of KS3 as a KS 
domain. 
 Overall, the similarity (by BLASTx) of KS4/CLF2 to other KS domains is 
weaker than was found with KS1, KS2, or KS3.  Still, the similarities are strong 
enough to classify this gene as at least “KS-like”.  The most significant feature of 
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KS4/CLF2 is the absence of an encoded cysteine residue at the expected position 
needed for acyl binding (Figure 5.3, Panel A).  It does encode the other two expected 
histidine motifs (Figure 2B and C) as well as a conforming “ending motif” (Figure 
5.3, Panel D).  The KS4/CLF2 3’ UTR is predicted to be 124 bp in length. 
 The canonical cysteine residue for acyl attachment does not align at the 
appropriate position in KS5/CLF1 either (Figure 5.3, Panel A); instead it is 2 amino 
acids upstream.  KS5/CLF1 is encoded by a particularly long cDNA (3308 bp total, 
excluding the poly-A tail).  The similarity of this cDNA to KS domains does not 
begin until base pair number 773 and the last stop codon found in-frame before the 
region of KS-domain similarity is found at base pair number 77.  This situation leaves 
many ATG sequences as potential start codons (7 including the ATG at position 776, 
which is part of the region similar to KS domains).  Size and MW statistics of the 
longest possible KS5/CLF1 open reading frame (ORF) are described in Table 5.1.  
The predicted 3’ UTR of KS5/CLF1 is 139 bp.  Assuming that the transcript encoding 
KS5/CLF1 is correct and that the longest ORF identified is the correct one, the 5’ 
UTR of KS/CLF1 is 97 bp.  Lastly, three of the clones composing the KS5/CLF1 
contig were unable to form a consensus sequence in a short region of just 19 bp 
located immediately upstream of the poly-A tail.  The sequence of KS5/CLF1, listed 
in Supplement 5.1, is of one clone (cli_018d_h06) alone and does not reflect this 
discrepancy in the consensus. 
 Sequences Similar to FAS and PKS: malonyl-CoA:ACP transacylase (MAT) 
  Four cDNAs were found to encode sequences bearing high similarity 
to malonyl-CoA:ACP transacylases (MAT).  Three of these cDNAs were from the 
“cn” library and the fourth was found among the “cot50” clones.  The largest of these 
clones was found to span the entire assembled contig and possessed a poly-A tail.  
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The largest open reading frame encoding the region of similarity to other MAT 
domains spans base pairs 20-1699 (Table 5.1), but the similarity to MAT domains is 
only found in the last half of this region.  The first half of the largest predicted MAT 
ORF encodes a region with moderate similarity to ankyrin repeats.  The strongest hit 
was from accession number XP_789640 “similar to ankyrin 3, epithelial isoform b” of 
Strongylocentrotus purpuratus with a bit-score of 55.5.  Three alignments were 
produced from these “ankyrin repeats” spanning base pairs 245-499, 146-445, and 
245-545.  Three individual repeats were found and each repeat is approximately 34 
residues long as encoded by this C. cohnii MAT homolog.  Ten potential “ATG” start 
codons were found in-frame before the region of similarity to MAT and three of these 
were found before any of the regions aligning to an ankyrin repeat.  The 3’ UTR of 
MAT is apparently 196 bp and the 5’ UTR, as predicted from the first possible start 
codon, is only 19 bp.  The next two start codons (which are in-frame with regions of 
BLASTx similarity to other proteins) begin at positions 71 and 80.  A motif 
implicated as the malonyl/acetyl-chain binding site of MAT can be identified 
“GLSLG” and is encoded by base pairs 1031-1045. 
 Sequences Similar to FAS and PKS: ketoacyl reductase (KR) 
  Three cDNA clones formed a contig which appears to encode a protein 
similar to ketoacyl reductase domains primarily from polyketide synthases.  Two of 
these cDNA clones came from the “cn” library and the remaining clone was from 
“cli” and all of them possessed a poly-A tail.  The best scoring alignment to these C. 
cohnii cDNA sequences came from one of the many uncharacterized polyketide 
synthase modules of Nostoc punctiforme.  While this alignment only spanned the 
middle third of the of the query sequence, the third-highest scoring hit (from another 
PKS system in the same strain of N. punctiforme) produced an alignment spanning 
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base pairs 74-1507, encompassing nearly all of the largest predicted ORF.  The 
predicted length of 5’ and 3’ UTRs would then be 16 and 157 bp, respectively. 
 Sequences Similar to FAS and PKS: acyltransferase - acyl carrier proteins 
(MAT2xACP) 
  A single cDNA (from the “cn” library) was found with weak similarity 
to acyltransferases (AT) and malonyl-CoA:ACP transacylases (MAT) in the first half 
of the query sequence and to acyl carrier proteins (ACP) in the second.  The best 
scoring alignment was to the S-malonyltransferase domain of an un-annotated protein 
from Aspergillus oryzae which appears to be a fatty acid synthase.  The second-best 
scoring alignment was similar in that it was to the S-malonyltransferase domain of un-
annotated protein from Neurospora crassa.  The third-best scoring alignment was 
generated with the properly annotated and experimentally verified S-
malonyltransferase domain of fatty acid synthase from Schizosaccharomyces pombe.  
A motif which agrees well with the consensus of catalytic sites from other MAT and 
AT domains was encoded between base pairs 621-635 (“GHSQG”). 
 The similarity of the downstream sequence of this cDNA to ACPs was not 
readily detected by BLASTx comparison.  Instead, the longest ORF encoding the 
putative MAT domain was conceptually translated and used as a BLASTp query 
versus “nr”.  The similarity of the first half of the conceptual translation was strongest 
to MAT and AT domains as expected.  The similarity of the second half of the 
translation was best (but only weakly) to ACP domains of PKSs.  Two 
phosphopantetheine-binding motifs were found in this region; “GLRSN” encoded by 
base pairs 1527-1541 and “GPDSL” encoded by base pairs 1827-1841.  Despite the 
lower-scoring similarity of these domains, all three were identified by comparison to 
the Conserved Domain Database (National Center for Biotechnology Information, 
  174
Bethesda, MD), supporting their assignments as MAT and ACP domains.  The 5’ 
UTR of the transcript for MAT2xACP was isolated by RACE, but no possible 
alternate start codons were identified in the additional sequence.  The 5’ UTR was 
found to be 197 bp long and the 3’ UTR, 163 bp. 
 Sequences Similar to FAS and PKS: acyl carrier protein (ACP) 
  Two cDNA clones (one from “cn” and one from “cli”) were found 
with strong similarity to ACP domains (particularly from PKS systems like that of 
Polyangium cellulosum (Table 5.1)) and very weak similarity to various other proteins 
with tetratricopeptide repeats.  The phosphopantetheine binding motif of this ACP 
appears to be encoded by bases 1141-1155 (“GLDSL”).  Also, the last few bases of 
the two cDNA clones encoding this ACP domain do not agree.  Clone cli_12b_c04 
ends with the sequence “AT GTG GTG TCC TAA G-(poly-A)” whereas cn_23c_b10 
ends with “GTG TGG TGT CC-(poly-A)”.  The codon beginning 4 bases upstream of 
the poly-A tail in cDNA clone cli_12b_c04 is in-frame with the predicted coding 
region of the ACP domain and would have been assigned as a stop codon if it agreed 
with the sequence derived from clone cn_23c_b10, which has no recognized stop 
codons in-frame with the predicted coding region.  Lastly, it should be emphasized 
that even though the clones appear truncated at both the 3’ and 5’ ends, this sequence 
is unusual in that the ACP domain only constitutes a very small portion of the total, 
and that no other obviously catalytic domains were detected.  The sequence of clone 
cn_23c_b10 is included in Supplement 5.1. 
 Sequences Similar to Elongase (ELO4) 
  Seven cDNA clones (6 clones from the “cn” library and 1 from the 
“cot10” library) were found which appeared to encode an elongase (annotated as 
“ELO4”) nearly identical in predicted protein sequence to one isolated by Heinz et al. 
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(Accession AX214452).  The corresponding DNA sequence of the clones isolated in 
this study are considerably longer than that of the Heinz elongase (1462 bp vs. 708 
bp) and the only disagreements between the two are clustered near the ends of Heinz’s 
elongase DNA sequence (Accession CAC69358).  The single “histidine box” motif is 
readily identified in an alignment of the predicted protein sequence (Figure 5.4 
(boxed)) although this motif differs from the usual motif which has a third histidine 
(Beaudoin, 2000) at the position where a glutamine is found.  The 5’ UTR of ELO4 is 
apparently 106 bp and the 3’ UTR is 398 bp. 
 Sequences Similar to Desaturase 
  Two cDNA clones from the “cn” library, sharing similarity to a 
number of the so-called “front end” desaturases (∆4 and ∆5 primarily), were 
designated “DES1”.  The hallmark cytochrome b5 domain of front end desaturases 
“HPGG” is encoded between bp 185-196 and one motif, which agreed with the first 
of three “histidine boxes” usually associated with fatty acid desaturases (for reviews 
see: Los and Murata, 1998 and Sperling et al., 2003), is encoded between bp 557-571 
(“HSAVH”).  An additional motif was identified between bp 695-709 (“HFWHH”), 
however this putative “histidine box” motif is one residue short of the accepted 
consensus (HXXXHH).  The hypothetical 5’ UTR of DES1 is 49 bp and, because 
these clones were only partially sequenced from the 5’ end, no 3’UTR is apparent. 
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M S A X X X L X Q A L S X V X S A L V T L X H D V S S P S A F X X V T Majority
10 20 30
M S A I T N L S Q A L S S V S S A L V T L Q H D V S S P S A F R T V T  1 ELO4
- - - - - - - - - - - - - - - - - - - - - R H E V H - - - - - - - - -  1 CAC69358
M S A F M T L P Q A L S D V T S A L V T L G K D V S S P S A F Q A V T  1 CAI58880 & CAJ30828
- - - M A S Y Q Q A F S E L A R A L S T L N H D F S S V E P F K V V T  1 CAI58881 & CAJ30829
X F C R E Q W G I P T V F C X G Y L A M V Y A A R R P X A Q H X Y M X Majority
40 50 60 70
S F C R E Q W G I P A F F C V S Y L V M V Y A A R R P M A Q H S H M L  36 ELO4
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  6 CAC69358
G F C R E Q W G I P T V F C L G Y L A M V Y A A R R P L P Q H G Y M V  36 CAI58880 & CAJ30828
Q F C R D Q W A I P T V F C I G Y L A M V Y A T R R P I A K H P Y M S  33 CAI58881 & CAJ30829
A V D R C F A A W N L X L S V F S T W G F Y H M A V G L Y N M T E K R Majority
80 90 100
A V D R C F A A W N L F L S V F S T W G V Y H M G K G L Y N M T E K R  71 ELO4
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M T E K R  6 CAC69358
A V D R C F A A W N L A L S V F S T W G F Y H M A V G L Y N M T E T R  71 CAI58880 & CAJ30828
L V D R C F A A W N L G L S L F S C W G F Y H M A V G L S H T T W N F  68 CAI58881 & CAJ30829
G L Q F T I C G S T G E L V Q N L Q D G P T A L A L C L F C F S K I P Majority
110 120 130 140
G L Q F T I C G S T G E L V Q N L Q D G P T A L A L C L F C F S K I P  106 ELO4
G L Q F T I C G S T G E L V Q N L Q D G P T A L A L C L F C F S K I P  11 CAC69358
G L Q F T I C G S T G E L V Q N L Q T G P T A L A L C L F C F S K I P  106 CAI58880 & CAJ30828
G L Q F T I C G S T T E L V N G F Q K G P A A L A L I L F C F S K I P  103 CAI58881 & CAJ30829
E L M D T V F L I L K G K K V R F L Q W Y H H A T V M L F C W L A L A Majority
150 160 170
E L M D T V F L I L K G K K V R F L Q W Y H H A T V M L F C W L A L A  141 ELO4
E L M D T V F L I L K G K K V R F L Q W Y H H A T V M L F C W L A L A  46 CAC69358
E L M D T V F L I L K A K K V R F L Q W Y H H A T V M L F C W L A L A  141 CAI58880 & CAJ30828
E L G D T V F L I L K G K K V R F L Q W Y H H T T V M L F C W M A L A  138 CAI58881 & CAJ30829
T E Y T P G L W F A A T N Y F V H S I M Y M Y F F L M T F K T A A K V Majority
180 190 200 210
T E Y T P G L W F A A T N Y F V H S I M Y M Y F F L M T F K T A A K V  176 ELO4
T E Y T P G L W F A A T N Y F V H S I M Y M Y F F L M T F K T A A K V  81 CAC69358
T E Y T P G L W F A A T N Y F V H S I M Y M Y F F L M T F K S A A K V  176 CAI58880 & CAJ30828
T E Y T P G L W F A A T N Y F V H S I M Y M Y F F L M T F K T A A G I  173 CAI58881 & CAJ30829
V K P I A P L I T I I Q I A Q M V W G L I V N G I A I T T F F T T G A Majority
220 230 240
V K P I A P L I T I I Q I A Q M V W G L I V N G I A I T T F F T T G A  211 ELO4
V K P I A P L I T I I Q I A Q M V W G L I V N G I A I T T F F T T G A  116 CAC69358
V K P I A P L I T V I Q I A Q M V W G L I V N G I A I T T F F T T G A  211 CAI58880 & CAJ30828
I K P I A P L I T I I Q I S Q M V W G L V V N A I A V G T F F T T G N  208 CAI58881 & CAJ30829
C Q I Q S V T V Y S A I V M Y A S Y F Y L F S Q L F L E A Y G S A G K Majority
250 260 270 280
C Q I Q S V T V Y S A I V M Y A S Y F Y L F S Q L F L E A Y G S A G K  246 ELO4
C Q I Q S V T V Y S A I V M Y A S Y F Y L F S Q L F L E A Y G S A G K  151 CAC69358
C Q I Q S V T V Y S A I I M Y A S Y F Y L F S Q L F F E A H G A A G K  246 CAI58880 & CAJ30828
C Q I Q A V T V Y S A I V M Y A S Y F Y L F G Q L F F E A Q G S A G K  243 CAI58881 & CAJ30829
N K K K L A R E L S R K I S E A L L N S G D E V A K H L K V N Majority
290 300 310
N K K K L A R E L S R K I S E A L L N S G D E V A K H L K V N      281 ELO4
N K K K L A R E L S R K I S E A L L N S G D E V A K H L K        186 CAC69358
N K K K L T R E L S R K I S E A L L N T G D E V S K H L K V N      281 CAI58880 & CAJ30828
D K K K L A R E L S R K V S R A L T A T G E E V S K H M K V N      278 CAI58881 & CAJ30829  
Figure 5.4  Predicted protein sequence alignments of elongases from C. cohnii.  The 
specificity of the protein encoded by the sequence referenced with accession number 
CAC69358 is not specified, but the sequences referenced by accession numbers CAI5880 and 
CAI5881 are both classified as ∆5 elongases.  The published sequences of accession numbers 
CAI5880 and CAJ30828 are identical, as are the sequences of CAI5881and CAJ30829.  
Residues differing from ELO4 are shaded black and the histidine motif described in the text is 
boxed. 
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Chapter 5 Discussion 
 
 Several thousand ESTs from Crypthecodinium cohnii were generated and 
compared to public sequence datasets.  Forty-three percent of these sequences 
matched known sequences with a 1 in 10,000 or lower probability of being non-
random (Altshul et al., 1997).  Of the 6,933 unique C. cohnii expressed sequences, 
only 1176 (17%) could be organized into Gene Ontologies (Ashburner et al., 2000) 
and only 235 could be assigned EC numbers 
(http://www.chem.qmul.ac.uk/iubmb/enzyme/).  At a lower threshold e-value (<9. 9  
x 10-9), 32% of the C. cohnii sequences matched a known sequence in Genbank.  This 
is slightly larger than the statistic reported by Hackett et al. (2005) when comparing 
assembled ESTs from the photosynthetic dinoflagellate Alexandrium tamarense to 
Swissprot using similar threshold values (~20%).  This suggests either that C. cohnii 
is less divergent a dinoflagellate than A tamarense, or that the time between Hackett’s 
study and the present study has seen enough sequence data from dinoflagellates and 
related organisms added to public databases to result in the detection of many new 
sequences with higher degrees of overall sequence similarity.  The latter possibility 
seems the most likely.   
 The Gene Ontology (GO) database is the largest tool for providing a common 
vocabulary to gene products from a variety of organisms.  A similar systematic 
nomenclature has been provided by the Enzyme Consortium.  Automatically assigned 
Gene Ontologies are organized into levels where gene descriptors at the top most 
levels are the most general, and gene descriptors at the lowest levels are the most 
specific.  As an example, glyceraldehyde-3-phosphate dehydrogenase would fall into 
the GO category of “biological process” at GO level 1, “metabolism” at GO level 3, 
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and at a lower level, the GO category of “glycolysis”.  Any automated gene 
annotation scheme has advantages any disadvantages.   
 Automatically assigned Gene Ontologies corresponding to unique C. cohnii 
transcripts were advantageous in revealing some interesting details (Figure 5.2).  For 
instance, at GO level 3, one gene was expected to be involved in the biological 
process of photosynthesis.  This sequence appears to encode a form II ribulose 1,5-
bisphosphate carboxylase oxygenase (RuBisCO).  C. cohnii is an obligate 
heterotroph, so the expression of a RuBisCO transcript is surprising and may be 
indicative of a photosynthetic history.  This gene, and other potentially ancestral 
photosynthetic genes from C. cohnii, has been previously discussed by Sanchez-
Puerta et al. (2006).  A potential disadvantage of the Gene Ontologies relates to more 
species-specific homologs used to define gene classes, such as the 8 sequences 
classified as being related to “organ development”.  Each of these sequences encodes 
a particular enzyme involved in a variety of biological processes among different 
organisms, indicating that this particular GO classification is erroneous.  Another 
limitation of GO classification involves the depth at which ontologies are analyzed 
and presented.  Figure 5.2 was drawn with only level 3 ontologies, which are not 
particularly informative for the biological processes of “metabolism” or “cellular 
physiological processes” and the “cell part” and “membrane-bound organelle” cell 
components.  More specific ontologies (level 5, not shown) reveal that 88 sequences 
encode products that were classified as part of “nucleobase, nucleoside, nucleotide 
and nucleic acid metabolism”, 72 sequences were classified under “biopolymer 
metabolism”, 45 were under “carbon metabolism” but only 18 encode products 
involved in “cellular lipid metabolism”.  Most of these 18 sequences encoded 
products involved in isoprenoid biosynthesis and none of them encoded enzymes 
  179
clearly involved in fatty acid biosynthesis.  This finding implies that the gene products 
involved in the tremendous accumulation of DHA in C. cohnii are too divergent to be 
easily detected by automated annotation techniques. 
 Because of this, more targeted approaches were adopted to identify genes that 
might encode proteins involved in fatty acid or polyketide biosynthesis.  Specifically, 
the ESTs were used as queries versus Genbank (without any scoring cut-offs), and the 
definition lines of the top several hits for each query sequence were entered into a 
text-searchable database.  Also, the ESTs themselves were formatted for interrogation 
with BLAST algorithms.  Text searches and BLAST queries revealed several 
sequences which were clearly related to sequences encoding FAS and PKS systems.   
 Unfortunately, several sequences were truncated at their 5’ ends, diluting the 
certainty of annotation.  In each library, inserts were cloned to the vector pExpress-1 
directionally such that the 5’ end of each insert could be sequenced from the SP6 
promoter-priming site.  Directional cloning is dependent upon restriction enzyme 
digestion of the cDNA inserts before they are ligated to the target vector (pExpress-1).  
In some cases this can lead to truncation of cDNAs.  In other cases truncation may be 
caused simply by incomplete reverse transcription of mRNA due to secondary 
structure in the transcripts or decaying enzyme activity.  Attempts to isolate the 
missing 5’ ends of cDNAs by RACE were successful for KS1 and MAT2xACP.  The 
RACE procedure depends on the presence of a 5’ nucleotide triphosphate cap to serve 
as a substrate for Tobacco Acid Pyrophosphatase (TAP) on targeted transcripts (such 
as the typical methylguanosine triphosphate cap).  This structure is common to many 
eukaryotic mRNAs but has never been observed in dinoflagellate transcripts (although 
methylcytosine has previously been found in dinoflagellate gDNA) (Banerjee, 1980, 
Steele and Rae, 1980).  Strangely, neither of the RACE-extended sequences starts 
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with a guanosine base, raising the possibility that other triphosphate nucleotides may 
be used for 5’ caps of C. cohnii transcripts (assuming that TAP treatment was truly 
vital to the isolation of the RACE amplicons).  Because of the fact that cDNAs from 
libraries are rarely full-length (Wellenreuther et al., 2004), any predictions involving 
5’ UTR lengths or consensus sequences should be considered only tentative unless the 
5’ UTR sequence is confirmed by RACE.  With this in mind, the lengths of the 
presumed 5’ UTRs for MAT2xACP, ELO4, and KS5/CLF1 (which are 197 bp, 106 
bp, and 97 bp, respectively (Table 5.1)) seem reasonably close to the average lengths 
observed for 5’UTRs of other eukaryotes (human 5’ UTRs are around 125 bp (Suzuki 
et al., 2000) and 5’ UTRs from transcripts of higher plant pollens 126 bp in average 
length (Hulzink et al., 2003)).  The 5’UTRs of KS1, MAT, and KR (11, 16, and 19 
bp, respectively (Table 5.1)) are then suspiciously short and may be abbreviated.  
Further efforts to obtain additional 5’ sequences from these three genes may reveal 
extensions to their conceptual translations as none of them harbor in-frame stop 
codons in their 5’ UTRs.   
 Among the conceptual translations described in this work, the most notable 
appear to encode ketoacyl synthases (Figure 5.3).  Five KS-like sequences were 
identified, at least two of which appear to encode the active-site cysteine in the 
appropriate location (KS1 and KS3).  KS domains can be either directly catalytic or 
play an accessory role.  During the course of acyl-chain elongation, KS domains are 
thought to form a dimeric structure such that a hydrophobic tunnel or groove is 
formed between domains to accommodate the growing chain (Wakil, 1989).  The 
catalytic KS domain, which possesses a specifically located, acyl-chain-binding 
cysteine residue, is responsible for adding two-carbon units to the growing acyl chain.  
The KS “active site triad” also involves two histidine residues which are usually as 
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well-conserved as the cysteine.  The non-catalytic KS domain, which does not usually 
possess the canonical cysteine residue of the active site triad (which may or may not 
retain the histidine residues), is responsible for keeping the acyl chain appropriately 
aligned in the complex and also seems to play a role in determining the ultimate 
length of the acyl chain before it is released from the complex (Keatinge-Clay et al., 
2004).  Thus, these non-catalytic KS domains are often referred to as “chain length 
factors” (CLFs) although they are probably not the only determinant of acyl chain 
length (Singh et al., 1984, Watanabe, 2004).  Two of the KS-like sequences appear to 
be more like a CLF (KS4/CLF2 and KS5/CLF1).  However one of them, KS5/CLF1, 
does have a cysteine just two residues upstream of its position in the consensus for 
catalytic KSs (Figure 5.3, Panel A).  Similarly, this gene also has a histidine in the 3rd 
motif (Figure 5.3, Panel C) which seems to be displaced three residues upstream.  The 
protein sequences of these C. cohnii KS domains are all very similar to each other as 
could be inferred from the fact that they each generate the T. gondii type I FAS as 
their top hit (Table 5.1).  The most divergent conceptual translation of the group 
belongs to KS3, although this is most likely due to one or more frame shift mutations 
affecting the last half of the conceptual translations (*Figure 5.3, Panels C and D).  
The first two KS motifs of KS3 are translated in the second reading frame, but if the 
conceptual translation of these regions is adjusted to alternate reading frames, much 
better alignments for the 3rd and 4th KS motifs shown in Panels C and D of Figure 5.3 
can be produced.  For instance, if KS3 were translated in the first frame, the 3rd KS 
motif shown in Figure 5.3, Panel C becomes “KINLGHTEAHA” and if translated in 
the third frame, the 4th KS motif shown in Figure 5.3, Panel D becomes 
“GVSSFGFGGSNGR”, both of which vastly improve agreement with the consensus 
sequence.  These putative frame-shift causing mutations are most likely a 
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consequence of the reverse transcription reaction which can be relatively error-prone 
due to a lack of exonucleolytic proofreading activity.  Additional cloning of KS3 
cDNAs or a corresponding gDNA fragment will be required to definitively annotate 
this gene. 
 Other PKS- and FAS-like domains were found including sequences encoding 
an ACP, a MAT, a KR and a sequence with a fusion of three catalytic domains 
referred to as MAT2xACP.  Unfortunately, none of the sequences discussed in this 
study were primarily similar to PUFA-producing PKS systems from Schizochytrium, 
Moritella, Shewanella, or others, although the MAT2xACP sequence shares some 
domain organization with PUFA-PKS systems (Figure 5.5).  Tandem repeats of ACP 
domains are unusual in PKS systems (Huang et al., 2001), but are so far ubiquitous 
among the known PUFA-PKS systems.  The purpose of these tandem ACP repeats is 
not yet understood.  However, if C. cohnii does in fact possess a PUFA-PKS system 
for making DHA, like that of Schizochytrium, Moritella, or Shewanella, then one 
would also expect C. cohnii to express a PUFA-PKS component with tandem repeats 
of ACPs. 
 Aside from MAT2xACP, the MAT gene product was the only other described 
sequence to encode a fusion protein (to a small number of short ankyrin repeats).  
These repeats are not catalytic, instead usually being involved in protein complex 
formation.  None of the other PKS- or FAS-like conceptual proteins discussed have 
detectably similar domains for mediating protein association, so the relevance of this 
observation is unclear. 
 Whether C. cohnii should have a type I or a type II PUFA-PKS is still a 
debatable issue.  The main part of the Nostoc Hgl cluster is composed of five proteins, 
two of which encode just a single catalytic domain (a KS and an ER).  Because of 
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Figure 5.5.  A representation of the domain organization of PKS system proteins.  The bottom 
three proteins are each part of a PUFA-PKS system in their respective organisms.  The Nostoc 
Hgl E gene product is part of a PKS-like, heterocyst glycolipid synthase, which may be 
involved in making hydroxylated fatty acids.  The C. cohnii MAT2xACP gene is shown at 
top.  Other proteins listed include: Nostoc Hgl E (AAB82059), Schizochytrium ORF A 
(AAK72879), M. marina ORF 8 (BAA89382), and Shewanella sp. SCRC-2738 ORF 5 
(AAB81123).  Domains are abbreviated as: KS - ketoacyl synthase, MAT - malonyl-
CoA:ACP transacylase, ACP - acyl carrier protein, KR - ketoacyl reductase, DH - 
dehydratase. 
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this, the Nostoc Hgl complex might best be thought of as a hybrid between type I and 
type II.  The Schizochytrium PUFA-PKS is composed of just three proteins and may 
be best considered a type I system.  Also, the purification and biochemical 
characterization of the C. cohnii saturated FAS implicates it as type I (Sonnenborn 
and Kunau, 1982, Jun Wang, Martek Biosciences Columbia Corp., Columbia, MD, 
personal communication).  The apicomplexan parasites are another group of ciliates 
that cluster together with dinoflagellates in phylogenetic analyses (Van de Peer and 
De Wachter, 1997).  They are known to make their saturated fatty acids by means of a 
type II FAS which is located in a degenerate plastid of the same ancestry as 
dinoflagellate plastids (suggesting a photosynthetic ancestry for the apicomplexans) 
(Waller et al., 1998, Fast et al., 2001).  C. cohnii may also have had a recent past as a 
plastid-bearing phototroph as it appears to still harbor several plastid associated genes 
(including the putative RuBisCO mentioned earlier) (Sanchez-Puerta et al. 2006).  
Also, Kubai and Ris (1969) observed structures they believed to be plastids in a 
different strain of C. cohnii than the one used in this study, but none of the present 
author’s attempts to grow this strain of C. cohnii phototrophically have ever been 
successful (data not shown).   
 In light of Sonnenborn’s biochemical data (Sonnenborn and Kunau, 1982), the 
mechanisms and components of fatty acid biosynthesis may be more similar to those 
of the exceptional apicomplexan Cryptosporidium which, unlike its brethren 
Toxoplasma and Plasmodium, does not appear to possess a type II FAS but instead 
harbors two very large type I PKS systems.  It is not yet clear what the exact products 
of these systems are, but it is assumed that at least one of them is responsible for 
saturated fatty acid biosynthesis (Zhu, 2004).  Domains of both of these 
Cryptosporidium PKSs share strong primary sequence similarity to the C. cohnii 
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sequences discussed here and to KS domains from other dinoflagellates (Snyder et al., 
2005).  In fact, at least two of the single-domain sequences described in this study are 
likely part of larger transcripts.  Both KS5/CLF1 and ACP have poor consensus 
sequences within the 10 bases preceding their poly-A tails, which would seem to 
indicate that the first-strand cDNAs for each of these transcripts may have been 
primed from adenine-rich internal sequences rather than from a true poly-A tail, 
resulting in varied 3’ ends between otherwise identical cDNA clones.  For ACP, this 
also means the difference between having a stop codon or not, as one cDNA encodes 
an in-frame stop “TAA” where the last two bases of this stop codon also form the first 
two bases of the clone’s poly-A tail.  In the other ACP cDNA, this stop codon does 
not exist, and the reading frame flows directly into the potentially artificial poly-A tail 
(the latter cDNA clone’s sequence is given for ACP in Supplement 5.1). 
 There were a number of other genes found among the ESTs which did not 
encode PKS- or FAS-like products but were still related to fatty acid biosynthesis.  
For instance, a classical pathway ∆5 elongase was identified, as was a putative front 
end desaturase.  The ELO4 gene was nearly identical to a partial cDNA of a putative 
elongase previously discovered by Heinz et al (2001) presumably from their own 
unpublished EST project (accession number CAC69358).  Most of the sequence 
disagreement between the apparently full-length elongase mentioned in this study and 
the Heinz elongase occurs in the ends of the Heinz elongase, suggesting that it may 
have been derived from just a single cDNA clone and that the mismatched bases may 
be due to normal errors commonly found at the ends of dideoxy-terminator-derived 
sequences.  In fact, the only elongases found in C. cohnii are all ∆5 elongases, an 
observation which agrees with the fact that the ∆5 elongation of 20-carbon PUFAs is 
the only PUFA-elongase activity detected in C. cohnii (Figure 4.4).  No desaturase 
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genes have previously been discovered in C. cohnii.  Although the currently available 
sequence of this putative desaturase only provides confident matches to two of four 
motifs used to identify desaturases, further sequencing may clarify the missing motifs.  
The presence of the cytochrome b5 domain on this putative desaturase gene 
implicates it as a front-end desaturase.  Since the ∆4 desaturation of 22:4 n6 and 22:5 
n3 were the only front end desaturase activities detected in C. cohnii (Figure 4.4) the 
DES1 gene most likely encodes a ∆4 desaturase. 
 In addition to the elongase and the desaturase, other genes involved in 
downstream pathways of lipid biosynthesis were also identified, including acyl-CoA 
synthases, thioesterases, enzymes of the Kennedy pathway (Kennedy and Weiss, 
1956), and enzymes of fatty acid β-oxidation.  Further analysis of these genes was 
considered beyond the scope of the present study, but may be the subject of later ones. 
 Other genes that may play a role in PKS- or FAS-mediated fatty acid 
biosynthesis were not discussed due to inherent ambiguities.  While KS domains are 
readily identifiable from a few key domains, other enzymes such as enoyl reductases 
and ketoacyl reductases are members of, and share great primary sequence similarity 
with, the large superfamily of alcohol dehydrogenases (Riveros-Rosas et al., 2003).  
This superfamily is the most well represented among the C. cohnii ESTs and many 
members were identified including polyol dehydrogenases, threonine dehydrogenases, 
quinone oxidoreductase and others.  The one sequence identified in this study as a 
ketoacyl reductase, however, was similar enough to an authentic KR to enable its 
annotation as more than just another member of the alcohol dehydrogenase 
superfamily.  A similar barrier to annotation of dehydratases, which are part of the 
thioesterase superfamily, was also encountered (Leesong et al., 1996).  No clear fatty 
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acid dehydratases were found among the C. cohnii ESTs.  Although several hits to 
related hydratases of β-oxidation were identified. 
 It was hoped that the subtraction libraries (“cot”), derived from mRNA of the 
auxotrophic mutants described in Chapter 4, might produce a transcript that clearly 
encoded a PUFA-PKS system.  This was not the case, but these libraries were still 
useful in that they did produce three previously unidentified KS domains.  However, 
the most productive library (in terms of generating sequences exhibiting similarity to 
FAS- and PKS-like domains) was the normalized one, from which 6 of the 10 genes 
described were found distributed among 17 individual cDNA clones.   
 Even though no unequivocal genetic evidence of a C. cohnii PUFA-PKS 
system was provided by these ESTs, several sequences will serve as strong candidates 
for further study.  Isolation of a full-length transcript or genomic clone of some of 
these candidate sequences are likely to lead to more conclusive identification of a 
PUFA-PKS system responsible for making DHA in C. cohnii.  Barring the 
development of a C. cohnii transformation system (with which the auxotrophic 
mutants, described in the previous chapter, could be complemented), the only other 
methods for connecting these genes to a function rely on purification of the putative 
DHA synthase or its components.  
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7>KS1 cDNA+RACE sequence (cot500_003c_b09+RACE) 
CCCAAAAAGGCATGGACGATTTTCAGTCAAGTTTGAACAGCTACCACTACCATGGCGGGCTTTGTGCGGACGAATTCGTTATGGGC
TTCGACAACGATGCCTTCGGCATCTCTACAGATGAGGCCTCAATATTGCATCCGAACCAGAGGAAAGTGTTGGAAGTTGGCTATAT
GGCGCTCCACCACGCTGGCCACAACAAGTCCATGGATGAAGGAAAGCCTATCATCGTCGGTGTCGGGGACTCCGGCACTGAGTGGC
ACAACATGCTCTTTTCATCGAGGTACTCGCGACAGGTTGGCGAGACGCCGCTCATAGGCACCATGGAACACCCCGAAAGGTTAGAT
TGGAGCACCGCCGGTGCCACGAGCGCGGTAGGGACGAGGATCTCTTACCAGCTTGGACTCATAGGCCCGTGCTTCACGGTTGACAC
CGCCTGCTCGTCTGGACTTTCGGCCTTTAACACCACTGTCTTCATGCTTCGAAGTCCAGACATGGGAGGCCAGCTGAACATGAGCT
ACTCTGGTGCTCTAGCCGGCGGCGTCAACCAGATCATGGATCCCTTCCTCTACATCGGCTGCTGTGCGCAGCACATGGTCTCCGTT
CGGGGTCGCTGCTTCACCTTCGACTCCTCTGGGGACGGCTACGGCAAGGGCGAGGGCGTGGGCATGCTCTACTCGGAGCGAGGTGA
CGGCTCCTACATAGAGAGACAACTTGGTGCGGCCATTGGCTCTAGGTTGAACCAGGATGGTCGAAGTGCCAGCATGACGGCGCCGA
ACGGACCTGCCCAGCAGGCCTGCATCAAAGCGTCCCTGCGCGAGGCAGGCATCAGACCGCGCGACATCACGACGCAGGAGTGTCAC
GGCACAGGGACTGCGCTCGGAGATCCCATCGAGATCGGTTCCCTTCGAGGCGTCCAGGAAACCGATACTCGAGACGACCCCACGGT
GTGCACGAGCGCGAAGAGCAATTTGGGGCATCAAGAGCCCAATGCGGGCACCATCGGCTTGATCAAGTGCGTCTTGATGGGCAAGT
ATGGCATGTCGCCCCCCAACGTCCACTTGCGGTGCATGAACCCCCACTTGGACACGACAGGTTGGCCAGTGTGGTTCCAGAATGAG
ATCGTGGACGTCGGAGTCAATAGCGGCATCGCAGGCGTCTCCTCCTTCGGCGTCTCGGGCACAAACGCGCACTGCGAAGTTTGGGC
GAGGGCATTACATGGGCCAAACAACTCGATGCGCCTGATGCGACCGGCACTCGAGATGTTGGATCAGGTGATAGTAACCTGTCCCA
TCACGTTCGCGCCCATCGACTACCTCACGGGCGAGCCTGCACCCGCACAGGGCCGAACAGGGCCGCACGGAGAGAAGGTGCGAGTT
CGAGCAGACGTGCTGCGCGAAGAGATGGCTTCCTACGACGTCTCAAGCTACGCATACAATGGCGGATATCGATATCGTCGTGAAGC
ATTGGATGAAACTTTTGGCCTGTTGGAAGAGTCGGCTGTTCCCCATATCTGCGGGTCGTGGTCCGGTTGGCAAGAGATGGAAGAGA
TGGTGGCTCAGGAAGACGGAGCCTACAGCTTCGTGTTCCGCCTTGGCGAAACGCGAGCAGAGAGCTTTTTCGTCACATTGAACGGA
GATACGAGCATGAGGCTCTACCCAGGCTCCTTGGGCGTCTGCGACAGGTCCGATGTTTGGGTCGAAGGCCCAAACGAAGGCGGCGA
GGGCGCGCGCTGGCTCGTCGACGGCCTCCGCGAGGAGTACCCGTCGGGAAGTGCGATTAAGGTGCTTTTCTGGTGGGGTCCTGTTC
GCAAAAAGGTCGAGTGGGAGCGCGTTGGCTTTTCACTAGCGCCGAAGTCACTGCCCTACAGGCACAGCTACGCACTCATCGCCTCG
TGGACCTCGGGTCTAGCCACGGCACTAAGAGAGGCGGATGGCGAGGGCGGGAAAGCTTGGGAGACTAACTTTAGGTTGGGTCCATC
AGGACGCGAGACGTTCTCCATTCTGCGTGACTTCGACCAGCTGCAGGCCATCTACCCAGCTGGTCCACTCGACCCAACCCGACTCT
GCGGTCCGGACCACCTTGGCGACGGCAAGCATTTCGTGGTGACTGGACGCTCGGATGAGCGGAAGCACATACGCCTGGAGGTTGTG
GACGGCCTGGTGGAGCTGACAGTCAGTTCGGACTTCTCTCGGCCCGAGATTTGGCGAAGTTGCCCATCGGGGAAAGCTGAGCTCAT
GGTGATGGACGAAGATCACCCTGGTGTTTTCAGGCCGTGATAGCTGGGTTCGATGCGATGTTGGGGTGAGAAGTTCGAAAGCGAAC
AGAAAACCCGAAGAAGTCGTGTCTGACAGCTTCGCAAAGCGAGAGTGTTGTTTGCATGGTTTTGTCCACATGCGTAGTGACATGTA
TATAGTTGGTCCTCCCCTCCCCCACGACTCCAAAAATGCCTCTTTCGCACGGTCCGAAAACACTGTAAAATACAGGGTTTAATGCA
TTTGCCTGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
>KS1 Predicted coding region  (Table 1) 
MDDFQSSLNSYHYHGGLCADEFVMGFDNDAFGISTDEASILHPNQRKVLEVGYMALHHAGHNKSMDEGKPIIVGVGDSGTEWHNML
FSSRYSRQVGETPLIGTMEHPERLDWSTAGATSAVGTRISYQLGLIGPCFTVDTACSSGLSAFNTTVFMLRSPDMGGQLNMSYSGA
LAGGVNQIMDPFLYIGCCAQHMVSVRGRCFTFDSSGDGYGKGEGVGMLYSERGDGSYIERQLGAAIGSRLNQDGRSASMTAPNGPA
QQACIKASLREAGIRPRDITTQECHGTGTALGDPIEIGSLRGVQETDTRDDPTVCTSAKSNLGHQEPNAGTIGLIKCVLMGKYGMS
PPNVHLRCMNPHLDTTGWPVWFQNEIVDVGVNSGIAGVSSFGVSGTNAHCEVWARALHGPNNSMRLMRPALEMLDQVIVTCPITFA
PIDYLTGEPAPAQGRTGPHGEKVRVRADVLREEMASYDVSSYAYNGGYRYRREALDETFGLLEESAVPHICGSWSGWQEMEEMVAQ
EDGAYSFVFRLGETRAESFFVTLNGDTSMRLYPGSLGVCDRSDVWVEGPNEGGEGARWLVDGLREEYPSGSAIKVLFWWGPVRKKV
EWERVGFSLAPKSLPYRHSYALIASWTSGLATALREADGEGGKAWETNFRLGPSGRETFSILRDFDQLQAIYPAGPLDPTRLCGPD
HLGDGKHFVVTGRSDERKHIRLEVVDGLVELTVSSDFSRPEIWRSCPSGKAELMVMDEDHPGVFRP 
 
>KS2 cDNA sequence (cot10_001d_g05) 
GAGATCCTTCACCTTTGATCAGAACGCCAATGGCTTTCTCCGCGGTGAGGGGGTCGGCGGTCTTTTTGCTACCCTGAACGACTCCG
ACGAGAGCGCTCAGCGAATGCTTGCTTGCCTAGTCGGAAGTGCTGTGAACCAGGATGGCCGATCAGCAAGTATGACTGCGCCTCAT
GGACCATCTCAGCAAAGTTGCATAAGAGCATCGATGGATGAGGCCGGTCTAAAAGCCAGCGAGATCACCGTCGCGGAGTGCCACGG
AACCGGGACCGCCCTCGGAGACCCCATCGAGGTTGGGGCTCTCCGTGCAGTGATGAAGGATCGGGGTGTCGACCCTGTGGTCTTGA
CAACTTCCAAGGCCAACTTTGGTCACATGGAGGCATGTGCTGGGATGGGCGGAATCGGCAAGTGCGTTCTGATGCTGAACTCGATG
GTTGGATCCTGCAACATCCACCTGCACAAGCTCAACGACCACATCGAGGAAGCTGGTTTCCCAGCCCTCTTTGTGGACGAACATGT
TCCACTGAATGTGCGAAGTGGCGTCGCCGGAGTTTCTTCCTTTGGTGTTGGTGGCACGAACGCTCGCTCGGACATGTGGGCTCGCT
GTACACAAGGTCACCTGGCAACGAAGGAGATCTACACGAGAGACCGCCAGTCTCTTCAGCTGGCCAGCTTCACCAAGGCACTCAAC
GACGAAGGCGCTCTGGTGGGCCCTGCAAGCAGTTGGGCACATCGAGATCTGCTTTGCTGCCATCGCCCCCTCCCGGACTCTCGAAG
TCTGTGTGGGGACAACGGTCAACTGTGCGCGTCGTGCGAAAGGCTGGTAACTGCGAAGAGTCAGGCTCTGCAAGGTGATGTTGAAT
GAATGAAGAAATAGTTCCTAATGCCTCGACTTTGCTCTTGAGCTTAAGTAGGCTTACTCTACCAATCGATCGCTTCTGTCAATGTG
CTTGTTTGGACGGTCTTGTGAGCACCAGCAAAGAAGGTGCACCGAGGCCTTGCATGCGTGTATATAGATCCAGACCGATTTCACCC
TCAGCTACTGAGAGTGTCGAGTCTGAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAA 
 
>KS2 Predicted coding region (Table 1) 
RSFTFDQNANGFLRGEGVGGLFATLNDSDESAQRMLACLVGSAVNQDGRSASMTAPHGPSQQSCIRASMDEAGLKASEITVAECHG
TGTALGDPIEVGALRAVMKDRGVDPVVLTTSKANFGHMEACAGMGGIGKCVLMLNSMVGSCNIHLHKLNDHIEEAGFPALFVDEHV
PLNVRSGVAGVSSFGVGGTNARSDMWARCTQGHLATKEIYTRDRQSLQLASFTKALNDEGALVGPASSWAHRDLLCCHRPLPDSRS
LCGDNGQLCASCERLVTAKSQALQGDVE 
 
>KS3 cDNA sequence (cot500_001c_d11)* 
GGAAGCTACTTGCATGATGCCCGAGCAGCGACTGGTCCTCGAAACCGGCTTCCGAACTTTGATCAGAGCTGGCTTCGTTCAAGAGA
AGCTGCGAGGGAGCAATATCGGCGTCTTCGTCGGAGATGTTGGTTCAGAGGAACTTCTACCTCCTCCTTTCAACACATACACCAAC
                                                 
7 Supplement 5.1 (continuing) 
  197
GAGGGTTTGCAGGGTGGTCTAACTGCCTCCCGATTAAGCTATGTCCTTGATTTGAAAGGTCCATCCTCCTCTCATGATACGGCCTG
CTCGTCAACACTTATGGCGCTGGGGTTTGCTCATTGGAAAATGAAGGCCTGTGTAGACCGTCCCCTACCAGCCGCGATCGTCTCTG
GTGTGAACTTACACATGACCCCTTTCAGGTACATTGCCCTAGGTTCGGGCGGCATGCTTACTAAGAAGGGTCGATGTTTCACTTTC
GACGCGAGCGCCGATGGCTACCTCAGAGGGGAGGGCTGTGGAGCTTTAGCGCTGAGGGTTGCCACCGCGGAAACCGACAAAGAAGA
GAGGTATGCCGAATGCATTGGGTCCGCCTTGAACCAGGACGGTAGAAGTGCATCTTTGACGGCTCCGAATGGACCTTCCCAGACAG
CTGCCATCAAGTCATCCATGAGGATGGCCAACATCGGGCCCGAGATGGTGGGGGCAGCAGAGTGTCATGGGACTGGGAACCGCCCT
CGGAGACCCCATCGAAATCGGAGCGATGATGGCGGCTCTTGGAAATCGACCAACGGGGGACGAGGCCGCTCGCTTTCACAACCAGT
AAGATCAACCTCGGCCACACAGAAGCCCATGCAGGCATGGCGGGCATCGCGAAGTGCGTTATGGTGTGCTCCCAGGGGACCGTTGC
TCCGCACGCCCACCTTCGAGGGCTCAGCCCACACCTCTCGCTGGAGGGTTTCCCCTGCTTCGTGGGGACAGAGCCCACCGACCTCT
TCGCCACCAGCAATGTGGTGGGAGTGTCTTCTTTCGGTTTCGGAGGTTCGAACGGACGAGCGGATTTTTGGGGACGATCAACGAAT
GGTATGAGGCAGCTGGAAGAGTCCTCTGACTACATCGAAGTGGGCTGTCCGGTATGCTCAGGCCCCATGTGTTGGCTCTGTGGCAT
GAGCATTCCCACAGATGCCCCGCCTGTGAAGCATCATTGCTCCCTCGTTCGATCTCCCGGTGCTAGCTACGAACACTGCGGCCACT
GCTACGGAGGTCCTTTTCTGCACGGCGAGGTTCTCCAACTTGTGCCGCCCCTACCAGGGAAAAAGTTGTTTGCCCTGGGAACTTGG
GACGGCTGGAAAGTTCCCTGCGCTCTGTCCCGAGTGGATAGCGAAAACTATGTTTTTACAATTACCCTTGGAGACTCTAGGTGGGA
GCGGTTTTACTTGCTCGTAGATGAGGATCGGAAGCAAGCGCTCTACCCAGCTGGCAACAGCTCCGACGCAAGCGCTCGAGTGCTCG
GTCCCGACGACCAAAGAGGGGCGAGGACATGGGTCATTGATGGTCGCAAGGATGGGTTTGGTCAAGGCACCTCCTTCAACGTCACG
GTCAGATGGACAGACGCTGTGCAGGTGTCTTGGGAAAGCATTCCTCAACTAACGGAAGGCCAGACTGCCCTCGCAGCTGCTGGGGC
CTCCCTCACTGAAATTGCGGCCTCTGGAAGCGATGGCCTCGATGATCATAAGTACTCCCTTCGCGGCTCTTGGACGGGCTACCGGC
TGCAGGCGATGAAGGTGCGCTACGACAAGAAGCTCTATGAAGCGACTTTCAAGATTGGTTCGAATCGCTTTGAAGAGTTCAACATC
GTGCGCGACCAGGATCTCACGCAAATCATCCATCCCAGACATGCGAGGTCGCCAATCGCCGGAAGTCACATAGAAGAGCCTGATGA
TAATCTATCCAAAACCTGGCTCGTACAAGGCGCCCCGAACGAATCTGTTCGCGTTCGTTTCGTCGTGAAGAACGGCGAATTTCTTG
TCGAAGTTTCGAGCGCGACTGGCGGATTGCGAAGATGTCGTGGTGGTTTGGCGGAGGTCGGAAGATAGAGATCAAATCTTCAAGAC
TTGTCCATTTCTTCGCTTTCGAATATCTGCATGATCGAATCTGATCGAAATTTGTTGGCCGCACATCGGCCCAAAAAAAAAAAAAA
AAAAAAAAAAA 
 
>KS3 Predicted coding region (Table 1) 
EATCMMPEQRLVLETGFRTLIRAGFVQEKLRGSNIGVFVGDVGSEELLPPPFNTYTNEGLQGGLTASRLSYVLDLKGPSSSHDTAC
SSTLMALGFAHWKMKACVDRPLPAAIVSGVNLHMTPFRYIALGSGGMLTKKGRCFTFDASADGYLRGEGCGALALRVATAETDKEE
RYAECIGSALNQDGRSASLTAPNGPSQTAAIKSSMRMANIGPEMVGAAECHGTGNRPRRPHRNRSDDGGSWKSTNGGRGRSLSQPV
RSTSATQKPMQAWRASRSALWCAPRGPLLRTPTFEGSAHTSRWRVSPASWGQSPPTSSPPAMWWECLLSVSEVRTDERIFGDDQRM
V 
 
KS4/CLF2 cDNA sequence (cot10_002c_c08) 
TCGAGCACTTCGGGCAGGCGATACGAGCTGGTGGCGACCTTTCCACCGAAATTCCGAGAAAACGCTGGTTTTGGGAGGACTTCTAT
GACCCCGACCCACAGGGCCACCTGGACTTCAAGAGCTACACCAGACATGGCGTTTTCATGGAAGGGGCCCATCTGTTCGACAACAA
ACTCTTTGGAATCTCGAACATGGAGGCCGCTGGCATGGATCCGACGCAGTACTTGCTCATGGAGACCGCCTACGAGTCCCTGCAGC
GAGCCGGCTTCCGGAAGAAGTCCCTGATGAACAGCCTCATCGGCGTCTACATCGGACAAGGCGCCGTCGAGGCCGCCCCGAAGGAC
CAGGGAGCGCAGATGGGAGGCACCGGCGCGGCGCGCGCCGTCTCCTGCGGGCGAATCTCCTTCTCGCTAGGCATGCAGGGGCCCTG
CTGCGCCCTCGACGCGCACGGCGCCACGGCCTGGGCTTGCGTTGAGGTCGGCTTCCAAGCATTGAGGAATCAGTGGAAAAACTACA
AGACCGCGATTGCAGGCTGTGTGATGTTGAACTTAAGCCCGATCGTCTATGTACAAAACTGCGCGGCCGGCGTCCTTAGCCCGATC
GGAAGGTGTTGCAGCTTCGACAGCTCAGCGGCCGGCTATGTGAAGAGCGAGGGAGCGAGCTTCGCCTGCCTGGAGACGGAGCAGGA
GGGAGGCAGTGAGGAGGAGGAAAAACCCTCCCTGGGGCTGCTTTGCGCTTGCGAGATCGGCAGTTTGGGTCGCGCCGCGACGCTGG
GCGCCCCGAACGGGGCGGCCGAGCAGGCCATCGTCGCTGAAGCGCTTAGAAGCGCCGAGCTGTCGCCTCTGAACATTGAGGTCGTC
GAATGCTTCGCAGATGGCGACGCGATGAGCGATGCCATCGAAGTTTCGGCCCTTGCGAGAGGGCTGAGGATGCAGGACGAGGATCG
GCACCGGCCCCTCGTGGCTGGAGCAGTGATGTCAAACATCGGCTTCATGCGCGAGGTGGCGGGCTTCGCCCAGCTGCTCAAACTTC
TGGATGGTTTGAGCTACGGCCTCATGAACAACAACCTCCATCTGCACACCATCAACCCCTTGATAGACGTGGGGGTGGAGGAGAGC
TCCCTCCTCCCCACGGAGGCGCTGGGCTGCAGGCTGCCGACGAACTTCTGCGGCGCCACTTCGAGGGGGCTGGGGGGCACGGTGAC
GCACGCGGTGGTGGGCGTTGCCGTGCGCGAGTCTGAAGATCTGCCGCACGTGCTGCCGCAAAATACGTTGTGGCCTCCTCGCAAGG
AGGGCTTGACCAGTTGGCCACCCAAAGAGGGCGAGCCCAAACAAGAGCCGAAGTACGGCGTCTTCGACCCCTCCTCGTGGTCGACT
CGCTTGGAGGACACCCGAGTTGAATAACGAGGGCGCGGCAGACGTGAATTGCATGTGTGTATCATCGAGCCTGGCATCACCACCAA
GCTGTGGCAGGATGCAAATCGGCGAATGTATTCGGTTTTACTTGACCCCATTCAAGGAAACCAAAAAAAAAA 
 
>KS4/CLF1 Predicted coding region (Table 1) 
EHFGQAIRAGGDLSTEIPRKRWFWEDFYDPDPQGHLDFKSYTRHGVFMEGAHLFDNKLFGISNMEAAGMDPTQYLLMETAYESLQR
AGFRKKSLMNSLIGVYIGQGAVEAAPKDQGAQMGGTGAARAVSCGRISFSLGMQGPCCALDAHGATAWACVEVGFQALRNQWKNYK
TAIAGCVMLNLSPIVYVQNCAAGVLSPIGRCCSFDSSAAGYVKSEGASFACLETEQEGGSEEEEKPSLGLLCACEIGSLGRAATLG
APNGAAEQAIVAEALRSAELSPLNIEVVECFADGDAMSDAIEVSALARGLRMQDEDRHRPLVAGAVMSNIGFMREVAGFAQLLKLL
DGLSYGLMNNNLHLHTINPLIDVGVEESSLLPTEALGCRLPTNFCGATSRGLGGTVTHAVVGVAVRESEDLPHVLPQNTLWPPRKE
GLTSWPPKEGEPKQEPKYGVFDPSSWSTRLEDTRVE 
 
8>KS5/CLF1 cDNA sequence (cli_018d_h06) 
TTCAAACCATGGAGCGAAGACGTGTTGTTAATCGACATGCCCTGTTGTAACTACGAGGTTGCTGCAATGGATTGATTGAAATCGAA
GATTGGTTAAGATGTCGAACATGGATGACATCTCTTTGGAGCGGGTCTCCGGAAAATTGTTGGAAGCGGAGCTTGGACATGTGCTG
GGGCTGAAGGGGTTTTGCGTTCTGGATAGCGGTCTGGATGAAGATGCGCTCGAGACAGCAGCTGATGATGCAGGGACGATGCATAG
AGCCGGACGATTTCAGCTTCCGCCCGAGCAGGTGGTTGATGGAATTCTGGGCCCCGAAGGCACAAGGGAGCTGTGCTGGCTCGACG
ACGATGTGGCCTCACAACAGCCTCAGTTGGCTGCCGTCGTGGCGCTCCAGGCGTCTCTGGCAGGCGCTTGTCTGCCGTTTTGCTCC
TGGCTCGGCGAGCAAGTGGACTGCACTCGACCTCTACTCGTGAAGGGTGGCGAGGTGACTGAGGATGCTGTCGACATCACAGAGGA
GGATTGCATGGAGTGGCTAACCACACTCTCGCAGGCGAAACTCATGGTTATTTGCTTCCTGGGAGCCAACGAGGGCACTTTGGAAC
TGGAGCCGTTGGACGGTGAAGCTGGTGTTGTCGAGCTAACAACGAGGCGAGGCATGGTTGTTGTGCTGCGAGCCGACAAGTTGCTG
CACCGTCACGTCTCCAGCCCGGACGACTACTCGCTCTGCTGTTGGATCAAGGCAATCACGAGCGTCGGTCCACGTGGTTGGCAAGA
CATGGACCCCACCATCCTTGATGCTGTTCCCGCAGTTAAGGAGCTTAACCAGTGGATGCAGGGACGTCTGCAGGAAATTGCCGATT
TAGAAATGGAAGACAAGCTGGATGGAAAGGTGTCCAGAGAGTGGCGGCGATGGGCGCACCACACCTTCTTCCGGAAAGACAAAAAT
CCAGTGGCTGTTCGAGGGGACTCCTTACATGGGCCAGGTGCCTGGGACCCTGCAGTGTTCTGGACATCTCTGAATGTGGGAGTTGA
CTACCAAACTGAGGTTCCGATCATGCGTTGGGATCACTCGGAGTACTACGACCCCACACCCGATTCGTGGCTCCAGTCAACCCTGT
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ACCGTCCCCCAACGAACGTTCGGACGAATGTCCGGCACGGCCAATTCATCGAAGGGTGCGACTTATTCGACACCAAGTTCTTTGGT
ATCTCTGTGATGGAGGCGAAGGGCATGGACCCCATGCAGAAGCACGTCCTAGAGACGAGCTACGAAGCGCTGTTCGCCGCTGGCTA
CAAGAAAAAGGACCTCATGAATAGCTACATTGCCGTCTTCACTGGGTGTGCTCATTCGGAGTGGAACTACATCGATAAAGAAGCTG
GCGCTTGCTCCGGTACGGGAAGTTCGCAGGCCATCGTTTCGAACCGAACATCGTTCGCACTTGGTATGATGGGTCCCAGCTCTTCT
ATCGACTGCGAAATGAGTTCCGCATCCGTTGCTTTAATGGTCGGCGCCGCCGCCGTCTCAACCACCAACGACCGGCGGGTTGAGAG
TGGCGGTAATAGCTCCGCCGCCATTGTCGGCGGTGTTTTCTTGACCTTCACGCCGTTCATGTGGCCCCGCTACAACGCGTGGATGA
ACCCGAACGGGAGGTGTTTTTCCTTCGACGACGCTGCGAACGGCTATGTCAGGGGTGAGATGTGTGGCAGCGTCGCCCTCAAGCCC
TACGCCGAGAAGGTGGACAAGGACTTGGTTGTCCCTGACCAGCCGTGCATCGGATGCATCAACGGTTGGCGGATGGTCAGCAACGG
AAAGGGAGCAAGCCTAAATGCACCACACGGCCCGGCCATTCAAGAATGCGTTCACGACGCGATTCGGGATGCTAGCATCGACGTCC
TGGACGTCGACGCCGTTGAGTGCCATGGCATCGGTGGGGCTCTGGAGGACAGCGTCGAGGGCACTTCCATCGCTGCAGCCTTGCGA
GGCGGGAAATCAGGCGAGAGCGAGGCCCTCGTGCTCGGGGCCGTGAAGACCCACGTAGGCGCCCAATGCGAGGCGTGCGGTATGGC
GCAGCTCCTGAAAATCCTCTACAACATAGGCTTCGCTTCCCAATGTCCAAGTAACCACCTTCGCAGCCTCAATCCGCACATCGACT
TCGGAGGTGGTGCGGTCATGATCAACACCGAGGCTGTGGCCTACAAGGGTCGCAGCGCCTTCCACAGTTTCTCCTCTAGAGGTTTG
GGCGGAACAACTGTTCATGGAGTCGTTTGGTACCGCGCGAACGAGAAGCTCGTTCAGATGCCCGGGCCCGAGTTGGAAAGGCAGTC
TTTTACCTTTTGGCCCGGGGGCGGTGGCGTTCTGGAGCTGGGACAGCGCCCTTCCAGCGGCCGCTACGGCATACTAGGTTCCTGGG
CGAGCGAGCGCGAGGCCGAGGAGATGTCCAGATGCGAAGATGGCTCCTACTCGTTCATCGTGACGCTCGGGGTGAATCGCTTCGAG
TGCTTCCAGATATGTGTGGATGGTGACGAATCCAGGATCCTCCACCCCATGCGCCCGTTCGACGCCAGCGGCACTTCTGCTGAAGG
GCCCTCCGCGCCTGAAGAAGTCGAAGGGCTGAGGTGGAGAATCGATGGGCGCGGTGTCAGCGAATCGACAGCACCCTATGTTGGCC
GGGATGAGGGGCAGATCGGTGACAAGTACGAAGTCAAGCTGTGGGTCGCTGGCAAGTATCGCGCTGTGACTTGGCGAAAACTTCAA
GCACTGTCCGCAGAGCCATCTGCTGCAGGAGTGCAAGATCTCTCGCCTGCCTTGGCGGGGAGGTATTTCCTCGCAGGGGCCTGGAC
TGGATGGGAGTTCGAGGAAATGACAGAAACTGGGCCTGGAGTGTACTCCCTCGAAACTTGCCTCGGCTTCGGTGCCACCGACTTCG
TCGTGGCCAGAAATCGGGATTGGGATCAGGTCTTCTGCCCATCTTCACTCACAGCAGCGAAGGCGGCGTCGCCCACTGAGGTCATC
GGGCCTACTGACCTAAGCCTAGGACTAGCATGGAAGCTCAAAGGAAAAGCGGGAGAGTGGTTCAAGGTGGAGTTCCAGCGAACATT
CGAAGACAACCAAGACCTGAAACGGATATCTTGGAGAAGGTCGACTTCAGTGCTGGATAGTGCATGCTTGACTTAACTTGACCTAT
CCTCTTGCACGTTGTTTCCGACTCTTGTCGCATCGATAAGCACTCAAGGTGCTTGATGCGTGCACGAATGCTTCATGCTGGGCGTC
CGACTAATGCATTTTCTTAGGCCACCCAAAAGAATAAAACAAAAAAA 
 
9>KS5/CLF1 Predicted coding region (Table 1) 
MSNMDDISLERVSGKLLEAELGHVLGLKGFCVLDSGLDEDALETAADDAGTMHRAGRFQLPPEQVVDGILGPEGTRELCWLDDDVA
SQQPQLAAVVALQASLAGACLPFCSWLGEQVDCTRPLLVKGGEVTEDAVDITEEDCMEWLTTLSQAKLMVICFLGANEGTLELEPL
DGEAGVVELTTRRGMVVVLRADKLLHRHVSSPDDYSLCCWIKAITSVGPRGWQDMDPTILDAVPAVKELNQWMQGRLQEIADLEME
DKLDGKVSREWRRWAHHTFFRKDKNPVAVRGDSLHGPGAWDPAVFWTSLNVGVDYQTEVPIMRWDHSEYYDPTPDSWLQSTLYRPP
TNVRTNVRHGQFIEGCDLFDTKFFGISVMEAKGMDPMQKHVLETSYEALFAAGYKKKDLMNSYIAVFTGCAHSEWNYIDKEAGACS
GTGSSQAIVSNRTSFALGMMGPSSSIDCEMSSASVALMVGAAAVSTTNDRRVESGGNSSAAIVGGVFLTFTPFMWPRYNAWMNPNG
RCFSFDDAANGYVRGEMCGSVALKPYAEKVDKDLVVPDQPCIGCINGWRMVSNGKGASLNAPHGPAIQECVHDAIRDASIDVLDVD
AVECHGIGGALEDSVEGTSIAAALRGGKSGESEALVLGAVKTHVGAQCEACGMAQLLKILYNIGFASQCPSNHLRSLNPHIDFGGG
AVMINTEAVAYKGRSAFHSFSSRGLGGTTVHGVVWYRANEKLVQMPGPELERQSFTFWPGGGGVLELGQRPSSGRYGILGSWASER
EAEEMSRCEDGSYSFIVTLGVNRFECFQICVDGDESRILHPMRPFDASGTSAEGPSAPEEVEGLRWRIDGRGVSESTAPYVGRDEG
QIGDKYEVKLWVAGKYRAVTWRKLQALSAEPSAAGVQDLSPALAGRYFLAGAWTGWEFEEMTETGPGVYSLETCLGFGATDFVVAR
NRDWDQVFCPSSLTAAKAASPTEVIGPTDLSLGLAWKLKGKAGEWFKVEFQRTFEDNQDLKRISWRRSTSVLDSACLT 
 
>MAT cDNA sequence (cn_027a_g10) 
CTATTGCTCATCATCAAACATGCCATATCTGGAGGATGGCGAAACTTGGGATACGGACTATGGCCAGTACATGGAGGGAATGGCCG
AAAATAGGCCGGGTCACAAGAAGTTCGAGGACTACGAGCTGCCGAGGTGGGTGAAGCATCCCTTGAACCATCCCTTCAGCGGTCTT
CTCGTCGATGTGAAGGACTACGCCTACGCCAGCGTCAACGGGGCGCTAGATGGCCTAACGAACTTCCATCGGTGGGGCCCGGCCCA
CATCGCTTGCATGTATGGCGACATGGAGATGCTTACTTCATGCTCGGAGGCCGAGTTGAATGCCCAAACGTCCAACGGGGAAACGC
CCGCATACTACGCGGTTAGATACGGGACTTCCTGGTGCCTTCAGTGGCTCGTCGAAAATGGCTACGACTCCACCACCGCAGCGAAC
AATGGCTACACTCCCGCGCAATTGATCCACGCCAACAATTGCATTCACACCAACGAAGTGGAGTACTTAGAGCTGGCTCTAAGAGG
CGAGTTGGTGGAGAAGAAGAGCATTCAGGCGCAGGAGTTCAAGCTACAGCGCTGGAAGGTGGAGGGTCTCGACAAATATGCCGAGG
AGTTTCTTAGCAAGAACAAGGAAAAGCAACGATGGCATCTGTACAGAATGGGTGACTACAAATCTCCCTACAGAATGCCCTCGCAC
CGCGAAAACGTGCTGAAAGCAGACTTGCCCAGGTCCCAAGTGGCGATGCCACCAGAAAAGGCGAAACCTCCCCTGCCAGCAGCCAT
GCTCTTCCCCGGGCAGGGATCGCAGTACATCGGCATGTTGGCCGAAGCCTCCAAACTCCCAGCAGTGAAGGAACTGCTTTCCAAGG
CCCAGTCTGTCTTGGGCTGGGATGTCTTGGAGTTGTGCACCAAAGGTCCTGAGGCCAAGTTGTCGGAAACAAAGTACTGCCAACCT
GTTCTCTTCGTGGCCGGCCTGGCGGCCGTGGAGGTGTTGCGCGAGTCGAAGAAGGAGGTGGTGGAACGCCCGCAGGCCGTCGCGGG
CCTCAGTCTCGGCGAGTACACAGCGATCTGCGCAGCCGGTGTGCTGGACTTCGAGGATTGTCTGAGGCTCGTGCAGCTAAGAgCGG
AAGCCATGCAGGACGCGACTAACCTCGCCCCGCAGGGCATGGCATCAGTAGCTGGCCTCGATCGATCAACTTTAGAACGACTTTGC
CGCGAAGCGAAGGCAGCGGATAGCTCTGTCCAAGATCCAGTCTGCCAAATCGCAAACGTCTTCTTCCCCGCCGGCTTCGTTTGCGC
AGGGCACAAGAGCACCATCGATAAGCTTTGCGAAAAGGCCATGGCGGCACGAGCGCTGCAGGCGCGCGCCGTGAAGGCTGGAGGGG
CCTTCCACTGCCCGCTGATGCAGCCTGCTGCAGATAGACTTTCGAAGGCCATCGATGAGGCACTTCCCAAAATGCGACCACCTCGC
TGCTGCATCTACTTCAACGTGACGGGCAAAAAGGTAATGCCCGGAACATCACCGAAAGAGTTTGTGCAGTATATGAAGAGGCAGCT
TACTGGAGAGGTGCTTTGGGAGCAGACAGTGAAGCAGATGATAATGGACCAGGTGAAAGACTTCTATGAAACAGGACCGCTGAAGC
AAATCAAGGCCATGATCAAACGAATCGACCAGGACGCCTTCAAGCGCACCGAGAACATCTCTGTCTGACGACGGCAGAGGGGGATG
GTATCGGTTTCAACTCATGATGTTGTTGGCCTGCTCCCGGTTAGGATTTGTTTGTCACCACGCATGTCTTATGCTCCACGCGGCAA
AACTGCCCAGTGGATCGATGTCCCAAATGGTTCTACCTAATGTGAATGTGTGCAATTCGCACGACTCGTGCATGCCCGAGCATCAT
TCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
>MAT Predicted coding region (Table 1) (longest ORF, see text) 
MPYLEDGETWDTDYGQYMEGMAENRPGHKKFEDYELPRWVKHPLNHPFSGLLVDVKDYAYASVNGALDGLTNFHRWGPAHIACMYG
DMEMLTSCSEAELNAQTSNGETPAYYAVRYGTSWCLQWLVENGYDSTTAANNGYTPAQLIHANNCIHTNEVEYLELALRGELVEKK
SIQAQEFKLQRWKVEGLDKYAEEFLSKNKEKQRWHLYRMGDYKSPYRMPSHRENVLKADLPRSQVAMPPEKAKPPLPAAMLFPGQG
SQYIGMLAEASKLPAVKELLSKAQSVLGWDVLELCTKGPEAKLSETKYCQPVLFVAGLAAVEVLRESKKEVVERPQAVAGLSLGEY
TAICAAGVLDFEDCLRLVQLRAEAMQDATNLAPQGMASVAGLDRSTLERLCREAKAADSSVQDPVCQIANVFFPAGFVCAGHKSTI
DKLCEKAMAARALQARAVKAGGAFHCPLMQPAADRLSKAIDEALPKMRPPRCCIYFNVTGKKVMPGTSPKEFVQYMKRQLTGEVLW
EQTVKQMIMDQVKDFYETGPLKQIKAMIKRIDQDAFKRTENISV 
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>KR cDNA sequence (cli_020c_f06 + cn_009d_b07) 
GGAGGTGGCCCCCGAAATGTGCTGGCCGAAGGAGTGGTTTCCGGAACCTCTGGGCACAGAGAGTGGCCCTGGACACAACATGCACT
TCTTCCTCCAACATGCCGTTGCTCCGATCTCTTGTATTGACGGCGGCAAGTGGCCACCAACTGACGGGTCTGACATTCAGCCCGAG
GACGTGTTGGTGTTTGCGGACAGCTACGGATTCACAAAGGAAATCTTGGAGCAGGCTCCGCCTGGCAGACTTGGGATCCAGAATGT
TCAGACAAAAGTGGCCACGGGCTACGAAGAGAGCGCCGTAAAGCGACTTGTCTCCATGCATCCATGGGACCTCATCATCTTCGCAG
TTGGGATTGACCCTCCTGCCAGCAACGATATCGACGACATCCACAAGCAGCAGGATGCTGTCTGCAAGGTTCTTCTCGCCATTCTG
AAAGCCATCGGTGATGATGGTTCCCGCTGCAAGCGCCTTGCTGTGATCACATGTGACACCTTCGCCATGGAGCGCGAAATCCACGA
GGAGTGCGGGGTTGGTCTCATCACCAACTCGACTCTCTTCGGCATGGTCAACACTGCCAGATTAGAGTGCCAGATCCCCATACAAT
TTATCGATACCGAGTGGGCCTTGCGGTCGGAGAACACAAAATACATTGTCGCAGAGCTCTTCAGACATTCATCCTTTGGCCACAAC
AACGTGCGGATATTGAACCAAGGGCGGTTCGTCCACCGGGCAGTGCCCTCGAAGCCCTATGAGCGGCAGTCGGATTGGGTGCTGCC
GGATGATGGAGTCATTGGCATCTCAGGTGGCAATGGTGCGCTGGGCTTGGTGATGGGCTTGTGGTTGCTCAAAAAAGCCAAGGAGC
AAGGTGGCAAGCACTTCACTATCCAGTTCTTGTCCAGATCATGCAAGATCAGCGACCAAAACATGCCGAATTGGCGCGAGATCGAG
CGACTCGCGGCCGAAGTCGGAGTGAAGGTCGAGCAGGCAAAGTGTGATGTCAGCAGCCGGAAGGGTGTGGAGGAGTACATTGCTGC
TGTCACACCCAACCTGACTGGCTTCATCCACTCGGCTGGCGTCTTGCAGGATGCAATGCTTGCAAATCAGACCTGGGACAAGTGGG
ATGCTGTCTTCGCTGCGAAGTCTCGGGCAGCGCTGTACCTCCACCAAGCTCTCTTGGATCACGAAAACCCCAAACTTCGCTTCTTC
TGGATGtTTTCCTCGACTGCTGTCTATGGCAACATGGGCCAGCTCAACTACTCCACATCAAACTCCTTCTTGGACGGCTTGGCAAG
ACATAGGCAAGCTCTTGGCCTTCCAGGAACGGCACCCCAGTGGGGCGCCTGGGGTGATGTTGGTATGGCTGCGAATCTAGATGAGG
CTAGCAAGAGGCGAATGGCGAACTCGCCCATGCCTCCATTTAGCAACAGCGAGGGTCTTTATGGACTCGAGTGTGGACTCAGGAGT
GGGTTGGCCGGCTTCAGCGTCATGAAGGTGCGGCCTGACCTCTTCTTCGGCATGATTCAAGGAGATGATGTAGCCAACCAGTGCCA
CATGCGCAACTTCTGGTCTGCAATTATCCCTCCACCACCTGGGGATCCGCAGAAGAACCCTTACACAACCTACACCTACACGATGC
GGAAAGCCTGCCACCAACTCGAACTTGGCCTCGACTTCAGGTGGCGCTACCCCGTGGCTGCCGAATGCGACGTGGAATGAGTATGC
TCCCGCTCTACGAAAATGCTGCACCGTTGAATTGTTTCATCGCTTCGATGCTTGACGTGCAAATTCGTCGCTCTTGTTATCAGCAG
CGAATTCGCTGTTATGACAGTATGACAGCCTTGATCGCACAAAGTGCGAGTTTGCTCGTGGCAAAAAAAAAAAAAAAAaaaaaAAA
AAAAAA 
 
>KR Predicted coding region (Table 1) 
MCWPKEWFPEPLGTESGPGHNMHFFLQHAVAPISCIDGGKWPPTDGSDIQPEDVLVFADSYGFTKEILEQAPPGRLGIQNVQTKVA
TGYEESAVKRLVSMHPWDLIIFAVGIDPPASNDIDDIHKQQDAVCKVLLAILKAIGDDGSRCKRLAVITCDTFAMEREIHEECGVG
LITNSTLFGMVNTARLECQIPIQFIDTEWALRSENTKYIVAELFRHSSFGHNNVRILNQGRFVHRAVPSKPYERQSDWVLPDDGVI
GISGGNGALGLVMGLWLLKKAKEQGGKHFTIQFLSRSCKISDQNMPNWREIERLAAEVGVKVEQAKCDVSSRKGVEEYIAAVTPNL
TGFIHSAGVLQDAMLANQTWDKWDAVFAAKSRAALYLHQALLDHENPKLRFFWMFSSTAVYGNMGQLNYSTSNSFLDGLARHRQAL
GLPGTAPQWGAWGDVGMAANLDEASKRRMANSPMPPFSNSEGLYGLECGLRSGLAGFSVMKVRPDLFFGMIQGDDVANQCHMRNFW
SAIIPPPPGDPQKNPYTTYTYTMRKACHQLELGLDFRWRYPVAAECDVE 
 
>MAT2xACP cDNA sequence (cn_006a_g11 +RACE) 
ACCGTAGCCATTTTGGCTCAAGTTGCTCTGCTGGCACCTTCGTTCGCAATAGGCGCCCAAGCCACTTTGGACTTGTGCAGGAAGGT
GTGTTCACTTTTGTATATAGCCATCATACCGAACTACACACACACACACACGCATTGACCTGACAAACCTCCCAACTCTTTCAAAG
AGCATTTGTGATTCATTGTCGGACCATGTTCGCGTCGACCGAGCCCCATTGCCTCTCGGATTTACTGGATGTTCAAGCAGGGGACC
CTTGGGCGGACCAAACTCAGAAGGGCGGCTTCCGTGTCCTCGGCCGCTTTGCGGGTCAGGGCCATCGATTCGCGGACGAGTTGCAG
GGCCTGCACGCGAGGTCGCCTGCAGTGCAGGAGGAGCTCTTGGAGAAGGTCTCCGTCTCCTTGCGGGAGGCAGCAGCCACTCTGGA
GGTGGAGCCGCTGAATCCGATTTCCATCTTGGAGCTGGCTGCAACGCAGGACCACGGGAATTTCCTGCGGCCTGCCATCAGTTGCG
CCATGATCGGATTGACCCAGCTGGCGACCTTGTGGCAGGCTGTTGAGGAGTTTGGCCTGGGGAGTTTGCACCGCATCCGGAACTTG
TTCAAGGCAGGTCTCACGGGACATTCCCAAGGCGTGATTGCCGCGGTGGCCTTGGCCTCGGCGAAGCGCCGGGCGGAGCTTCTCAG
CGGCATCTGTTGGGCCGTGACGCTTTTGTGGCTTCTCGGGAGACAGACGGAGATGCAGCTGCAGGCTATCAACATGGAGGGTGCTA
TGGCTCTTATCGAAGGTCCCAGCCCTGACGCTATGCTGGCAACCTCTGTTTTGGAAGCTGCTCTGGCGCGCTTGGTAGCCGCCTCC
GTTGCCGGCGCAGAGGATCTCTGCATAGCTGGTCGCAATGCTCCTCACATTCTGGTTCTCTCTGGCCCAGTTTCTGGCTTGGAAGC
TTTCCGCTCTGCTCTGGAAGGTGGGACCTTGCCAGAGCTAGAAGGTTCCCGCTTCAGAAAGTTGCGGATCGAGGCTCCCTTTCATT
CTCGGCACCTCTCCGGTGTTCCTGAAGCTGTGGAATCAGACGCTGCCAAGCTGGGTCTGCGGCTGCCGAACTGCTGCTCCTTGCCG
GTGATCTCCGGCTCTGGCACTCTGCTGCCCTCGGAGCCCTCTGCGAAGCTCCTCGCGGCCCTCGTCTGCTCAGAGGAAATCGATTG
GCCAGGGGCCATGACGCAAGTTGCAGATTGCCGCTTTACAGTTGAATTTGGACCCGGAGCACCGCTCCCGCTGCCTCAAGGGCATC
GCCTCTCCGTGTTCTCGGTGGCCGCGGCCAACCAGGCTGCGTCGTCCGTCGATGCTGCACGAGATGCCGCCGCCGAAACAAAGGAC
AAGGCGGTAGCGAAGCGGACAAAGGAAGCCAAACCTGTGGTGAGATGGGAGACCAGCGAGATTCTCGTGGATCGTATACTCGGGGT
TCTCGCTGGAGCCCTTGGGTGTTCGAACGAAGAAGTTGATCTTGATACTCCTTTTTTCGATTTGGGCCTCAGGTCCAACGACTTGG
CCCGTTTTGCTGGGGCGCTTTCTGAAAGCTTCGGCGGTGCTGGCGTGGCTGCCCACGAGTTGTTCGACTATCCAACTGTGACTGCG
CTCGTGAATCGTTTGGACAAGCAGCTCTCTTCCAGGATGCCATATCCGGACATGGAGGAGGAGGTGGTGGTCGCTTCAGATTGTCC
TGATCCGGAGGACATTGCTGGCTGCGTTTTGTGGGTGATCGCAAGCGCGCTGAATTGTGACCGGGAGGACGTTGAGCCCAATGTGC
ACTTCGAGCTCTTGGGCTTGGGCCCTGACTCCCTGAAAAGAGTGGCTGCTGCCTTGGCGGAACGAATCCACATGCAGGTGTATGTC
GAGGACTTGACCGACTTCCCCACAGTGTCGAAGCTCATCTTCCGGTTGCAGCAACGACTCACCGGATTCCGAAACTTCGGACCTGC
CTGGGGACTGCTGGCTCCTGCGCGCGTCGACCCAGGCGTCGTGGAACGGATGCTTGTGGAACCTTGCATGACTTTGGATGTCGTGC
TGCAGGTCCAGAAAAAGTTGAGGAAGAGCATGGCTCAGCCAGATGTTCAAGCAGATCTGAAGCGCTTAGCCGACACCTGCTTCCCA
GACGGAGAGGCGTACTTGGCAGCCTTACATTGTCGTGTCATGGACGAGGAGGAAAAAATATACAAACGGCTTGGTTTCCGAAACGA
GGATACCAACTCCCTTCGGCAAAAGTCCTTGCGGATAGCTGCGGAGAACATGAAGAAACATCCTGACCTTCGCTTGCACAGCCAGA
AGTTGGTAGAACTTACATGGCCCTCGGACTCTGACCGTTGGAAATGGTGATGACTTGAGACTCTACGTAGAGAGAGAGAGAGAGAG
ACAGTCAACTCACGAAACGATCTTCCACACAGAATTCTCTGCATGCTTGTTCAGACGACATACTCATGATCGTGCCTGCGCGAGGG
CATGTGGTCTGTTGTCACCTGACCATCTCTTGATTTGGAAAAAAAAAAAAAAAAAAAAAAAAA 
 
10>MAT2xACP Predicted coding region (Table 1) 
MFASTEPHCLSDLLDVQAGDPWADQTQKGGFRVLGRFAGQGHRFADELQGLHARSPAVQEELLEKVSVSLREAAATLEVEPLNPIS
ILELAATQDHGNFLRPAISCAMIGLTQLATLWQAVEEFGLGSLHRIRNLFKAGLTGHSQGVIAAVALASAKRRAELLSGICWAVTL
LWLLGRQTEMQLQAINMEGAMALIEGPSPDAMLATSVLEAALARLVAASVAGAEDLCIAGRNAPHILVLSGPVSGLEAFRSALEGG
TLPELEGSRFRKLRIEAPFHSRHLSGVPEAVESDAAKLGLRLPNCCSLPVISGSGTLLPSEPSAKLLAALVCSEEIDWPGAMTQVA
DCRFTVEFGPGAPLPLPQGHRLSVFSVAAANQAASSVDAARDAAAETKDKAVAKRTKEAKPVVRWETSEILVDRILGVLAGALGCS
NEEVDLDTPFFDLGLRSNDLARFAGALSESFGGAGVAAHELFDYPTVTALVNRLDKQLSSRMPYPDMEEEVVVASDCPDPEDIAGC
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VLWVIASALNCDREDVEPNVHFELLGLGPDSLKRVAAALAERIHMQVYVEDLTDFPTVSKLIFRLQQRLTGFRNFGPAWGLLAPAR
VDPGVVERMLVEPCMTLDVVLQVQKKLRKSMAQPDVQADLKRLADTCFPDGEAYLAALHCRVMDEEEKIYKRLGFRNEDTNSLRQK
SLRIAAENMKKHPDLRLHSQKLVELTWPSDSDRWKW 
 
>ACP cDNA sequence (cn_23c_b10) 
GTTCGAGTCTTACTGCTGATCTCGACTCTCCATCGCGACCTCGAGAACTTTCCCAAGGCCGAGACAGCCGCAGGCCTGGCGAGGGA
GCTGGCCCAGGCTTCGAAGGACAGGGCTGGAGAGGCTCTGGCATTGCTAGGGCTCGCGGACCTCAGACTGCGCTTCGGACGCGAGG
AGCAAGAGGACCATGGTGGCAGCGCCAGCTGGCAAGCAGCCAGAGCAGCAGCCCTTCGTACTGCAGAGCAGGCACAGGCAGCAGTT
CAGAACCCGACGACAAAAGCTGAGAGGGAAAGCTTCGACAAGATCATACACTGGAAGGCTGATGTTCACTTCGAGCTTCATCAGGC
AGCTGAGGCTTTGAAAACAGCCAAGACAGGTCAGTCCATCTTGAAGAAGCACAAGTCCACAACAGAGCAGGAGAAAGCTCGGGTGA
AATTGTTGTCTGCTGAGGCCAAACTAGCGCTGCTGTGGGATTTGGACCTCGGCACCAATGATCGTTCCGAAGCAGCGGCAGAGGCG
GCAGTGACCAGGCGGCTGCGCCGGGAGTTGGAAGGAGCGATCAGAACTGGGGAGCTGGCTGTGCGCCTGGCGAGGCCTACGGACGA
CAGAGTCCTCCTGGCCAGCGCGCTTCACACTCTGGGCCAGATGTACTATTTCGGAAGCAGGTTCAGCGATGCACTTCTGGTTGCTG
CTGAAGCTGCTGCCTCTTTGGAAGCCGATGCCAAGTCTGTCTTGGAGTTGAGGGCCTTGGTGCTCTCTGCCCAGTGCCACGCTGCC
CTGGGAGAGACAGAGGCTGCGATGCATTGCTTGGGAGAGGCGATGCAGGCTGCTGGACAGCTTGGCCCCGAGTCTGGTGCTCTGGA
AGACGAGTTGCATGCATTAGAGCTGGACTTGCTCCAAACATCTTCAGCTGCCGCAGATACACATCACTTGAAAGTGACCAACCCGG
CAGCCTCGGACGAGCTGGAGGGTTCAGCCGCAGCAGAATCAGCGACTCCTCCTTCTCCTCCGGCTGATGCTGCTGCTGCTGCTGCT
GTCGTTGTCGTCGATGAAGAGGCAGTTCGGCAGACCGTGGAAGCCATGATCAAGGCCTCGGCGTTGACAACTGAGGATCTGGAGGA
CGAGACACCTCTCATGGACTCCGGCCTGGATAGCTTGTCGAGCGTGGAACTGAGGACGAGGTTGGAAAGCGAATTCTCTCTCAGAT
TGGGTGTTACAGTCATCTACAATTTCCCGACGATTGGTGCTCTGACGAGGCACATCATCGAAGAATGTCATGCTCAAGCGATTGCT
TGGAACGGAGCCTACACTAGTCTCCGCGAACCATCGCCCAGTGTGGTGTCCAAAAAAA 
 
>ACP predicted coding region (Table 1) 
VRVLLLISTLHRDLENFPKAETAAGLARELAQASKDRAGEALALLGLADLRLRFGREEQEDHGGSASWQAARAAALRTAEQAQAAV
QNPTTKAERESFDKIIHWKADVHFELHQAAEALKTAKTGQSILKKHKSTTEQEKARVKLLSAEAKLALLWDLDLGTNDRSEAAAEA
AVTRRLRRELEGAIRTGELAVRLARPTDDRVLLASALHTLGQMYYFGSRFSDALLVAAEAAASLEADAKSVLELRALVLSAQCHAA
LGETEAAMHCLGEAMQAAGQLGPESGALEDELHALELDLLQTSSAAADTHHLKVTNPAASDELEGSAAAESATPPSPPADAAAAAA
VVVVDEEAVRQTVEAMIKASALTTEDLEDETPLMDSGLDSLSSVELRTRLESEFSLRLGVTVIYNFPTIGALTRHIIEECHAQAIA
WNGAYTSLREPSPSVVS 
 
>ELO4 cDNA sequence (cn_22a_h02) 
TTTGGCTCAAGTTCCCCCCCCTCAGTGCACAGCATCTGCCATCGACTTCCTTGCAACTCATTCATCTCAGAGTCTTCAGAGTCCCC
ACACTTGCCTCTGATCGAAGATGTCTGCCATCACCAACCTCTCTCAGGCTCTCTCGAGCGTCAGCTCGGCCCTTGTCACCTTGCAG
CACGATGTGTCTAGCCCTTCCGCTTTCCGAACGGTCACCAGTTTTTGCCGGGAGCAGTGGGGCATTCCGGCTTTTTTCTGTGTGAG
CTACTTGGTCATGGTCTACGCTGCCAGAAGACCCATGGCTCAGCACAGCCACATGCTGGCAGTGGACCGATGCTTCGCGGCTTGGA
ACTTGTTCCTTTCCGTGTTCAGCACCTGGGGCGTCTATCACATGGGTAAGGGCCTCTACAACATGACCGAGAAGAGGGGACTGCAG
TTCACGATCTGCGGCTCTACTGGTGAGTTGGTGCAGAATCTCCAGGATGGTCCCACTGCCTTGGCGTTGTGCCTCTTTTGCTTCAG
CAAAATTCCCGAGTTGATGGACACGGTCTTTCTCATCTTGAAGGGCAAGAAGGTTCGCTTTTTGCAGTGGTACCACCACGCTACCG
TGATGCTCTTCTGCTGGTTGGCACTGGCTACGGAGTACACCCCGGGCCTCTGGTTCGCGGCCACTAACTACTTCGTGCACTCCATC
ATGTACATGTACTTCTTCTTGATGACCTTCAAGACGGCCGCAAAGGTCGTGAAGCCCATTGCCCCTCTCATCACCATCATCCAGAT
CGCCCAGATGGTCTGGGGTCTCATCGTCAACGGCATCGCGATCACCACTTTCTTCACCACGGGCGCCTGCCAGATCCAGTCCGTGA
CGGTCTACTCGGCCATTGTGATGTACGCTTCGTACTTCTACCTCTTCTCCCAGCTCTTCCTGGAGGCATACGGATCCGCTGGCAAG
AACAAGAAGAAGCTCGCCCGCGAGCTCTCCCGAAAGATCTCCGAGGCTCTCCTGAATAGTGGCGACGAGGTAGCCAAGCACCTCAA
GGTGAACTGAGCGACCTCATCTTGGTCTGGTCCGCCCAGAGTTGCACGCGTGCATGTGCATGACGAATGCCTTGTTTCCGACGTAA
GCAGCTTCGTCATTGTGTCCTTTTCGTTTTTGCACTGCTCTGCCCTGAGCGATGGTTGTTCGCTTCAGAGGCAGCTTGTCACAGCA
TGCCTCGCTGCATGCATGCTGTCGTTCCCCCCACTCAATTTTCTCTTGTACAGCAGCAAAGTCTCGCTGGTAAGGCCCAGCAACTA
AGCCTGTTCTCTGTGTGGCTCAGCTCGCTCCCTTTTATTCGGTGCCCCCTGCTGTACAGCCTTGTGTCTATGGAGCCACACATTGT
TGTTTCTTGTTCCTTGGAGGTGCCTTCTTCATGAGTCTTCCTCCCAGCACCCTCCAACAAGAAAAAAAAAAAAAAAAAAAAAAAAA 
 
>ELO4 Predicted coding region (Table 1) 
MSAITNLSQALSSVSSALVTLQHDVSSPSAFRTVTSFCREQWGIPAFFCVSYLVMVYAARRPMAQHSHMLAVDRCFAAWNLFLSVF
STWGVYHMGKGLYNMTEKRGLQFTICGSTGELVQNLQDGPTALALCLFCFSKIPELMDTVFLILKGKKVRFLQWYHHATVMLFCWL
ALATEYTPGLWFAATNYFVHSIMYMYFFLMTFKTAAKVVKPIAPLITIIQIAQMVWGLIVNGIAITTFFTTGACQIQSVTVYSAIV
MYASYFYLFSQLFLEAYGSAGKNKKKLARELSRKISEALLNSGDEVAKHLKVN 
 
11>DES1 cDNA sequence (cn_021c_f05.q1ca) 
CTTGCACACTTGCTTTCGCATGTAACCCTGATCAATCCCCACCTCGCACATGGCACGACAAGAGCTACTACAAGACGTCCATGAGG
AGGAACAGGCTTGGACGCTGAGCGAACTCTATGAGCAGCCATTCCTCTGGACGGTTGTGGATGAAGGAGTCTATGCTATTGGCCCA
TTTTTGCCGCATCATCCCGGCGGCAGAGAGCTCATAAACAGGGCCATCGGGGAGGACGTCACTGTGCTCTACCATACCCACCACAC
ATCTGAACGTGTCGACCGCATACTCGAGCAGTACCGCATTGGGCATGTTGCCCGCAACGCCTCGCGGGCTGCACCTCGGCCGCCGA
GGAAGCGCCGACCACTGCAGGAGGAGCTCAACAGGCGGATCGGTGCCCTCGGCCTGGAGAAAGCCTCCAGTGCGTGGCCTCTCGCC
GAGGCAGTTGCCTTTGGGATGTTGCTGCTGTACTTTGCCTGGTGCTGGCTCTCCTACGTCGAGGGTTGGTGGAAGCTCAATGTTGC
TCTCGCCTGGTTTTGGTGGCGACATCTAGATTCTGGGCTCCACAGTGCAGTGCATGGAGACTTTCGTGCGAGCCCACTTTGTCACT
CCCTGCTGCTCAATGCCTACAAAGTTCTGGCTCACCGAGCAGTTGAGTACTATGATGGGGATACTTCCTGCTCCTACCGTGGTTTG
TCCAAGCATTTTTGGCACCATGTGTACACAAATGATCCGGCCAAAGATCCTGATTGGGGAACGATGACTGGATTGCTATGGGTGCG
TCGGCATTTCACAGCC 
 
>DES1 Predicted coding region (Table 1) 
MARQELLQDVHEEEQAWTLSELYEQPFLWTVVDEGVYAIGPFLPHHPGGRELINRAIGEDVTVLYHTHHTSERVDRILEQYRIGHV
ARNASRAAPRPPRKRRPLQEELNRRIGALGLEKASSAWPLAEAVAFGMLLLYFAWCWLSYVEGWWKLNVALAWFWWRHLDSGLHSA
VHGDFRASPLCHSLLLNAYKVLAHRAVEYYDGDTSCSYRGLSKHFWHHVYTNDPAKDPDWGTMTGLLWVRRHFTA 
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Supplement 5.1 (continued).  Sequences described in text.  *May contain frameshift 
mutations, see text. 
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Chapter 6 - The Similar Nature of Polyunsaturated Fatty Acid 
Biosynthesis in Schizochytrium and Crypthecodinium cohnii 
 
Chapter 6 General Discussion 
 
 In this work, a transformation system for Schizochytrium was adapted to create 
gene knockouts which resulted in an auxotrophic requirement for supplemented 
PUFA.  Similar auxotrophic mutants of C. cohnii were created by random U/V 
mutagenesis and subsequent negative selection.  These auxotrophs were then used as 
a tool to dissect the pathways of PUFA biosynthesis in each organism.   
 This is the first time that auxotrophs of any stramenopile have been created by 
homologous recombination, opening many new avenues of study for these organisms.  
If transformation efficiencies can be increased, perhaps by optimization of alternate 
transformation techniques (other than particle bombardment), mass gene tagging 
experiments could then be developed and used to correlate hundreds of loci with 
phenotypes in a single experiment.  More targeted applications of this technology 
might also permit the use of Schizochytrium as a transgenic host for production of 
heterologous proteins or other products and allow for the removal or introduction of 
traits for strain improvements. 
 Unfortunately, no transformation system for C. cohnii exists.  In the absence 
of this technology, random mutagenesis has served well enough to achieve the desired 
ends.  The technique of random mutagenesis of C. cohnii to produce defined 
phenotypes is not new (Beam and Himes, 1974) but to date, no one has commented 
on certain implications of this organism’s mutability.  Dinoflagellates are known to 
make multiple copies of important or essential genes (Machabee et al., 1994, Moreau 
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et al., 1998, Zhang and Lin, 2003).  It has been demonstrated that the genes encoding 
proteins responsible for DHA biosynthesis in C. cohnii are essential, and yet, they are 
also randomly mutable (Chapter 4).  The fact that we are able to produce random 
mutants of C. cohnii which are deficient in DHA biosynthesis implies that the 
corresponding genes are not harbored in multiple, redundant copies as is thought to be 
typical for essential dinoflagellate genes.  However, alternative explanations exist.   
 Though it seems improbable, it may be that the genes encoding the putative 
DHA synthase actually are redundantly copied if the induced mutations are dominant.  
For example, it may be that the mutation does not occur in a DHA synthase 
component at all, but instead in a transcription activator, that when inactivated, causes 
every copy of a DHA synthase gene to remain unexpressed or repressed. 
 No matter how the auxotrophs came to be, the most significant finding of the 
work presented in this thesis may be that Schizochytrium and C. cohnii possess dual 
pathways for the synthesis of DHA: one primary pathway in each organism which 
produces DHA de novo from acetate, and another secondary pathway which converts 
smaller and less unsaturated PUFA to DHA.  This secondary, desaturase and 
elongase-mediated pathway is not capable of producing DHA de novo in either 
organism.  These observations naturally lead one to inquire why C. cohnii and 
Schizochytrium would possess two pathways for PUFA biosynthesis.  The situation is 
not entirely dissimilar from that of many other organisms (most notably fungi) which 
possess elongases for the extension of myristic to palmitic and palmitic to stearic 
acids in addition to a fatty acid synthase which produces these same saturated fatty 
acids (Toke and Martin, 1996, Dittrich et al., 1998).  A common hypothesis is that 
these elongases of saturated fatty acids exist to elongate short fatty acids which are 
prematurely released from FAS to more structurally useful products (like palmitate 
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and stearate).  Another hypothesis, compatible with the first, is that the elongases of 
saturated fatty acids are expressed or regulated in coordination with changing 
environmental conditions to produce saturated fatty acids of longer chain lengths for 
membranes that need increased rigidity.  In a similar vein, these hypotheses may serve 
useful in explaining the two synthetic approaches to DHA used in C. cohnii and 
Schizochytrium.   
 If the classic pathway enzymes in C. cohnii and Schizochytrium mainly serve 
to scavenge for fatty acids which are prematurely released from the presumed DHA 
synthase, it must first be recognized that most of the predicted intermediates of a 
PUFA-PKS system are different than those of the classic PUFA pathway (Figure 1.1 
and Figure 1.2).  The differences are not great however and most of the PUFA-PKS 
intermediates are only one elongation step away from becoming a classical pathway 
intermediate.  Some specific examples include the elongation of: 16:3 n6 and 16:4 n3 
to γ-linolenic acid (GLA) and stearidonic acid (SDA), 18:4 n6 and 18:5 n3 to 
arachidonic acid (ARA) and eicosapentaenoic acid (EPA), and lastly, 20:5 n6 and 
20:6 n3 to DPA n6 and DHA respectively.  Unfortunately, none of the presumed 
PUFA-PKS intermediates are commercially available as radiolabeled fatty acids so 
none of these conversions could be directly tested.  However, as shown in Chapter 2, 
Schizochytrium can convert GLA, SDA, ARA, EPA, and DPA n6 ultimately to DHA.   
 C. cohnii is more limited in the number of putative PUFA-PKS intermediates 
it could potentially convert to DHA by a classical pathway (Chapter 4).  Because C. 
cohnii only makes omega-3 PUFA and because it is capable of fewer steps in the 
classical pathway, the only PUFA-PKS intermediates that one could reasonably 
expect to be elongated to a classical pathway substrate or product are 18:5 n3 and 
20:6 n3 (to EPA and DHA respectively).  It may be worth noting that 18:5 n3 is not 
  205
an exotic fatty acid to dinoflagellates and has been observed to accumulate in lipids of 
many species (Mansour et al., 1999).  Although no information has been published as 
to how dinoflagellates might synthesize this fatty acid.  Elongation of a PUFA-PKS 
intermediate (such as 18:5 n3) could either be a consequence of, or prelude to, its 
release from the PUFA-PKS.  That is, the classical pathway elongases may only be 
able to act after the PUFA-PKS itself has subjected a given intermediate to an 
additional cycle of condensation without introducing another double bond (Figure 
1.2).  In any case, there is some evidence that C. cohnii does release some fatty acids 
from its putative PUFA-PKS prematurely.  In some nutrient-starved, wild type 
cultures, EPA sometimes accumulates in low levels (<2% of total lipids) and in at 
least one preliminary experiment where a culture of a saturated fatty acid axuotroph 
of C. cohnii was starved of any complementing fatty acid, EPA levels reached ~8% of 
total lipids (data not shown).  Whether the accumulation of EPA in C. cohnii results 
from elongation of 18:5 n3 (and consequent release) by the putative PUFA-PKS itself, 
or by classic-pathway type elongases after release from the putative PUFA PKS, can 
only be determined by further experimentation. 
 It is also be possible that the classic pathways of Schizochytrium and C. cohnii 
are vestigial processes that are gradually decaying over time, perhaps to a point where 
they may be completely lost.  The PUFA-PKS of Schizochytrium is very likely the 
result of a horizontal transfer from an α-proteobacterium.  Like certain dinoflagellates, 
some thraustochytrids are also known to be bacterivourous (Raghukumar, 1992), 
providing another potential mechanism for horizontal gene transfer.  No phylogenetic 
studies have specifically been done to verify this proposed transfer, but as previously 
mentioned, by primary sequence comparison, the Schizochytrium PUFA-PKS is most 
similar to those of bacteria like Shewanella and Moritella.   
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 The stramenopiles (of which Schizochytrium is a member) and in particular 
the alveolates, have a rich history of horizontal gene transfer.  Many dinoflagellates 
are predators which engulf their prey or siphon away their innards (Ucko et al., 1997, 
and for review see: Taylor, 1987).  This mechanism has been posited by others as a 
means for acquiring retained organelles and nuclei from other organisms (Delwiche, 
1999).  Genes from these captured genomes are thought to be transferred over time to 
the host nucleus until the acquired nucleus is reduced to a point where it is entirely 
lost (thus “horizontal” gene transfer as opposed to direct inheritance of genes which is 
“vertical” gene transfer).  Direct physical evidence for this kind of endosymbiosys can 
also be found in other stramenopiles, namely the diatoms.  Diatoms possess four 
membranes around their plastids.  It is believed that a diatom ancestor engulfed and 
retained another eukaryote which already possessed a plastid from a primary 
endosymbiotic event (like a red or green algae which is thought to have engulfed and 
retained a creature reminiscent of a cyanobacterium).  The inner two of the four 
membranes around the diatom plastid would correspond to the original plastid of the 
captured eukaryotic endosymbiont, and the outer two membranes would correspond 
to the host vacuole membrane and the captured endosymbiont’s outer membrane (for 
review see: Round et al., 1990).  Dinoflagellates have three membranes around their 
plastids but they are thought to have acquired plastids via a tertiary, rather than a 
secondary, endosymbiotic event (Yoon et al., 2002). 
 The question of whether the Schizochytrium PUFA-PKS was acquired through 
this kind of horizontal transfer, or through a simpler mechanism such as a viral 
infection or endocytosis of dead cell material, can only be addressed through formal 
phylogenetic analysis.  In any case, it seems most likely that the genes of the classic 
pathway in both Schizochytrium and C. cohnii were likely present in their ancestors 
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before they acquired the PUFA-PKS.  As a result, the stable presence of the new 
PUFA-PKS should have weakened selective pressure to retain enzymes of the classic 
pathway.  If the organisms required PUFA to live (which they do, as evidenced by the 
observed auxotrophies) and preferred DHA above all other PUFA (which they seem 
to), then the selective pressure on the classical pathway might hypothetically manifest 
as a gradient, where desaturases and elongases responsible for catalyzing reactions 
farthest from the DHA product would have the least selective pressure, and those 
enzymes catalyzing reactions leading more directly to DHA would have the most 
selective pressure for retention.  If so, then this may explain the early position of the 
observed lesions in the classical pathway of both organisms.  Also, if C. cohnii and 
Schizochytrium evolve at similar rates, one could additionally infer that the 
acquisition of a PUFA-PKS occurred relatively earlier in C. cohnii than in 
Schizochytrium, since Schizochytrium has a classical pathway that is closer to being 
“complete”.  This may also explain why the PUFA-PKS system in Schizochytrium 
was so easily identified by primary sequence similarity alone.  If such a system has 
indeed been harbored by C. cohnii longer, it may have diverged too much in primary 
sequence to be confidently identified by comparison to known PUFA-PKS systems, 
leaving open the possibility that the sequences identified in this study could be 
involved in PUFA biosynthesis, despite their lack of obvious primary sequence 
similarity to known PUFA-PKS systems. 
 Other than premature release of fatty acids from a PUFA-PKS, some selective 
pressure to retain those enzymes of the classic pathway which are proximal to DHA 
could also come from fastidiousness for simple PUFAs these organisms might find in 
marine animal waste or decaying algae in their environment.  Any organism that 
requires DHA to survive will be more fit if it can convert suitable, exogenous fatty 
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acids to DHA, whenever found.  Of course, this argument is based on the assumption 
that these conversions are mediated by elongases and desaturases and that the PUFA-
PKS systems can not efficiently accept PUFAs simpler than DHA as substrates. 
 FAS and PKS systems are generally not thought to accept fatty acids as 
substrates.  However, as previously mentioned Toke and Martin (1996) reported that 
yeast FAS was capable of elongating 14:0 and 16:0 to 18:0.  Also, some species of 
mycobacteria have a type II FAS that only accepts fatty acids of lengths between 12:0 
and 16:0 (inclusive) as precursors to fatty acids containing 40 carbons or more 
(Qureshi et al., 1984, for review see: Schweizer and Hofmann, 2004).  And as a final 
exception, the apicomplexan Cryptosporidium parvum expresses a large type I FAS 
which appears to accept 16:0 as a precursor for the manufacture of 22:0 (Zhu et al., 
2004).  While it is possible that the PUFA-PKS systems of Schizochytrium and C. 
cohnii are performing some of the observed classical pathway conversions at a low, 
non complementing level, it is unlikely, as the Schizochytrium ORF A disruption 
mutant (which does not transcribe any of the ACP domains required for condensation 
steps) can still convert EPA to DPA n3 (Table 2.2) and C. cohnii PUFA auxotrophs 
are capable of all the same free fatty acid conversions as wild type (Table 4.2). 
 With that said, there was one observed instance in this study where the 
putative C. cohnii PUFA-PKS may have accepted a simpler PUFA as a precursor to a 
more complex PUFA.  A single unknown peak was found in radio-HPLC traces of 
FAMEs from cultures of C. cohnii strains KO (wild type) and KO-18 (a PUFA 
auxotroph) equilibrium labeled with either DHA or DPA n6.  This peak did not elute 
in the same position as any of the available standards but it did migrate in a range 
similar to that calculated for 28:8 (Figure 6.1).  If this peak truly was 28:8, it is 
probably not being made by the classical pathway as no other peaks representing 
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Figure 6.1.  Radio-HPLC chromatogram of FAMEs derived from a wild type C. cohnii 
culture equilibrium labeled with 1-[14C]-DHA.  The peak corresponding to DHA is labeled as 
“22:6” and the unknown peak which may correspond to 28:8 is labeled “?”.  Peak intensities 
are plotted in counts per minute (cpm) versus time in minutes.  Peak area percent values are 
presented in Table 4.2. 
 
  210
predicted intermediates were detected.  It seems equally unlikely that it was made by 
the putative PUFA-PKS responsible for DHA biosynthesis as the conversion was also 
observed in the C. cohnii PUFA auxotroph KO-18, which presumably has lost this 
PUFA-PKS function (Table 4.2).  It also does not seem likely to be a product of β-
oxidation and re-incorporation of label, again as no other peaks (corresponding to 
16:0 and 18:1, for example) are detected.  This raises the possibility that C. cohnii 
may have yet another system, specifically for the formation of 28:8 from DHA. 
 While it is presumed that C. cohnii has a PUFA-PKS system for making DHA 
and that some of the genes described in Chapter 5 encode this PUFA-PKS, the 
possibility remains that these genes encode proteins unrelated to PUFA biosynthesis.  
For instance, as defensive agents, many dinoflagellates produce polyketide toxins, 
which are made by PKS systems.  C. cohnii has never been known to produce a toxin.  
However, it may make some relict, related polyketide product for some other 
unknown purpose.  It is also possible that C. cohnii may possess a discreet system for 
the biosynthesis of mitochondrial lipoic acid.  Sequences similar to lipoic acid 
synthases were not found among the C. cohnii ESTs.  However, considering the 
possibility that lipoic acid might be synthesized by a divergent, short-chain FAS, 
TargetP analysis (which predicts subcellular localization of proteins based on their N-
terminal amino acid sequence) (Emanuelsson, et al., 2000, Nielsen et al., 1997) of all 
the C. cohnii genes with similarity to FAS and PKS domains was conducted.  No 
organelle-specific target sequences were identified.  Even though this program did 
detect organellar signal sequences for several “control” C. cohnii sequences (ATP 
synthase α-subunit for mitochondria, catalase for peroxisome, lumen binding protein 
(BiP) for endoplasmic reticulum, and β-tubulin for cytoplasm) it should be noted that 
these programs are not trained on dinoflagellate sequences and may not be reliable for 
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this purpose.  For example, when TargetP was used to search for a targeting signal in 
ELO4 with the “plant” algorithm, it identified a plastid targeting sequence (data not 
shown).  When the “non-plant” algorithm was used, TargetP identified a secretory 
signal in ELO4 with higher confidence.  Because ELO4 is most similar to microsomal 
elongases from other organisms, the latter prediction seems the most likely.  TargetP 
was also used to detect any potential plastid targeting sequences among the FAS- and 
PKS-similar sequences in the event that C. cohnii possesses a degenerate plastid as a 
locale for fatty acid biosynthesis, analogous to the apicomplexans (Kohler et al., 
1997).  No plastid targeting sequences were identified either.  Hydropathy plot 
comparisons of the N-terminal sequences of the C. cohnii conceptual proteins 
discussed in Chapter 5 to putative C. cohnii plastid targeting signals identified by 
Sanchez-Puerta et al. (2006) were also inconclusive. 
 The similarity of the identified KS domains to type I systems of 
apicomplexans may be worth additional consideration.  By molecular phylogenetic 
analysis, the apicomplexan parasites such as Plasmodium, Cryptosporidium, and 
Toxoplasma all form a sister group with the dinoflagellates and by certain analyses 
may actually be considered a sub-group of the dinoflagellates (Fast et al., 2001).  
Most of the apicomplexans possess a degenerate plastid, dubbed an “apicoplast”, 
which is thought to be a remnant of a plastid from an ancestor which may not have 
been unlike modern photosynthetic dinoflagellates (Kohler et al., 1997).  In a typical 
apicomplexan such as Plasmodium, components of a type II fatty acid synthase are 
targeted to the apicoplast in a manner similar to that observed with all other 
photosynthetic eukaryotes (Waller et al., 2000).  This type II system then provides the 
parasite with its needs for fatty acids such as palmitate (Zhu et al., 2004).  An 
exception to this model is found in Cryptosporidium, which seems to have lost its 
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apicoplast entirely, and along with it, a capacity to synthesize fatty acids de novo.  
Instead, it acquires fatty acids from the host’s diet or the host’s intestinal epithelium, 
onto which it forms an extracellular parasitophorous vacuole to inhabit.  After 
acquiring palmitate from the host, the parasite may elongate it with a giant type I FAS 
system, to 22:0 (for review see: Zhu, 2004).  Lastly, Toxoplasma appears to possess 
both an apicoplast-targeted type II system for de novo synthesis of typical fatty acids 
and a Titanic type I system for further elongation of the type II FAS products 
(Crawford et al., 2003). 
 As previously discussed, the KS domains of C. cohnii are most similar to the 
KS domains of both the Toxoplasma and the Cryptosporidium type I FAS systems.  
This may not be particularly surprising in that KS domains usually form clades which 
reflect general phylogeny.  However, the transcripts encoding the KS domains of C. 
cohnii do not appear to encode any other obvious domains, and thus would seem to be 
members of a type II, multi-subunit FAS or PKS system despite their similarity to 
type I systems.  Unlike their KS domains, the AT domains of the Cryptosporidium 
type I system do not follow typical phylogenetic patterns and instead form a 
monophyletic clade between bacterial type I PKS and bacterial type II FAS systems 
(Zhu et al. 2002).  The most interesting revelation from these phylogenetic analyses is 
that the AT domain of the Schizochytrium PUFA-PKS falls directly between the 
clades of Cryptosporidium AT domains and those of the aforementioned bacterial 
type II FASs.  Zhu et al. qualify the suggestion of a relationship between the C. 
parvum AT domains and the bacterial type II systems (and by correlation, the 
Schizochytrium PUFA-PKS) by noting that, in their trees, the branch separating the 
bacterial type II systems (and the Schizochytrium PUFA-PKS) is very long, and that 
additional data will be required to firmly establish a relationship. 
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